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Metastasis, or the process by which cancer cells escape a primary tumor and travel 
through the body to form secondary tumors, is believed to be responsible for over 90% 
of the 7.9 million annual cancer-related fatalities reported worldwide. To migrate from 
the original tumor, cancer cells must navigate an extremely dense and heterogeneous 
stromal environment to arrive at a blood or lymph vessel, which they can then 
penetrate to enter the circulatory or lymphatic system. Each of these steps requires 
cells to pull on its matrix using contractile, or traction, forces. However, the precise 
relationship of force generation to metastatic cell structure and function remains 
largely unknown. 
 
Herein, I demonstrate that metastatic cells exert increased contractile forces 
which facilitate the invasion of the extracellular microenvironment (ECM). Using 
traction force microscopy, I show that human metastatic breast, prostate, and lung 
cancer cell lines exhibit increased traction stresses compared to non-metastatic 
counterparts on physiologically-relevant substrates. Additionally, I find that the 
increased collagen density and matrix stiffness previously shown to be a hallmark of 
the tumor microenvironment promote increased traction forces through cell spread 
area-dependent and independent mechanisms. Finally, I develop a novel 3D model for 
one mode of metastatic migration in which secondary cancer cells follow microtracks 
that are formed by leading tumor cells secreting proteases and cleaving ECM fibers. 
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By using physiologically relevant 3D collagen channels to study cancer cell migration, 
I specifically assessed the role of force in protease-independent migration, and, 
surprisingly, found that contractile force was dispensable for this form of protease-
independent migration. Instead, my results point to focal adhesion, actin filaments, and 
microtubules being key mediators of protease-independent migration within patterned 
collagen microtracks. Ultimately, these studies help to define the role that cellular 
force generation plays in metastatic invasion, and also yield insight into the 
biophysical mechanisms that tumor cells use to migrate. These insights could 
potentially lead to a targeted therapeutic approach to combating those mechanisms to 
delay or prevent metastasis and its subsequent fatal damage.  
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CHAPTER 1 
INTRODUCTION 
 
Portions of this chapter were published as a book chapter titled “Quantifying Traction 
Stresses in Adherent Cells” in Methods in Cell Biology (Kraning-Rush et al., 2012b) 
and also as a review titled “Controlling Matrix Stiffness and Topography for the Study 
of Tumor Cell Migration” in Cell Adhesion & Migration (Kraning-Rush and Reinhart-
King, 2012).  
 
1.1 Introduction to Cancer Cell Migration: A Biophysical Approach 
Of the 7.9 million cancer-related fatalities reported every year worldwide, over 90% 
are believed to be the result of metastatic disease (Christofori, 2006), in which a subset 
of cells from the original tumor spread throughout the body. Although advances have 
been made in the treatment of primary tumors through surgery, chemotherapy and 
radiation treatment, methods for effectively diagnosing the likelihood of metastasis or 
treating the disease after it has reached this stage remain elusive (Steeg, 2006). Despite 
its link to poor prognosis, there are no direct clinical tests available to definitively 
diagnose the metastatic potential for a given tumor (Steeg, 2006). While advances in 
genetic profiling have led to the generation of several multi-gene expression signatures 
for predicting clinical prognosis of specific cancers (Ramaswamy et al., 2003; Sotiriou 
et al., 2003), these signatures have not yet shown broad applicability to a wide range 
of patients, whose tumors display great heterogeneity both across patient populations 
and within a single patient (Gerlinger et al., 2012). Additionally, while these 
signatures may statistically correlate with poor clinical prognosis, they do not provide 
information on the physical attributes of the tumor cells which may contribute to 
metastatic invasion. However, though a single gene expression signature may not 
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function across a broad pool of patients, different alterations in gene expression 
patterns may result in similar phenotypic changes at the cellular level which result in 
invasive behavior. As such, the biophysical characteristics of tumor cells may be an 
excellent target both for determining patient prognosis and also for designing targeted 
therapies. 
 
To understand how the biophysical properties of tumor cells can affect invasion, it is 
important to fully characterize the physical mechanisms employed by metastatic 
cancer cells to invade. During metastasis, cells from the primary tumor acquire 
characteristics that enable them to escape and migrate through a heterogeneous 
stromal environment to establish secondary tumors. By no means a static system, as a 
tumor develops, the cancer cells within experience a wide range of effects, including 
increased matrix stiffness as the extracellular matrix (ECM) becomes highly cross-
linked and irregular (Lopez et al., 2011; Paszek et al., 2005), increased ligand density 
as tumor cells begin to secrete greater amounts of matrix proteins such as collagen or 
fibronectin (Ioachim et al., 2002; Levental et al., 2009), decreased or erratic exposure 
to oxygen caused by an irregular and leaky vasculature (Harris, 2002), and elevated 
interstitial pressure caused by increased proliferation within a confined environment 
(Tse et al., 2011). These often harsh conditions can have a profound phenotypic and 
epigenetic effect on these cancer cells, often leading to the generation of a highly 
invasive subpopulation capable of metastasizing. Moreover, to successfully navigate 
this dynamic microenvironment, metastasizing tumor cells must reorganize the 
basement membrane, invade into surrounding stroma (Rosel et al., 2008; Wolf et al., 
2007),  migrate along ECM fibers (Provenzano et al., 2008b; Wyckoff et al., 2006) 
and transmigrate through the endothelial cell barrier (Mierke et al., 2008b) to enter the 
circulatory or lymphatic system. In addition to enzymatically degrading the ECM with 
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matrix metallo-proteinases (MMPs), metastatic cells use contractile forces to 
mechanically rearrange their ECM to clear an open path for subsequent migration 
(Wolf et al., 2007). Because force generation plays a central role in several of these 
key behaviors, I focus on it here as a potential phenotypic marker of metastatic 
potential and further elucidate the specific role it plays during metastasis. 
 
In this chapter, I will first examine the use of cellular force in non-pathological cell 
behaviors and detail different methods for quantifying contractile force generation, 
while emphasizing the role that matrix stiffness plays in mediating these forces. Next, 
I will discuss previous research regarding cellular forces during disease progression, 
particularly in relation to cancer. Finally, I will illustrate the importance of translating 
these findings into a more physiological context by describing work done to mimic the 
native 3D architecture of the tumor and analyzing the role which force generation 
plays in different invasion mechanisms within this complex 3D microenvironment, 
with specific reference to the formation and migration within proteolytic microtracks. 
 
1.2 Cellular Force Generation in Cell Migration 
Cellular traction forces have been shown to drive cell adhesion (Reinhart-King et al., 
2003), spreading (Reinhart-King et al., 2005), migration (Dembo and Wang, 1999; 
Pelham and Wang, 1997), and extracellular matrix (ECM) deposition and remodeling 
(Lemmon et al., 2009). To migrate, a cell must undergo changes in cellular force 
production to modify both its shape and its internal tension to interact with the 
surrounding ECM, which provides both a substrate for the cell to adhere to as it moves 
forward, but also a barrier through which the cell must advance (Ehrbar et al., 2011). 
In most adherent cells, forward movement is initiated by actin polymerization, causing 
a pseudopod to extend from the leading edge of the cell. Cell extensions interact with 
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the surrounding ECM and initiate binding through transmembrane integrin receptors, 
forming focal complexes and focal adhesions (Hynes, 2002). 
 
Cell-matrix adhesions vary greatly in size, shape, and complexity, with over 100 
proteins estimated to play a role in their formation and dissociation (Fraley et al., 
2010; Parsons et al., 2010). One of the most important classes of adhesion proteins are 
integrins. Integrins are heterodimeric transmembrane proteins which exist in 24 
different configurations and bind to specific extracellular matrix proteins. Upon 
binding the extracellular matrix, integrins experience a conformational change in their 
intracellular tail domain which facilitates binding to the actin cytoskeleton through 
various linker proteins, including talin and vinculin (Wozniak et al., 2004). As 
integrins become connected to the actin cytoskeleton, other focal adhesion proteins are 
recruited to the complex, including scaffolding proteins such as paxillin and zyxin, 
and adaptor proteins, such as focal adhesion kinase (FAK) and p130Cas, which can 
further associate with additional signaling molecules and activate various pathways. In 
particular, the Rho/ROCK signaling pathway can be activated in this manner. This 
complex pathway consists of the Rho-family small guanosine triphosphatases 
(GTPases), including Rac, Rho, and Cdc42, which are regulated by the dynamic 
behavior of guanine nucleotide exchange factors (GEFs), which activate the Rho-
family GTPases by associating them with GTP, and GTPase-activating proteins 
(GAPs), which inactivate the GTPases by hydrolyzing GTP to GDP (Amano et al., 
2010). These GTPases subsequently regulate adhesion assembly and disassembly, thus 
controlling actomyosin contractility and cellular migration. For example, Rho will 
associate with its effector protein, Rho-associated kinase (ROCK) to control the 
activity of myosin via two distinct mechanisms. First, it will inactivate myosin light 
chain (MLC) phosphatase, thus inhibiting the dephosphorylation of MLC and 
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resulting in increased levels of phosphorylated MLC and thus increased contractility. 
Second, it can also phosphorylate MLC directly to enhance actomyosin contractility 
(Amano et al., 2010). Contractile force caused by actomyosin contraction generates 
both intracellular tension and extracellular tension transmitted to the substrate, 
ultimately causing the cell’s posterior focal adhesions to release and allowing the cell 
to move forward (Lauffenburger and Horwitz, 1996). While the signaling mechanisms 
and adhesion complexes present during 2D migration are well-characterized, their role 
in cell migration within 3D matrices is less clear. Recent studies indicate that classical 
focal adhesions are less prominent in 3D, and the proteins involved in their assembly 
and disassembly in 2D play different roles and have differing degrees of importance in 
regulating 3D cell migration (Fraley et al., 2012; Fraley et al., 2010). 
 
During migration, changes in the cytoskeleton alter cell-matrix dynamics and cellular 
force generation. Indeed, contractile force generation is intimately connected to the 
stiffness of the extracellular matrix either beneath the cell (i.e. on 2D substrates) or 
surrounding the cell (i.e. incorporated within 3D matrices). Stiffness within the human 
body varies greatly, ranging from very soft environments, such as those found in the 
brain (Young’s Modulus, E = ~250-500 Pa) (Miller et al., 2000) or in adipose tissue (E 
= ~20 Pa) (Wellman et al., 1999), to significantly more rigid environments, such as 
articular cartilage (E = ~950 kPa) (Freed et al., 1997) or rigid bone (E = ~GPa) (Zysset 
et al., 1999). Cells are able to detect and respond to changes in mechanical properties 
through the network of focal adhesion proteins discussed above, which act as 
mechanotransducers by linking the actin cytoskeleton to the ECM (Geiger et al., 
2009). Increased 2D matrix stiffness is associated with an increase in focal adhesion 
size and number (Engler et al., 2004), increased Rho activation (Huynh et al., 2011), 
and the formation of well-defined actin stress fibers (Yeung et al., 2005), which can all 
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contribute to increased migration. Because migration is fundamental to many essential 
biological processes including development, immune response, inflammation, and 
wound healing, and because cells must exert force to migrate, many groups have 
described methods to characterize force generation of adherent cells (Dembo and 
Wang, 1999; du Roure et al., 2005; Galbraith and Sheetz, 1997; Harris et al., 1980; 
Tan et al., 2003), and several of these will be discussed in the next section.    
 
1.3 Techniques for Quantifying Cellular Force Generation 
The earliest technique used to describe the traction forces exerted by cells was 
developed by Harris and colleagues in the 1980s. In this landmark paper, cells were 
seeded on top of an elastomeric silicone rubber substrate (Harris et al., 1980). As the 
cells adhere and migrate, they generate wrinkles within the substrate during 
contraction. While both the cells and the wrinkles they produced were easily 
visualized, it was difficult to extract out quantitative information regarding the cellular 
forces as the wrinkles were typically nonlinear and irregularly shaped. Therefore, 
although informative as a probe of cellular forces, this technique yielded only semi-
quantitative data in the form of number and length of wrinkles (Harris et al., 1981). In 
later work using wrinkling substrates, cellular force data was extracted by using 
flexible microneedles to exert a known force onto the substrate, reversing the wrinkle 
caused by the cell (Burton and Taylor, 1997).  
 
Building upon the work pioneered by Harris et al., in the early 1990s the idea of 
observing and measuring bead displacement in an elastic substratum, rather than 
wrinkles, was introduced. A thin layer of latex beads was airbrushed over a non-
wrinkling elastic film created by crosslinking silicone oil to the sides of a rigid vessel. 
This created a tightly stretched film upon which cellular forces transmitted to the 
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surface could be more directly detected through bead displacements (Lee et al., 1994; 
Oliver et al., 1995). This technique had the advantage of being more sensitive than the 
silicone rubber wrinkling technique, in that relatively small forces (~20 nN) could be 
detected based on bead movements. Additionally, the silicone oil could be cross-
linked to varying degrees to produce a range of substrate moduli. However, this 
approach did suffer from some limitations. For instance, more compliant silicone 
substrates were unable to completely recover from cellular deformation (Lee et al., 
1994). Moreover, these substrates were non-porous and poorly adhesive, and their 
mechanical properties could not be sufficiently tuned to match the strength of the 
majority of mammalian cell types (Dembo and Wang, 1999). 
 
These limitations were overcome in the late 1990s with the advent of polyacrylamide 
(PA) hydrogels as a substrate on which to plate cells (Brandley et al., 1987; Wang and 
Pelham, 1998). The mechanical and chemical properties of PA gels are ideal for the 
study of cellular forces. First, similar to the earlier generation of silicone films, PA 
gels are optically transparent, allowing cells cultured on them to be easily imaged, and 
they can also have fluorescent markers embedded into them, allowing the user to 
measure deformations caused by cell migration using standard fluorescent 
microscopy. More importantly, PA gels are elastic and will deform in direct 
proportion to a broad range of applied force. Once this force is removed, PA gels 
immediately and reproducibly recover to an unstressed conformation. PA gels have 
also been utilized to study the effects of stiffness on a wide variety of cell behaviors, 
including, but not limited to, proliferation (Brown et al., 2010; Klein et al., 2009), 
adhesion (Jannat et al., 2010; Willcox et al., 2005), migration (Isenberg et al., 2009; 
Lo et al., 2000; Peyton and Putnam, 2005), differentiation (Engler et al., 2006; 
Trappmann et al., 2012), matrix degradation (Alexander et al., 2008), network 
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formation (Califano and Reinhart-King, 2008), cell-cell and cell-matrix interactions 
(Califano and Reinhart-King, 2008; Califano and Reinhart-King, 2010b). PA gels are 
ideal for these studies because stiffness can be precisely tuned simply by varying the 
ratio of monomer (acrylamide) to cross-linker (bis-acrylamide) to achieve a Young’s 
modulus (E) in the range of tens of pascals to hundreds of kilopascals (Kraning-Rush 
et al., 2012b; Yeung et al., 2005). Additionally, PA gels can be functionalized using 
any protein or amino acid fragment of interest, and the concentration of this protein 
can be held constant, independent of the gel stiffness. PA gels are also nontoxic and 
create a more physiologic environment than glass or PDMS for short term culture of a 
wide variety of adherent mammalian cell types (Wang and Pelham, 1998).  
 
The polyacrylamide system was rapidly adapted for use in quantifying the traction 
forces of adherent cells by Dembo and co-workers, giving rise to the technique of 
traction force microscopy (TFM), which is the primary technique used by our lab to 
quantify cellular force (Dembo and Wang, 1999).  
 
Traction Force Microscopy 
Traction force microscopy (TFM) is a technique that allows for the precise 
quantification of traction stresses generated by cells adherent to an underlying two-
dimensional substrate, most often a PA gel, as described above (Dembo et al., 1996). 
As cells adhere to and migrate over sufficiently compliant substrates, traction forces 
generated by the cell create deformations. These deformations are detected by the 
inclusion of markers (usually sub-micron diameter fluorescent beads) within the PA  
gel that relax back to their original position when the cell is either released chemically 
from the substrate (e.g. with trypsin) (Fig 1.1A-B), or when it migrates away from the 
field of interest during a time-course study. Because this technique relies on the cell’s 
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Figure 1.1. Traction force microscopy is used to quantify traction forces in 2D. 
MDA-MB-231 cells were seeded onto a polyacrylamide substrate (A). To quantify 
traction forces, fluorescent images are acquired of the bead field beneath the cell 
during force generation (B, red) and after the cell has been released with trypsin (B, 
green). An overlay of these two images indicates the regions of greatest bead 
displacement (inset, white arrow). To calculate the most likely traction field causing 
the observed bead displacement, the cells is first discretized into a mesh (C). 
Individual tractions are then calculated for each node of the mesh (D).  From these 
tractions, a color contour plot can be generated indicating regions of highest and 
lowest traction forces (E). Scale bar = 50 m.  
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ability to deform its substrate by a detectable amount, the range of substrate stiffness 
testable using TFM is inherently limited. While there is considerable variation 
between the strength of different cell types, TFM may have an upper limit of E ~ 10-
30 kPa. Above this range, the displacement of fiduciary markers is typically 
negligible.  
 
Experimentally, calculation of the substrate strain field requires images of the bead 
field in both its stressed state (with the cell present) and relaxed state (without the 
cell). The image of the beads in their relaxed state is typically captured after the cell is 
removed and the beads in the field of view have returned to their “unstressed” position 
due to the elastic nature of the PA gel substrate. The displacements caused by the cells 
are computed by comparing the stressed and relaxed images of the bead field. The 
calculation of traction forces is based on the Boussinesq equations, which describe the 
relationship between the deformation of a material due to forces applied to its free 
surface (Landau et al., 1986). In this regard, the elastic PA gel substrate is assumed to 
be a uniform and isotropic elastic material, and it is assumed that the inclusion of 
marker beads in the substrate does not perturb this elastic behavior. Additionally, the 
external loads acting on the substrate surface are assumed to be solely tangential, thus 
satisfying a condition of plane stress (this assumes that the normal and shear stress 
components in the z-direction are negligible or zero). Therefore, because compliant 
substrates may not adequately support the weight of adherent cells and will allow 
significant bead displacement in the z direction, violating the plane stress 
approximation, TFM has a lower limit of ~1 kPa. 
 
Substrate deformations are calculated based on the movements of beads embedded 
within the PA gel substrate.  While it is possible, in theory, to map individual bead 
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movements by hand, this would be cumbersome.  To automate this process, Marganski 
et al developed an algorithm based on correlation-based optical flow, which has been 
refined since it original description (Marganski et al., 2003). This algorithm takes two 
images (the stressed and relaxed bead field images described above) as the input. Bead 
tracking is done by systematically scanning all pixels in the null image to find the 
pixel coordinates of the fluorescent beads (identified as strict pixel intensity maxima 
after image intensity normalization). For each bead that is tracked, a box of pixels 
centered on the local maximum intensity pixel is defined and the relative pixel 
intensities in that box serve as a ‘fingerprint’ for the tracked bead. This search box is 
used to determine the coordinates of the corresponding ‘fingerprint’ in the stressed 
image. This process is iterated for every pixel in the image and is able to determine the 
bead displacements with sub-micron resolution.  
 
Once the substrate deformations have been properly mapped, the calculation of 
traction stresses is solved as an inverse problem, meaning that the measurements of 
substrate deformation are used to statistically compute the most likely traction stress 
field that will give rise to the observed deformations (Fig 1.1C-D). TFM solves the 
problem using the formulas original described by Boussinesq for a point force acting 
on an elastic half-space (Landau et al., 1986). Specifically, the displacement d of the 
pth bead marker is related to the traction field (T) by Eq. (1.1), 
                                         (1.1) 
where           represent the coefficients of a Green’s tensor that give the 
substrate displacement in the  direction at location m induced by a force in the  
direction acting at location r (Dembo and Wang, 1999).   The functions for the 
coefficients of the Green’s tensor incorporate both the Poisson’s ratio and Young’s 
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modulus (E) of the polyacrylamide substrate (Dembo and Wang, 1999). Importantly, 
the E is a parameter which can be determined experimentally (Lo et al., 2000). 
 
To ensure the existence of such an integral relationship, it is sufficient that the traction 
field satisfy a constraint of global force balance. The traction field is thus derived from 
numerical integrals computed over the mesh to determine the maximum likelihood 
tractions based on the displacement field. These tractions are tied to chi-square and 
Bayesian statistics that iterate until convergence. Once solved, the magnitude and 
direction of traction forces, and other parameters including the bead displacement 
vector field and strain energy density field may be examined (Fig 1.1D-E). For many 
cells types, the magnitude of traction forces is on the order of ~0.05-2 N (Califano 
and Reinhart-King, 2010a; Gaudet et al., 2003; Paszek et al., 2005; Reinhart-King et 
al., 2003). Others have used a similar experimental system (PA gels embedded with 
fluorescent beads), but have solved the inverse problem using Fourier's method to 
solve the general equations of equilibrium relating displacements to tractions (Butler 
et al., 2002).  
 
TFM has been widely utilized to study the specific mechanisms by which cells use 
force to migrate. Performing TFM on cells while manipulating the actomyosin 
cytoskeleton has revealed that actin stress fibers are critical for the transmission of 
forces to the substrate (Kraning-Rush et al., 2011; Pelham and Wang, 1999). In a 
study by Kumar et al, a single actin stress fiber within a living cell was ablated using 
multiphoton laser nanoscissors, resulting in large scale cytoskeletal rearrangement, 
particularly on compliant substrates (Kumar et al., 2006). This study and others lend 
support to the tensegrity model of cellular architecture, wherein a network of 
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cytoskeletal elements maintains a prestress within the cell which drives its adhesion 
and migration behavior (Wang et al., 1993; Wang et al., 2001). 
 
Studies in fibroblasts have also revealed that traction forces tend to be spatially 
concentrated at the periphery of the cell, with little to no force being exerted beneath 
the nucleus of the cell. Force generation is also generally greater at the leading edge, 
or anterior of the cell, with weaker, more passive forces located in the posterior of the 
cell (Dembo and Wang, 1999; Munevar et al., 2001; Pelham and Wang, 1999). 
Interestingly, this trend is reversed in neutrophil migration, when forces are 
concentrated in the uropod of the cell during migration (Smith et al., 2007). 
Additionally, in fibroblast (Gaudet et al., 2003) and endothelial cell (Califano and 
Reinhart-King, 2010a; Reinhart-King et al., 2003) models, increasing the density of 
ECM protein conjugated to the surface of PA gels has been shown to increase both the 
spread area of cells and the magnitude of the force generated by these cells, although 
whether this phenomenon is driven by stronger cells spreading more or by larger cells 
inherently exerting greater forces remains an area of debate. Moreover, in this 
fibroblast model, the increase in force and area was also directly correlated to an 
increase in migration speed with increasing collagen density, suggesting that stronger 
traction forces drive increased cell motility (Gaudet et al., 2003). 
 
In addition to the widespread use in the study of mammalian cells described here, 2D 
TFM has also been used to study the forces generated by several other unique cell 
types, for example, during the unique single cell and multicellular stages in the life of 
the amoeba Dictyostelium discoideum (Delanoe-Ayari et al., 2008; Lombardi et al., 
2007), during migration of the malarial parasite Plasmodium berghei  in the stage after 
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it is injected into the host’s skin during a mosquito bite (Munter et al., 2009), and 
during the migration of fish keratocytes on compliant substrates (Lee, 2007). 
 
Alternative 2D Methods 
In addition to traction force microscopy, several other techniques have been developed 
to quantify traction forces during cell migration. In the late 1990’s, Galbraith and 
Sheetz developed a micro-machined device consisting of an array of lithographically 
patterned silicon cantilever pads coated with ECM protein (Galbraith and Sheetz, 
1997). This method allows for the quantification of isolated subcellular tractions, and 
as a result is quite sensitive, measuring forces on the order of single nN/m2. 
However, an individual cell can only depress a limited number of cantilevers at a time, 
limiting the spatial resolution of forces. Additionally, because the cantilevers can 
move in only one direction, they can only be used to quantify traction forces in that 
direction. For cells that do not cross the cantilever beam at a 90
o
 angle, forces are 
calculated based on the assumption that traction stresses are directed along only the 
long axis of the cell, which is not necessarily always valid (Califano and Reinhart-
King, 2010a; Dembo and Wang, 1999). Moreover, production of the device requires 
an elaborate fabrication procedure that requires specialized technology that may not be 
readily accessible for many labs. 
 
The most commonly used alternative to traction force microscopy is the use of 
microfabricated post array detection systems (mPADs) (du Roure et al., 2005; Tan et 
al., 2003). In this method, cylindrical microposts are fabricated out of 
polydimethylsiloxane (PDMS), and extracellular matrix protein is conjugated to the 
top of the posts to enable cell adhesion. Traction forces are based on the extent of 
deflection of the posts from their original position. Post deflection can then be linearly 
 33 
 
correlated to the local traction forces exerted by the cell using classical beam bending 
theory. In this system, the height of the micropost can be varied to adjust the rigidity 
of the posts, and thus to adjust the stiffness of the substrate sensed by the cell. Each 
post acts as an individual vertical cantilever, sensing force at a discrete location 
beneath the cell. Moreover, unlike the silicon cantilevers described above, mPADs are 
able to detect forces generated in all directions of the x-y plane. A more detailed 
description of the fabrication process and supporting theory and computation can be 
found elsewhere (Fu et al., 2010; Sniadecki and Chen, 2007; Yang et al., 2011).  
 
While elastomeric microposts offer several advantages over the original silicon 
cantilever system, there are several disadvantages that are important to note, especially 
when comparing this technique to PA gel-based traction force microscopy. First, there 
is considerable controversy over the appropriateness of culturing cells on a 
topographical landscape which is very distinct from the native environment of 
mammalian cells. mPADs restrict adhesions to distinct circular patches, imposing 
arbitrary constrictions on the size, shape, and location of focal adhesions, thus 
controlling where and how the cell transmits force (Yang et al., 2007). While this 
system has been used to elegantly determine the amount of force that individual focal 
adhesions can exert (Fu et al., 2010), it remains unclear how these calculations relate 
to the forces actually transmitted in the native physiological environment. 
Additionally, while the elastomeric posts may be more easily fabricated than the 
silicon cantilevers, and protocols have been published describing this process in great 
detail (Yang et al., 2011), an advanced microfabrication facility is still required to 
reproducibly fabricate the posts. PA gels, on the other hand, are easily produced using 
standard laboratory chemicals and equipment. 
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Another significant limitation of mPAD technology is the lower limit of E that can be 
produced. Posts have been successfully fabricated with a lower limit of E ~ 1.5 kPa 
(Fu et al., 2010), which is considerably higher than that of PA gels (E ~ 0.1 kPa), 
although it should be fairly noted that performing traction force microscopy on PA 
gels of E < 1 kPa has its own limitations. PA gels can also be used to examine the 
effect of mechanical communication of multiple cells through the underlying substrate 
(Califano and Reinhart-King, 2010a; Reinhart-King et al., 2008), a technique that 
could not be done using microposts, which effectively isolate cells from one another. 
On the other hand, the ability to mechanically isolate cells can be advantageous. For 
example, microposts were recently used to determine specific point forces at cell-cell 
junctions (Liu et al., 2010). In summary, elastomeric microposts and PA gels each 
have their own distinct advantages and disadvantages which must be considered when 
determining the appropriate system to use for quantifying traction forces in a given 
experiment. 
 
3D Force Generation 
While traction forces have been well characterized in 2D, very few cells exist 
physiologically in a strictly 2D environment. Rather, most cells reside in a fully 3D 
environment, surrounded by a fibrous and spatially complex extracellular matrix. 
However, the nature of processes known to be governed by traction forces, such as 
adhesion, migration, ECM deposition and remodeling, has been shown to be 
drastically altered in 3D compared to 2D. For example, when cells are embedded 
within a 3D collagen matrix, focal adhesions become smaller, often below the 
detection limit of conventional microscopy (Fraley et al., 2010). However, despite the 
apparent absence of classical focal adhesions, focal adhesion proteins still govern 
adhesion and motility in 3D by controlling protrusive behavior and matrix 
 35 
 
deformation (Fraley et al., 2012; Fraley et al., 2010), two behaviors unimportant in 
controlling 2D migration. Additionally, the composition and regulation of these 
adhesions are significantly altered in 3D.  
 
As in 2D, cell migration in 3D is partially governed by cellular force generation and 
matrix stiffness, although the connection and regulation of these aspects is much more 
complex and difficult to clearly elucidate (Dikovsky et al., 2008; Fraley et al., 2010; 
Mierke et al., 2008a; Zaman et al., 2006). Unlike 2D migration, cell migration in 3D is 
considerably restricted, controlled in large part by the pore size of the surrounding 
matrix (Carey et al., 2012; Wolf et al., 2003). While it is unclear what the precise role 
of force generation is in governing 3D cell motility, it is known that cells are able to 
exert force and contract a 3D matrix. There are a variety of techniques that have been 
developed to quantify single cell traction stresses within in vitro 3D 
microenvironments, typically relying on tracking either beads, as in a 3D analog of 2D 
traction force microscopy (Fraley et al., 2010; Shih and Yamada, 2010), or on tracking 
structural components of the matrix (Friedl et al., 1997; Kim et al., 2006) as the cell 
migrates in 3D.  
 
The most common technique for mapping 3D traction forces is to track the 
displacement of fluorescent beads which have been embedded in a 3D matrix. There 
are two primary challenges this to this technique. First is the difficulty inherent in 
tracking bead displacement in three dimensions. This cannot be done reliably using 
traditional phase or epifluorescent microscopy, but rather requires rapid scanning 
confocal microscopy to precisely localize the beads in relation to the cell boundary 
with spatial accuracy in three dimensions.  Second is the challenge of the matrix itself. 
Traditional 2D techniques require that the mechanics of the matrix be well-
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characterized and isotropic. However, the native physiological environment in which 
cells normally reside is anything but isotropic. Rather, it is known to be extremely 
heterogeneous in terms of both chemical and mechanical composition. Synthetic 
hydrogels can be created which are mechanically isotropic, but which lack the fibrous 
nature of the native environment. For example, Legant et al. have developed an 
isotropic PEG hydrogel which they have used to calculate traction stresses of 
individual cells in 3D, finding that fibroblasts can exert forces up to 5 kPa, with forces 
primarily localized at polarized cell protrusions (Legant et al., 2010). This study 
represents one of the most thorough quantitative descriptions of traction forces in 3D 
to date, and is an excellent starting point for future work. However, the fibrous nature 
of the ECM cannot be ignored, as it imparts complex mechanical and chemical 
properties to the ECM, and is a critical determinant of cell behavior both in vivo and in 
vitro. An isotropic matrix which lacks fibrous architecture may not induce analogous 
force behavior in cells 
 
To this end, other studies have translated changes in the native dynamic architecture of 
a fibrous ECM into quantifications of cellular forces. The use of a fibrous ECM 
permits native cell behaviors including ECM deposition, ECM remodeling and 
crosslinking, proteolytic path making and following. Additionally, because of the 
difference in refractive index between fibers and the surrounding media, the ECM 
fibers can be imaged using confocal reflectance microscopy. Therefore, interactions 
between individual cells and individual matrix fibers can be tracked in real time, 
allowing ECM reorganization to be used to describe cellular force generation in 3D 
environments both qualitatively and quantitatively.  
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1.4  Matrix Stiffening and Force Generation in Disease States 
Matrix stiffness is altered during the progression of multiple diseases, including cancer 
(Levental et al., 2009; Paszek et al., 2005) and cardiovascular disease (Huynh et al., 
2011), which together account for over 50% of fatalities in people over the age of 65. 
For example, during both aging and atherosclerosis, blood vessels stiffen dramatically, 
a phenomenon which has been shown by Huynh et al. to destabilize endothelial cell-
cell contacts (Califano and Reinhart-King, 2008) and increase vascular permeability,  
further promoting atherogenesis (Huynh et al., 2011; Krishnan et al., 2011). While this 
study focused on the mechanisms of atherosclerotic progression, one could speculate 
from their results that the observed increase in permeability of blood vessels on stiff 
substrates could also have profound implications for tumor vasculature. It is well 
established that tumor vasculature is generally highly disorganized and leaky, which 
causes difficulties in effectively delivering chemotherapeutics to the tumor site (Pink 
et al., 2012). One possible cause of this deviance from normal vasculature could be the 
increased stiffness of the tumor microenvironment, which could drive an increase in 
endothelial cell branching and permeability, in a manner parallel to that previously 
observed in atherogenesis (Huynh et al., 2011). Further studies will be required to 
determine if this is indeed the case. Additionally, changes in matrix stiffness have 
been linked to many other disorders such as diabetes (Airaksinen et al., 1993), liver 
fibrosis and cirrhosis (Wells, 2008), emphysema (Kononov et al., 2001), and 
scleroderma (Enomoto et al., 1996). 
 
During neoplastic progression, increased ECM deposition and crosslinking lead to a 
significant increase in tumor stiffness (Baker et al., 2012; Paszek et al., 2005). For 
example, in breast cancer, while a healthy mammary gland is highly compliant (E = 
~200 Pa), the average tumor is over an order of magnitude stiffer (E = ~4000 Pa) 
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(Paszek et al., 2005). Additionally, both the stroma surrounding the tumor and the 
tumor vasculature exhibit increased stiffness (E = ~800-1000 Pa and ~450 Pa, 
respectively) compared to healthy mammary tissue and vasculature (E = ~200 Pa) 
(Lopez et al., 2011; Paszek et al., 2005). Interestingly, recent work by Lopez et al. has 
also shown that the tumor epithelium is significantly stiffer than isolated tumor 
epithelial cells (Lopez et al., 2011), suggesting that the stromal  microenvironment 
plays a critical role in maintaining the stiff mechanical phenotype of the tumor. This 
increase in matrix stiffness has been shown to cluster integrins, upregulate focal 
adhesions, increase invasion, alter cell growth and morphology, and increase cell 
contractility (Baker et al., 2012; Kraning-Rush et al., 2012a; Levental et al., 2009; 
Paszek et al., 2005). Several of these effects have recently been shown to be mediated 
by increased phosphorylation of the focal adhesion kinase (FAK)/Src-signaling 
pathway resulting from enhanced enzymatic crosslinking of the tumor’s extracellular 
matrix (Baker et al., 2012).  
 
Given the intimate role that matrix stiffness plays in controlling traction forces, it is 
logical that cell contractility will likewise be affected by disease-induced matrix 
stiffening, or perhaps even a factor driving this stiffening. In the seminal work on 
tensional homeostasis during tumor progression, Paszek et al. found that increasing the 
stiffness of the 3D microenvironment surrounding mammary epithelial cells drives 
malignant progression by clustering integrins, increasing focal adhesion formation, 
disrupting adherens junctions, and increasing cell proliferation (Paszek et al., 2005). 
Likewise, Tang et al. found that increasing 2D stiffness promotes a metastasis-like 
phenotype in colon carcinoma cells (Tang et al., 2010), suggesting that increased 
mechanical stiffness may be an important driving factor in a wide range of cancer 
models. Additionally, Paszek et al. examined the relationship between malignancy and 
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contractile force generation. Using the human isogenic nonmalignant S-1 mammary 
epithelial cells and malignant T4-2 cell lines, they found that tractions forces were 
significantly elevated in the malignant cancer cells, and that these forces were RhoA-
dependent (Paszek et al., 2005). Likewise, Rosel et al. found that in a rat sarcoma 
model of protease-independent amoeboid migration, highly metastatic A3 cells 
generated traction forces that were five times greater than the spontaneously 
transformed, non-metastatic K2 cells, with traction forces at the leading edge found to 
be even higher (Rosel et al., 2008). Moreover, using a Deformation Quantification and 
Analysis (DQA) algorithm to quantify collagen fiber deformation, Wyckoff et al. 
found that during non-proteolytic amoeboid migration, metastatic MTLn3E murine 
mammary tumor cells generated increased force, and were thus able to push through 
collagen fibers and invade into the ECM in 3D, while their non-metastatic parental 
cells were unable to invade (Wyckoff et al., 2006). However, more recent research has 
called into question the existence of protease-independent migration in native collagen 
environments, and this remains an area of great controversy in three dimensional 
tumor migration research (Sabeh et al., 2009), which will be discussed in more detail 
in the following section. 
 
Surprisingly, in contrast to these four studies, Indra et al. recently found that in yet a 
different set of murine mammary tumor cells, traction forces actually decreased as the 
metastatic potential of the subpopulations increased (Indra et al., 2011). Similarly, 
using patterned PA gels and inducing tumoral transformation, Tseng et al. found that 
increased contractility appeared to be dependent on the method of transformation, with 
TGF-treated mammary epithelial cells generating increased force, while ErbB2 
receptor-activated cells and CK2b-knockdown cells exerted weaker forces (Tseng et 
al., 2011). Given these conflicting results, the precise role of force generation in 
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cancer progression, and particularly in relation to proteolytic activity, remains 
somewhat unclear. It may be that the effect of malignant transformation on force 
generation is specific to the type of cancer and the underlying genetic mutations. 
Additionally, one significant challenge that remains in the study of the effects of 
matrix stiffening on tumor progression and force generation is difficulty in decoupling 
the effects of chemical and structural changes (e.g. ECM fiber crosslinking, 
reorganization, and bundling) from the effects of the intrinsic changes in stiffness that 
have been shown to accompany these changes.  
 
1.5 ECM Architecture Affects Cancer Cell Behavior in 3D 
Cells in the body experience a rich 3D topographical environment resulting from the 
various structural proteins of the ECM, which has proven difficult to effectively 
replicate in vitro. Collagen is the dominant structural protein in the human body, and 
as such gels consisting of polymerized collagen fibers have become one of the most 
popular in vitro systems for studying cellular response to physiological topographical 
cues (Carey et al., 2012; Kraning-Rush et al., 2012b; Kraning-Rush et al., 2011; 
Paszek et al., 2005; Provenzano et al., 2008b). Notably, increased stromal collagen 
deposition and crosslinking have been linked to poor prognosis in cancer patients 
(Ioachim et al., 2002; Levental et al., 2009; Provenzano et al., 2008a; Ramaswamy et 
al., 2003). While these factors contribute to the increased matrix stiffness of the tumor 
microenvironment, as discussed above, they also significantly alter the architecture of 
the ECM, which has been shown to directly mediate tumor cell migration. Metastatic 
cancer cells have been shown to disseminate from the primary tumor using a variety of 
techniques, migrating either as individual cell using amoeboid or mesenchymal-type 
movement, or collectively as cell sheets, strands, or clusters (Friedl 2003 Nat Rev). 
Moreover, recent work has shown that cancer cells can actively remodel the ECM 
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fibers surrounding a tumor, using contractile force to align the fibers perpendicularly 
to the tumor (Provenzano et al., 2006; Provenzano et al., 2008b). Cancer cells have 
been shown to then persistently migrate along these aligned fibers in a largely one-
dimensional fashion both in vitro and in vivo (Conklin et al., 2011; Provenzano et al., 
2008b). Indeed, Conklin et al. recently linked the presence of bundled and aligned 
collagen fibers to poor long-term survival in breast cancer patients (Conklin et al., 
2011).  
 
Microtrack Formation in Cancer Invasion  
Cancer cell migration on the single cell level has been traditionally defined in two 
main categories: protease-dependent and protease-independent (Friedl and Wolf, 
2003; Sabeh et al., 2009; Wolf et al., 2003; Wyckoff et al., 2006). Protease-dependent 
migration relies on the ability of cells to produce matrix metalloproteinases (MMPs) 
which can cleave ECM fibers and clear a pathway for the cell body (Sabeh et al., 
2004; Sabeh et al., 2009). Protease-independent migration relies on mechanical forces 
exerted by the cell to displace the ECM fibers, and allows cells to move through the 
resulting space by adopting an amoeboid-like morphology (Sahai and Marshall, 2003; 
Wyckoff et al., 2006). Extensive work has been done in the last decade to show that 
when one of these pathways is inhibited, cancer cells are able switch their behavior 
and continue the invasion process (Friedl and Wolf, 2010; Wolf et al., 2003). 
However, these results have recently been called into question (Sabeh et al., 2009). 
New evidence suggests that many of these experiments utilized collagen which had 
been extracted with pepsin (Sahai and Marshall, 2003; Wolf et al., 2003), a process 
which removes the nonhelical telopeptides at the ends of the collagen molecules and 
prevents the fibrils from forming the covalent cross-links which are found in vivo 
(Sabeh et al., 2009). This lack of covalent cross-links has been shown to allow 
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protease-independent cancer cell migration that is not recapitulated in the more 
physiologically relevant, non-pepsinized collagen which retains robust cross-links 
(Sabeh et al., 2009). These data would suggest that all cancer cells rely on MMP 
activity to invade and metastasize, and perhaps have a lesser requirement for force 
generation. However, work has also been done on tumor cells in vivo showing that 
ROCK-mediated force generation, not MMP activity, is required for cancer cell 
motility (Wyckoff et al., 2006). Additionally, MMP-inhibitors to date have largely 
failed in clinical trials (Hua et al., 2011), suggesting that more studies need to be 
performed to validate this hypothesis. Moreover, extensive research on cancer cells in 
a broad variety of contexts has shown that, when presented with an obstacle or 
challenge, cancer cells will dramatically alter their metabolism, signaling, and 
behavior to adapt and survive (Hanahan and Weinberg, 2000; Hanahan and Weinberg, 
2011). Additionally, it is known that some cancer cells can use proteolysis to form 
tube-like “microtracks” (Friedl and Wolf, 2008) which other cancer cells can then use 
to invade without using MMPs themselves. 
 
Microtrack formation begins when individual cells disperse from the primary tumor 
using mesenchymal migration. Cells will generate protrusions along the leading edge 
which will attach to the ECM through integrin binding and activation (Friedl and 
Wolf, 2003). As the pseudopod elongates, the cell will generate traction forces to pull 
itself through the matrix. When the cell encounters a zone of physical resistance, 
where it is restricted by the surrounding ECM fibers, it will activate pericellular 
proteolysis to cleave these fibers and free the cell body to continue migrating forward 
(Friedl and Wolf, 2008). As the cell pushes forwards, it will mechanically reorient and 
align the surrounding collagen fibers along the direction of migration. Finally, the 
anterior of the cell will release its matrix adhesions to allow itself to glide forward. 
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Thus, in its wake the cell will leave a proteolytic microtrack, approximately the width 
of a single cell. As subsequent cells move into this space, they no longer encounter a 
zone of physical resistance, and therefore have no impetus to degrade the ECM 
further. As multiple cells enter the microtrack, the microtrack can be widened further, 
both with and without further degradation, eventually forming a ‘macrotrack’ and 
enabling collective cell invasion, in the form of strands or sheets, through the ECM 
(Ilina et al., 2011; Wolf et al., 2007). This mode of migration in the secondary cancer 
cells may be one example of true protease-independent migration which exists in vivo, 
and may also help to explain the failure of clinical MMP inhibitors, if they are 
administered after initial invasion has begun.  
 
3D Microfabricated Structures for the Study of ECM Architecture on Cell 
Behavior 
Given the importance of studying cells in environments which mimic their native 
environment, there has been a movement over the past few decades to recapitulate the 
topographical features encounter by normal and neoplastic cells in vivo. There has 
been a considerable amount of research using rigid micro- and nano-fabricated 
substrates such as polydimethylsiloxane (PDMS), poly(methylmethacrylate) (PMMA), 
silicon, and others to specifically assess the effects of tightly controlled topographical 
features on cell adhesion (Biela et al., 2009), morphology (Biela et al., 2009; Curtis 
and Wilkinson, 1999; Kulangara and Leong, 2009), migration behavior (Bettinger et 
al., 2009; Curtis and Wilkinson, 1999; Teixeira et al., 2003), and other cell functions. 
Cell behavior has been extensively analyzed on substrates containing features such as 
grooves, ridges, posts, and wells that are fabricated at the sub-cellular, cellular, and 
super-cellular scales (for detailed reviews, see (Curtis and Wilkinson, 1999), 
(Kulangara and Leong, 2009) and (Bettinger et al., 2009)). Nanogratings or ridges in 
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particular have been used by many labs to induce cytoskeletal alignment and guided 
migration in different cell types, including smooth muscle cells, macrophages, corneal 
epithelial cells, fibroblasts, endothelial cells, and neurons, with optimal ridge width 
varying significantly with cell type (Biela et al., 2009; Corey and Feldman, 2003; 
Teixeira et al., 2003; Wojciak-Stothard et al., 1996). Interestingly, in a seminal study 
by Doyle et al., fibroblast migration on micropatterned 1D substrates was found to 
closely mimic 3D migration along ECM fibers (Doyle et al., 2009). They also found 
that the mechanisms of migration employed by the fibroblasts were similar between 
1D and 3D environments, but were in distinct contrast to 2D migration mechanisms 
(Doyle et al., 2009), thus highlighting the ongoing need for improved 3D and 3D-like 
topographical model systems. 
 
Additionally, several groups have used microfabricated structures to study cancer cell 
migration under conditions of mechanical confinement within narrow PDMS channels 
which mimic the dimensions of microtracks created by tumor cells in vivo, as 
discussed in the previous section (Irimia and Toner, 2009; Mak et al., 2011; Rolli et 
al., 2010; Scherber et al., 2012; Tong et al., 2012). When introduced to channels that 
are of average cell-width (approximately 3-10 m), cancer cells have been shown to 
preferentially and persistently invade through these channels, with (Tong et al., 2012) 
or without (Irimia and Toner, 2009; Mak et al., 2011) the application of the chemical 
gradients often required to induce persistent cell migration on planar 2D substrates. 
Interestingly, this mechanism of migration appears to resemble the migration in 1D 
and 3D fibrillar environments by Doyle et al., discussed above (Doyle et al., 2009), 
particularly in its dependence on intact microtubule dynamics (Irimia and Toner, 
2009). In another example of using rigid substrates to study cancer cell migration, Liu 
et al. have used microfabricated silicon posts with height of several hundred microns, 
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nicknamed Tepuis, to study metastatic prostate cancer invasion behavior (Liu et al., 
2011). They found that highly metastatic PC-3 prostate cancer cells efficiently invade 
the Tepui tops and proceed to confluency, while less metastatic LNCaP cells are not 
able to achieve similar levels of invasion (Liu et al., 2011).   
 
While these systems have been used to elegantly describe the effects of different 
micro- and nano-topographical features on several key cell functions, it remains 
difficult to interpret their physiological relevance, as no surface within the body (with 
the exception of bone) shares such a rigid stiffness. As discussed previously, matrix 
stiffness has been shown to have a dramatic effect on cell migration, adhesion, force 
generation, and multiple other behaviors. Therefore, to more accurately assess the 
effects of topographical features on cell behavior, there is a great need to adapt 
methods to create topography on softer, more physiologically-relevant substrates. 
Additionally, to specifically determine the mechanisms guiding cancer migration 
within cell-generated microtracks, a system must be generated which recapitulates as 
closely as possible the native microtrack environment. 
 
1.6 Organization of the Dissertation 
The objective of this work is to elucidate the role of force generation during metastatic 
invasion, particularly in relation to invasion through proteolytic microtracks. Herein, I 
present data describing how matrix composition, including mechanical stiffness, 
ligand availability, and three-dimensional architecture, affects cancer cell behavior in 
terms of both force generation and motility.  
 
In Chapter 2, I demonstrate that force generation on 2D substrates is increased in 
metastatic breast, prostate, and lung cancer cells, compared to their non-metastatic 
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counterparts. Additionally, I show that traction forces are increased with increased 
matrix stiffness and collagen density. This work implicates traction forces as a 
potential contributor to metastatic invasion. These studies are the first to my 
knowledge to compare the traction stresses of paired metastatic and non-metastatic 
cells from several human cancer models. Moreover, these findings provide the first 
evidence that differential profiles of metastatic cancer cells may aid in determining 
metastatic ability, and could be useful as a mechanical biomarker of metastatic 
potential.   
 
In Chapter 3, I present a novel method for creating 3D collagen microtracks which 
recapitulate the natural proteolytic tracks formed during metastatic invasion. Using 
this technique, I show that migration speed and invasion distance within these 
microtracks is increased in both tumor cells and non-invasive mammary epithelial 
cells. Finally, I demonstrate that this migration occurs entirely independently of MMP 
activity, revealing novel insight into the clinical challenges of treating patients with 
MMP inhibitors.  
 
In Chapter 4, I examine in more detail the specific mechanisms guiding cancer cell 
migration within the collagen microtracks first described in Chapter 3. Surprisingly, I 
show that migration continues to occur when contractility is inhibited via the 
Rho/ROCK pathway. Instead, I find that migration is contingent upon having an intact 
and polarized actin and microtubule cytoskeleton and, additionally, is also dependent 
on focal adhesion formation. This work is the first to identify the governing principles 
of MMP-independent migration within the 3D microtrack environment.  
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In Chapter 5, additional data related to various side projects is discussed, including the 
effects of hypoxia on force generation. In Chapter 6, conclusions and future directions 
are presented. Experimental protocols are provided in the appendices. 
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CHAPTER 2 
 
CELLULAR TRACTION STRESSES INCREASE WITH INCREASING 
METASTATIC POTENTIAL 
 
This chapter was published in PLoS One (Kraning-Rush et al., 2012a).  
 
2.1  Abstract 
Cancer cells exist in a mechanically and chemically heterogeneous microenvironment 
which undergoes dynamic changes throughout neoplastic progression.  During 
metastasis, cells from a primary tumor acquire characteristics that enable them to 
escape from the primary tumor and migrate through the heterogeneous stromal 
environment to establish secondary tumors.  Despite being linked to poor prognosis, 
there are no direct clinical tests available to diagnose the likelihood of metastasis.  
Moreover, the physical mechanisms employed by metastatic cancer cells to migrate 
are poorly understood.  Because metastasis of most solid tumors requires cells to exert 
force to reorganize and navigate through dense stroma, we investigated differences in 
cellular force generation between metastatic and non-metastatic cells.  Using traction 
force microscopy, we found that in human metastatic breast, prostate and lung cancer 
cell lines, traction stresses were significantly increased compared to non-metastatic 
counterparts.  This trend was recapitulated in the isogenic MCF10AT series of breast 
cancer cells.  Our data also indicate that increased matrix stiffness and collagen 
density promote increased traction forces, and that metastatic cells generate higher 
forces than non-metastatic cells across all matrix properties studied.  Additionally, we 
found that cell spreading for these cell lines has a direct relationship with collagen 
density, but a biphasic relationship with substrate stiffness, indicating that cell area 
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alone does not dictate the magnitude of traction stress generation.  Together, these data 
suggest that cellular contractile force may play an important role in metastasis, and 
that the physical properties of the stromal environment may regulate cellular force 
generation.  These findings are critical for understanding the physical mechanisms of 
metastasis and the role of the extracellular microenvironment in metastatic 
progression. 
 
2.2  Introduction 
While significant advances have been made in the treatment of primary tumors 
through surgery, chemotherapy and radiation treatment, a mechanism for effectively 
diagnosing the likelihood of metastasis remains elusive (Steeg, 2006).  Metastasis is 
the leading cause of death among cancer patients, resulting in over 90% of cancer-
related fatalities (Christofori, 2006).  Moreover, there is currently no procedure or test 
that can definitively determine the metastatic potential of a specific tumor.  Clinical 
oncologists routinely rely on pathology reports and historical statistics to determine 
patient prognosis and to design a course of palliative therapy (Ravdin et al., 2001).  
 
Because metastasis has become the primary obstacle in cancer treatment, there is a 
substantial body of work attempting to discover a biological marker (or set of markers) 
for metastasis, but with marginal success (Sidransky, 2002).  Previous studies have 
linked overexpression of VEGF-D (Stacker et al., 2001), urokinase plasminogen 
activator (Duffy, 1996), the growth factor receptor CXCR2 (Mierke et al., 2008b) and 
activator protein-1 (Ozanne et al., 2000) to increased metastatic breast cancer invasion 
in vitro and in vivo.  Additionally, studies have shown that a combination of genes can 
affect organ-specific tropism (Kang et al., 2003).  However, these discoveries have 
generally not been applicable to multiple cancer types, or even within subtypes of a 
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single cancer.  Recently, advances in genetic profiling have led to the identification of 
a 17-gene expression signature for metastasis in primary adenocarcinomas 
(Ramaswamy et al., 2003), as well as a 70-gene expression signature for predicting the 
clinical prognosis of breast cancer (Sotiriou et al., 2003).  While patients whose 
tumors contain these expression patterns will benefit from this kind of genetic 
analysis, it may not be applicable to a broad spectrum of patients with heterogeneous 
tumor populations.  Additionally, while these signatures may show significant 
statistical correlation with poor prognosis, they are not descriptive of the physical 
behaviors of the tumor cells that lead to these clinical results.  
 
Alterations in gene expression patterns result in phenotypic changes at the cellular 
level during cancer progression.  As such, the biophysical characteristics of tumor 
cells may be a more appropriate and accessible clinical indicator than individual 
genetic alterations.  During metastatic invasion, cancer cells encounter a complex and 
constantly evolving microenvironment (Kumar and Weaver, 2009) consisting of 
upregulated extracellular matrix proteins (Ioachim et al., 2002; Levental et al., 2009; 
Ramaswamy et al., 2003), different degrees of extracellular matrix (ECM) 
crosslinking (Levental et al., 2009), mechanical heterogeneity (Lopez et al., 2011; 
Paszek et al., 2005), varying oxygen levels (Harris, 2002), as well as exposure to shear 
stress and interstitial pressure (Kumar and Weaver, 2009).  To successfully navigate 
this dynamic microenvironment, tumor cells must generate force to reorganize the 
basement membrane, invade into surrounding stroma (Rosel et al., 2008; Wolf et al., 
2007),  migrate along ECM fibers (Provenzano et al., 2008b; Wyckoff et al., 2006) 
and transmigrate through the endothelial cell barrier (Mierke et al., 2008b) to enter the 
circulatory or lympathic system.  In addition to enzymatically degrading the ECM 
with matrix metalloproteinases, metastatic cells can use force to mechanically 
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rearrange their ECM to clear a path for migration (Wolf et al., 2007).  There is 
evidence from in vivo imaging that cells use re-oriented fibers as “train-tracks” to 
guide their migration away from the primary tumor (Provenzano et al., 2008b).  
Traction forces have previously been shown to mediate normal cell migration 
(Lauffenburger and Horwitz, 1996), adhesion (Pelham and Wang, 1997; Reinhart-
King, 2008), mechanotransduction (Discher et al., 2005), and ECM remodeling 
(Bloom et al., 2008; Lemmon et al., 2009; Provenzano et al., 2008b).  Notably, these 
processes are also involved in cancer progression.  Paszek et al. have shown a marked 
difference in the magnitude and organization of traction stresses between cancerous 
and untransformed mammary epithelial cells, suggesting inherent differences in cell 
force generation in the cancerous phenotype (Paszek et al., 2005).  However, the 
effects of metastatic potential on force generation have not yet been thoroughly 
investigated. 
 
Matrix stiffness has been shown to have a distinct effect on force-mediated cellular 
behaviors including migration (Baker et al., 2009; Gjorevski and Nelson, 2010; Ulrich 
et al., 2009; Zaman et al., 2006), adhesion (Discher et al., 2005; Huynh et al., 2011; 
Kim and Asthagiri, 2011), and ECM remodeling (Levental et al., 2009; Wolf et al., 
2007).  Because metastasizing cancer cells are exposed to both the increased stiffness 
of the stroma surrounding most solid tumors, as well as more compliant adipose 
tissue, it is important to understand the effects of a dynamic mechanical environment 
on cancer cell force generation.  Similarly, ligand density has also been shown to have 
a significant effect on the force generation of non-cancerous cell types, such as 
endothelial cells and fibroblasts (Califano and Reinhart-King, 2010a; Gaudet et al., 
2003; Willcox et al., 2005).  During cancer progression, the chemical nature of the 
extracellular matrix experiences significant changes, affecting the number and nature 
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of binding sites available for tumor cell adhesion and migration.  Collagen metabolism 
has been shown to be dysregulated, with elevated expression, increased deposition, 
and an increase in collagen crosslinking that contributes to the overall stiffening of the 
surrounding microenvironment (Levental et al., 2009).  These factors lead to an 
increase in mammographic density, which has been specifically correlated to an 
increased risk for the development of breast cancer (Martin and Boyd, 2008).  An 
increase in collagen expression has also been clinically linked to metastatic tumors by 
genetic analysis of tumor biopsies (Ramaswamy et al., 2003).  Therefore, 
understanding the independent and interdependent relationships between substrate 
mechanics, collagen density, and force generation is critical for understanding the 
mechanism(s) driving metastatic progression. 
 
In this study, we investigate traction force generation as a biophysical marker of 
metastatic potential.  We quantify contractile forces of highly metastatic breast, 
prostate, and lung cancer cell lines compared to non-tumorigenic epithelial cell lines 
seeded on substrates of varying stiffness and collagen density using traction force 
microscopy.  Here, we show that highly metastatic cancer cells exert significantly 
increased forces across all matrix properties studied.  Moreover, our data show that 
increased matrix stiffness and collagen density both promote increased traction forces.  
These findings provide the first evidence to our knowledge that differential force 
profiles of metastatic cells may aid in determining metastatic potential. 
 
2.3 Materials and Methods 
Cell Culture  
MCF10A mammary epithelial cells (American Type Culture Collection (ATCC), 
Rockville, MD) were maintained in Dulbecco’s Modified Eagle’s Media 
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supplemented with 5% horse serum, 20 ng/mL EGF (Invitrogen, Carlsbad, CA), 10 
g/mL insulin, 0.5 g/mL hydrocortisone, 100 ng/mL cholera toxin (Sigma-Aldrich, 
St. Louis, MO), and 1% penicillin-streptomycin (Invitrogen)(Debnath et al., 2003).  
MDAMB231 highly metastatic breast adenocarcinoma cells (ATCC) were maintained 
in Minimum Essential Medium supplemented with 10% fetal bovine serum, and 1% 
penicillin-streptomycin (Invitrogen). 
 
PC3 highly metastatic prostate adenocarcinoma cells (ATCC) were maintained in 
Kaighn’s Modification of Ham’s F-12 Medium (ATCC) supplemented with 10% fetal 
bovine serum and 1% penicillin-streptomycin (Invitrogen).  PrEC primary human 
prostate epithelial cells (Lonza, Walkersville, MD) were maintained in PrEGM 
prostate epithelial cell growth medium (Lonza) supplemented with SingleQuots 
(Lonza) according to the manufacturer’s recommended protocol.  
 
BEAS2B bronchial epithelial cells (ATCC) were maintained in BEBM bronchial 
epithelial cell basal medium (Lonza) supplemented with SingleQuots (Lonza) 
according to ATCC recommended protocol, and 1% penicillin-streptomycin 
(Invitrogen).  A549 metastatic lung carcinoma cells (ATCC, CCL-185) were kindly 
provided by Paraskevi Giannakakou (Weill Cornell Medical College) and were 
maintained in RPMI 1640 supplemented with 10% fetal bovine serum, 1% penicillin-
streptomycin, and 1 g/mL puromycin (Invitrogen).  
 
MCF10AT1 transformed mammary epithelial cells and MCF10CA1a metastatic 
mammary epithelial cells were obtained from the Barbara Ann Karmanos Cancer 
Institute (Detroit, MI) and were maintained in 1:1 Dulbecco’s Modified Eagle’s Media 
/ F12 supplemented with 5% horse serum, 20 ng/mL EGF (Invitrogen), 10 g/mL 
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insulin, 0.5 g/mL hydrocortisone, 100 ng/mL cholera toxin (Sigma-Aldrich), and 1% 
penicillin-streptomycin (Invitrogen)(Santner et al., 2001).  All cells were cultured at 
37
o
C and 5% CO2.  Live cell imaging was performed in a custom temperature, 
humidity, and CO2- controlled stage of a Zeiss Axio Observer Z1m inverted phase 
contrast microscope with a Hamamatsu ORCA-ER camera. 
 
Substrate Synthesis and Traction Force Microscopy 
Substrates of various Young’s moduli (1 – 10 kPa) were synthesized with varying 
ratios of 3-7.5% acrylamide (40% w/v solution, Bio-Rad, Hercules, CA) and 0.1-
0.35% N,N’-methylene-bis-acrylamide (2% w/v solution, Bio-Rad) as described 
previously (Kraning-Rush et al., 2012b; Reinhart-King, 2008).  Substrate surfaces 
were functionalized using N-6-((acryloyl)amido)hexanoic acid, synthesized in our lab 
(Califano and Reinhart-King, 2010a), covalently bound to 0.0001-0.1 mg/mL type I 
rat-tail collagen (Becton Dickinson, Franklin Lakes, NJ).  The Young’s modulus (E) 
of the polyacrylamide substrates was verified as previously described (Califano and 
Reinhart-King, 2010a; Huynh et al., 2011; Kraning-Rush et al., 2012b).  Traction 
force microscopy (TFM) was performed as previously described (Dembo and Wang, 
1999; Kraning-Rush et al., 2012b; Kraning-Rush et al., 2011).  Briefly, cells were 
seeded on polyacrylamide substrates (E = 1-10 kPa) embedded with 0.5-m 
fluorescent beads and allowed to adhere overnight.  Cells were then imaged in phase 
and bead distributions were imaged in fluorescence before and after removal of the 
cell with trypsin.  Bead displacement within the substrate was tracked with 
correlation-based optical flow and converted into a strain field.  These strain fields 
were converted into traction stresses using the LIBTRC analysis library developed by 
Professor Micah Dembo of Boston University, who invented the basic theory that 
underlies TFM (Dembo and Wang, 1999).  Images were processed with LIBTRC 
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software to determine the cellular traction vectors, T, the total magnitude of the force, 
|F|, and the projected cell area. |F| is an integral of the traction field over the entire area 
of the cell, 
           
      dxdyyxTyxTF yx
2/122 ,,
         (2.1) 
where  
      yxTyxTyxT yx ,,,,   is the continuous field of local traction vectors 
defined at local spatial coordinates (x,y) in the projected cell area (Reinhart-King et 
al., 2005).  More than 40 cells were analyzed per condition.  
 
Statistical Tests 
Data were compared with analysis of variance and Tukey’s Honestly Significantly 
Different test or Student’s t test where appropriate in JMP software (v.8, SAS, Cary, 
NC).  All data were logarithmically transformed prior to analysis to ensure normal 
distribution.  All data are reported as mean ± standard error of the mean (SEM). 
 
2.4  Results 
Metastatic Cancer Cells Exert Stronger Traction Forces 
To investigate the relationship between cellular traction force generation and 
metastatic potential, we examined the differences in traction force generation in three 
independent cancer models: breast, prostate, and lung cancer.  These cancers comprise 
the three most fatal cancers in both men and women (Pickle et al., 2007), with 
metastatic disease being the ultimate cause of death in over 90% of these patients 
(Christofori, 2006).  During metastatic progression, phenotypic changes in cancer cells 
result in altered adhesion and migration behavior, allowing cells to escape from the 
tumor mass into surrounding tissue (Kumar and Weaver, 2009).  Because contractile 
force is known to mediate these behaviors in normal cells (Pelham and Wang, 1997; 
Reinhart-King, 2008), we hypothesized that cancer cells require increased force 
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generation to metastasize.  For each type of cancer, we chose a cell line (breast, 
prostate, lung, respectively) that was previously characterized as highly invasive in 
vitro and metastatic in vivo (MDAMB231, PC3, and A549), as well as a non-
tumorigenic, non-metastatic control cell population that is representative of healthy 
native epithelial tissue (MCF10A, PrEC, and BEAS-2B, respectively).  
 
At a moderate stiffness mimicking tumorigenic conditions in breast tissue (Young’s 
Modulus (E) = 5 kPa)(Paszek et al., 2005), measurements of cellular force using TFM 
indicate that MDAMB231 highly metastatic breast cancer cells exhibited stronger 
traction stresses compared to the non-metastatic MCF10A mammary epithelial cells 
(Fig. 2.1A).  Likewise, both the PC-3 highly metastatic prostate cancer cells (Fig. 
2.1B) and the A549 metastatic lung cancer cells (Fig. 2.1C) exhibited significantly 
greater traction stresses than the non-metastatic PrEC primary prostate epithelial cells 
and the BEAS-2B lung epithelial cells, respectively.  These data suggest that 
increasing force generation in cells of high metastatic potential may be a biophysical 
characteristic of metastatic cells that could potentially act as a mechanical marker for 
metastasis.  
 
Substrate Stiffness and Collagen Density Mediate Magnitude of Traction Force 
Because cancer cells encounter heterogeneous environments exhibiting a range of 
stiffness during metastatic progression in vivo, such as stiff, matrix-dense regions near 
the tumor and compliant adipose tissue during stromal invasion (Paszek et al., 2005), 
we measured the traction forces exerted on substrates of varying stiffness (E = 1 – 10 
kPa), with collagen density being held constant (0.1 mg/mL).  We found that, in 
addition to exerting greater forces on substrates of tumorigenic stiffness (Fig. 2.1A), 
MDAMB231 cells also have a greater overall net traction force (|F|) than MCF10A 
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Figure 2.1. Metastatic cancer cells exert greater forces than non-metastatic cells.  
(A) Representative traction maps (left), corresponding phase images (middle), and 
overall net traction force (|F|, right) of non-metastatic mammary epithelial (MCF10A) 
and highly metastatic (MDAMB231) cancer cells.   (B) Representative traction maps 
(left), corresponding phase images (middle), and |F| (right) of non-metastatic primary 
prostate epithelial cells (PrEC) and highly metastatic prostate cancer cells (PC3).  (C) 
Representative traction maps (left), corresponding phase images (middle), and |F| 
(right) of non-metastatic bronchial epithelial cells (BEAS2B) and metastatic lung 
adenocarcinoma cells (A549).  All cells are on polyacrylamide substrates with 
Young’s Modulus (E) = 5 kPa and type I collagen concentration of 0.1 mg/mL.  Scale 
bar = 50 m. Mean + SEM; *** indicates p < 0.001. 
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trend was also recapitulated with the prostate and lung cancer models, in which the 
metastatic PC3 (Fig. 2.2B) and A549 (Fig. 2.2C) prostate and lung cancer cells exerted 
significantly greater forces than non-metastatic PrEC and BEAS2B cells on stiff 
substrates.  On more compliant substrates (E = 1 kPa), the metastatic cells of each 
cancer type studied exert slightly higher forces than their non-metastatic counterparts.  
Additionally, we observed a significant increase in net traction force with increasing 
substrate stiffness within all 6 cell lines (p < 0.01), suggesting that the stiffness of the 
environment surrounding cancer cells can directly contribute to the amount of traction 
force exerted at a single cell level.  These data indicate that the stiffness of the 
microenvironment significantly affects the magnitude of forces generated by 
metastatic and non-metastatic cells, and suggest that, in general, metastatic cells are 
able to exert greater net traction forces than non-metastatic cells.   
 
Collagen content of the microenvironment also changes throughout neoplastic 
progression (Levental et al., 2009), with increased collagen expression particularly 
noted in clinical analyses of high grade tumors (Ramaswamy et al., 2003).  As such, 
we examined the effect of collagen density on cancer cell traction forces.  Using 
substrates of constant stiffness (E = 5 kPa) and varying collagen density (0.0001 – 0.1 
mg/mL), we found that metastatic MDAMB231 breast cancer cells exert a greater net 
traction force (|F|) than non-metastatic MCF10A cells across the entire range of 
collagen densities tested (Fig. 2.3A).  This trend is recapitulated with both the prostate 
and the lung cells, with metastatic PC3 (Fig. 2.3B) and A549 (Fig. 2.3C) prostate and 
lung cancer cells exerting greater forces than their non-metastatic counterparts, PrEC 
and BEAS2B cells, on substrates with varying collagen density.  Similar to the 
previously observed trend of increasing force with increasing stiffness, all 6 cell lines 
also showed a significant increase (p < 0.01) in net traction force with increasing 
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Figure 2.2. Increased matrix stiffness contributes to increased force generation.  
Net traction force (|F|) increases with increasing substrate stiffness (E = 1-10 kPa) for 
(A) MCF10A non-metastatic mammary epithelial cells and MDAMB231 metastatic 
cancer cells, (B) PrEC non-metastatic primary prostate epithelial cells and PC3 
metastatic prostate cancer cells, and (C) BEAS2B non-metastatic bronchial epithelial 
cells and A549 metastatic lung cancer cells.  Ligand density is maintained at 0.1 
mg/mL collagen I.  5 kPa data is from Fig. 1.  Note also that the metastatic cancer cells 
(black) exert greater forces than non-metastatic cells (white) at all matrix stiffness 
levels studied.  Mean + SEM; * indicates p < 0.05; *** indicates p < 0.001.  
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Figure 2.3. Increased collagen density contributes to increased force generation.  
Net traction force (|F|) increases with collagen density (0.0001-0.1 mg/mL collagen I) 
for (A) MCF10A non-metastatic mammary epithelial cells and MDAMB231 
metastatic cancer cells, (B) PrEC non-metastatic primary prostate epithelial cells and 
PC3 metastatic prostate cancer cells, and (C) BEAS2B non-metastatic bronchial 
epithelial cells and A549 metastatic lung cancer cells.  Stiffness is maintained at E = 5 
kPa. 0.1 mg/mL collagen I data is from Fig. 1.  Note also that the metastatic cancer 
cells (black) exert greater forces than non-metastatic cells (white) at all collagen 
densities studied.  Mean + SEM; * indicates p < 0.05; ** indicates p < 0.01; *** 
indicates p < 0.001. 
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density, suggesting that increased collagen content within the tumor 
microenvironment can also drive force generation of cancer cells.  Together these data 
indicate that metastatic and non-metastatic cells have differential force profiles that are 
significantly affected by mechanical and chemical matrix properties of the tumor 
microenvironment. 
  
Differences in Force Generation are not Correlated to Differences in Cell 
Spreading 
Because cellular force generation has been linked to cell spread area in previous 
studies (Califano and Reinhart-King, 2010a; Gaudet et al., 2003), we assessed whether 
increased cellular traction force in metastatic cells on both stiff matrices and those 
displaying high densities of collagen was simply caused by an increase in cell area 
 (i.e. that larger cells exert higher forces).  The area of isolated cells was measured 
during the TFM experiments previously described.  We observed no significant or 
consistent trend when comparing the spreading area of metastatic breast, prostate, and 
lung cancer cells to their non-metastatic epithelial cell counterparts across substrates 
of constant collagen density and varying stiffness (Fig. 2.4A) or across substrates of 
constant stiffness and varying collagen density (Fig. 2.4B) (p > 0.05).  These data 
indicate that the observed increases in traction force in metastatic versus non-
metastatic cells are not linked to cell area.  Interestingly, we noted that five of the six 
cell lines (excluding the non-metastatic PrEC prostate epithelial cells) exhibited a 
biphasic relationship with substrate stiffness, with the maximum cell spreading area 
occurring on polyacrylamide substrates of an intermediate stiffness (E = 5 kPa) (Fig. 
2.4A).  In contrast, we observed that these same five cell lines exhibited a direct 
relationship between spreading area and collagen density across the range of 0.0001 –  
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Figure 2.4. Cell area is differentially altered by matrix stiffness and collagen 
density.  Projected cell area shows a biphasic relationship with substrate stiffness (A) 
and a direct relationship with collagen density (B) in the majority of the metastatic 
(black) and non-metastatic cells (white) studied.  No consistent trend was observed 
when comparing the projected cell area of complementary metastatic and non-
metastatic cells.  
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0.1 mg/mL, with increased area correlating with increased collagen density (Fig. 
2.4B).  
 
To further investigate the role of cell area in the generation of traction forces, we 
analyzed the net traction force (|F|) of each cell normalized by its projected area (|F|/A) 
as a measurement of average traction stress.  When the traction forces of cells plated 
on substrates of variable stiffness were normalized by their respective areas, average 
traction stress increased with increasing stiffness (p < 0.0001, Fig. 2.5A).  Therefore, 
the increased force on stiffer substrates is not due to increased cell spreading.  
However, the average traction stress of cells plated on substrates of variable collagen 
density revealed an overall equalization of forces across the collagen concentrations 
tested (Fig. 2.5B).  These data suggest that increased collagen density may promote 
force generation by causing an increase in cell spreading.  
 
Metastatic Cells Exert Increased Force in an Isogenic Model 
Because the cell lines used in these experiments are of genetically distinct lineages, we 
further investigated our hypothesis that metastatic cells generated increased traction 
forces compared to non-metastatic cells using an isogenic cell model: the 10AT series 
of cell lines.  The 10AT series consists of several cell lines which have been 
developed to represent the full spectrum of neoplastic progression (Santner et al., 
2001).  We focused on the MCF10AT1 and MCF10CA1a lines (Kim et al., 2009; 
Mehta et al., 2004; Santner et al., 2001), compared to their parental spontaneously 
immortalized MCF10A cells used previously in this work.  MCF10AT1 cells were 
derived from MCF10A cells transfected with the constitutively active Ha-ras 
oncogene. These cells are considered ‘premalignant’ and will first form simple ducts  
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Figure 2.5. Average traction stress increases with stiffness, not collagen density.  
|F| of each cell is normalized by its projected area (|F|/A) as a measurement of average 
traction stress.  Average traction stresses increase with increasing substrate stiffness 
(A) and become relatively uniform with increasing collagen density (B).  
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in nude mice xenografts, followed by benign lesions which occasionally progress to 
carcinomas (Mehta et al., 2004). MCF10CA1a cells were selectively derived from the 
MCF10AT1 carcinoma populations.  These cells form undifferentiated carcinomas 
and rapidly growing metastases within the lungs Together, the MCF10A, MCF10AT1, 
and MCF10CA1a are isogenic human cell lines representative of different stages of 
metastatic potential: non-tumorigenic, premalignant, and highly metastatic (Fig. 2.6A) 
(Kim et al., 2009; Mehta et al., 2004; Santner et al., 2001). The highly metastatic 
MCF10CA1a derivative exerted significantly greater traction forces compared to the 
benign MCF10AT1 and non-tumorigenic parental MCF10A cells (Fig. 2.6B) on 
substrates mimicking the stiffness of tumorigenic breast tissue (E = 5 kPa)(Paszek et 
al., 2005).  When the net traction force was normalized by projected area, there was a 
significant increasing trend in average traction stress (p < 0.001, Fig. 2.6D).  Overall, 
these data from an isogenic cell model correlate well with the data from breast, 
prostate, and lung cells derived from different genetic backgrounds (Fig. 2.1). 
 
2.5  Discussion 
To date, there is no universal molecular marker of metastasis.  Because of the known 
role of cellular force in cell migration, we explored traction force generation as a 
potential biophysical marker characteristic of cells with metastatic ability.  The results 
presented here show that highly invasive breast, prostate, and lung cancer cells exert 
significantly greater traction forces than their non-invasive epithelial cell counterparts 
on 2D substrates of physiologically relevant stiffness and varying collagen density.  
These findings indicate that inherent force differences exist in cells of differing 
metastatic potential. Additionally, increased matrix stiffness and ligand density 
promote increased contractile force generation in contrasting ways: collagen density 
appears to lead to increased cellular force generation by directly mediating cell  
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Figure 2.6. Metastatic derivative in a series of isogenic cell lines exerts greater 
forces.  (A) Phase images of parental untransformed cells (MCF10A), transformed 
premalignant (MCF10AT1) and highly metastatic (MCF10CA1a) derivatives.  (B) Net 
traction forces increase with increasing metastatic potential, with the highest forces 
exerted by the metastatic MCF10CA1a cells.  (C) Average traction stress (|F|/A) 
increases with increasing metastatic potential.  Mean ± SEM; ** indicates p < 0.01; 
*** indicates p < 0.001. 
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spreading, while matrix stiffness appears to increase cell forces independently of cell 
spreading.  
 
Previous studies by others have also explored various biophysical traits as potential 
markers of metastasis.  Atomic force microscopy (AFM) and optical stretching 
measurements have shown that metastatic cancer cells are more compliant than benign 
cells, both in established cell lines (Darling et al., 2007; Guck et al., 2005) and in 
primary tumor samples (Cross et al., 2007).  These data allow speculation that a 
difference in the plasticity of cancer cells may contribute to their enhanced migration 
away from the primary tumor by allowing them to more easily maneuver through the 
ECM.  These studies are the first indications that there are mechanical properties 
inherent in some cancer cells that may promote malignant and metastatic behavior.  In 
our study, we explore another aspect of cell mechanics, cellular force generation, to 
show that metastatic cancer cells from a variety of cancer types exert greater traction 
stresses than their non-metastatic counterparts.  We speculate that these higher forces 
could potentially drive cancer progression by promoting cellular behaviors such as cell 
migration, adhesion, and ECM remodeling during metastatic invasion. 
 
Cellular mechanical properties can also be affected by the microenvironment.  Using 
particle-tracking microrheology, Baker et al. showed that cells embedded in 3D 
matrices are stiffer than those plated on 2D substrates (Baker et al., 2009).  They also 
show that 3D matrix stiffness and collagen density significantly affect the intracellular 
tension in tumor cells, although this relationship is dependent on both the type of cell 
and the cell’s transformation state (Baker et al., 2009; Baker et al.).  Increased matrix 
stiffness in turn has been shown to enhance cell motility in 2D and 3D (Ulrich et al., 
2009; Zaman et al., 2006), while decreasing the stiffness of the tumor 
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microenvironment has been shown to inhibit malignant progression (Levental et al., 
2009; Paszek et al., 2005).  Increased ECM density has been identified as a risk factor 
for breast cancer (Martin and Boyd, 2008), and has also been shown to promote 
invasion by enhancing integrin clustering, upregulating Rho and PI3 kinase activity, 
and increasing focal adhesion formation (Levental et al., 2009; Paszek et al., 2005).  
Recently, Levental et. al. has shown that inhibiting collagen crosslinking increases 
tumor latency, reduces cell proliferation, and reduces tumor volume and incidence in a 
mouse model (Levental et al., 2009).  In this work, we have shown that matrix 
stiffness and collagen density both mediate cellular force generation, with cells 
exerting greater force on substrates with either increased stiffness or increased 
collagen density.  
 
Since both matrix stiffness and ligand density have been associated with increased cell 
spreading (Califano and Reinhart-King, 2010a; Engler et al., 2004; Gaudet et al., 
2003; Willcox et al., 2005; Yeung et al., 2005), we examined their effects on cell 
spreading area here.  We find that in the majority of the cell lines employed in this 
study, there existed a biphasic relationship between cell spreading and substrate 
stiffness (Fig. 2.4A), but a direct relationship between cell spreading and collagen 
density (Fig. 2.4B).  While the relationship between area and collagen density is 
consistent with previous studies in numerous cell types (Califano and Reinhart-King, 
2010a; Gaudet et al., 2003; Reinhart-King et al., 2005), the relationship between 
substrate stiffness and cell spreading contrasts with similar studies performed on 
several different non-cancerous cell types (Califano and Reinhart-King, 2010a; Engler 
et al., 2004; Yeung et al., 2005).  However, there has been some evidence reported 
previously that the effect of matrix stiffness on cell spreading is highly variable and 
cell-type specific, particularly in cancer cells (Tilghman et al.).  
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Interestingly, we observe that cells on substrates of increasing stiffness exhibit 
increased average traction stresses, while cells on substrates of increasing collagen 
density exhibit no change in average traction stresses (Fig. 2.5).  We speculate that 
matrix stiffness is able to promote force generation through a mechanosensing-
mechanism which causes an upregulation of contractility-related proteins, while 
collagen density promotes force generation by controlling the number of available 
integrin binding sites available to the cell, therefore directly mediating the cell 
spreading area and allowing larger cells to exert greater forces.  Importantly, 
metastatic cancer cells exert increased force compared to non-metastatic cells 
regardless of cell spreading area.  This suggests increased force generation is 
inherently tied to the metastatic phenotype regardless of the microenvironment.  It is 
also important to note that while this data is acquired in a 2D environment, previous 
work in our lab has shown that forces in 2D reflect the forces generated within a 3D 
environment (Kraning-Rush et al., 2011). 
 
While we chose to focus on three of the most common metastatic cancers (breast, 
prostate, and lung), we cannot claim that contractile force will be a universal predictor 
of metastatic behavior without thoroughly characterizing every type of cancer.  
Indeed, recent work has shown that the method of transformation or exposure to 
different tumorigenic signals can significantly affect cellular mechanical properties in 
contrasting ways (Baker et al., 2010; Tseng et al.).  Additionally, a recent study using 
a series of murine breast cancer cell lines of increasing metastatic potential observed 
the reverse trend to our data, showing that cells of increasing metastatic potential exert 
weaker contractile forces (Indra et al., 2011).  While it is an elegant model of 
metastatic potential, the relevance of mouse-derived cancers to cancers which develop 
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within the human body continues to be disputed (Dennis, 2006).  Based on the data 
shown in this study, particularly on the work done using the isogenic MCF10AT series 
of cell lines, we believe that pursuing traction force generation as a mechanical 
indicator of metastasis could potentially reveal mechanistic details that will lead to a 
better understanding of the initiation and progression of metastatic cancer.  
Additionally, examining proteins which are known to play key roles in mediating cell 
force, such as RhoA, ROCK, or myosin light chain phosphatase, may reveal a protein 
marker for traction stresses which could be more directly employed clinically to 
diagnose metastasis.  Further studies will be needed on a broader range of cancer cells 
to determine the applicability of this kind of marker to a wide variety of cancers. 
 
In conclusion, we have shown that metastatic cells exert significantly greater traction 
forces than non-metastatic cells in breast, prostate, and lung cancer models, and that 
these forces can be driven by the mechanical and chemical properties of the tumor 
microenvironment.  These findings suggest that inherent force differences exist in 
cells of differing metastatic potential, and that these differences could be developed 
into a biophysical marker that could be used to determine the likelihood of metastasis.  
Additionally, our data suggest that identifying a mechanism to therapeutically target 
cellular force may be a promising avenue for inhibiting metastatic progression. 
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CHAPTER 3 
 
MICROFABRICATED COLLAGEN TRACKS FACILITATE SINGLE CELL 
METASTATIC INVASION IN 3D 
 
This chapter was published in Integrative Biology (Kraning-Rush et al., 2013). 
 
3.1 Abstract 
While the mechanisms employed by metastatic cancer cells to migrate remain poorly 
understood, it has been widely accepted that metastatic cancer cells can invade the 
tumor stroma by degrading the extracellular matrix (ECM) with matrix 
metalloproteinases (MMPs). Although MMP inhibitors showed early promise in 
preventing metastasis in animal models, they have largely failed clinically. Recently, 
studies have shown that some cancer cells can use proteolysis to mechanically 
rearrange their ECM to form tube-like “microtracks” which other cells can follow 
without using MMPs themselves. We speculate that this mode of migration in the 
secondary cells may be one example of migration which can occur without 
endogenous protease activity in the secondary cells. Here we present a technique to 
study this migration in a 3D, collagen-based environment which mimics the size and 
topography of the tracks produced by proteolytically active cancer cells. Using time-
lapse phase-contrast microscopy, we find that these microtracks permit the rapid and 
persistent migration of noninvasive MCF10A mammary epithelial cells, which are 
unable to otherwise migrate in 3D collagen. Additionally, while highly metastatic 
MDAMB231 breast cancer cells are able to invade a 3D collagen matrix, seeding 
within the patterned microtracks induced significantly increased cell migration speed, 
which was not decreased by pharmacological MMP inhibition. Together, these data 
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suggest that microtracks within a 3D ECM may facilitate the migration of cells in an 
MMP-independent fashion, and may reveal novel insight into the clinical challenges 
facing MMP inhibitors. 
 
3.2 Introduction 
During metastatic invasion, cancer cells escape from the primary tumor site and 
migrate through the body to secondary locations, forming new tumors. Although this 
process is the cause of over 90% of cancer-related fatalities (Christofori, 2006), the 
precise nature of the mechanisms governing this behavior remains elusive. 
Additionally, tumor cell migration has been shown to be adaptable to both inherent 
and induced changes in their microenvironment (Friedl and Wolf, 2010; Sanz-Moreno 
et al., 2008), a phenomenon which remains difficult to accurately study in vivo or in 
vitro (Sabeh et al., 2009). 
 
As tumors develop, they induce changes in the peritumoral microenvironment 
(Levental et al., 2009). Fibroblasts and other stromal cells deposit increased amounts 
of fibrillar collagen (Provenzano et al., 2008a), collagen crosslinking by lysyl oxidases 
and tissue transglutaminases is upregulated (Levental et al., 2009; Mehta et al., 2004), 
and increased tension generated on the extracellular matrix (ECM)(Samuel et al., 
2011) leads to collagen fiber bundling and alignment perpendicular to the tumor front 
(Provenzano et al., 2006). This alignment has been shown to drive cancer cell 
invasion, as cells will migrate away from the tumor along these aligned fibers 
(Provenzano et al., 2008b; Wang et al., 2002). Moreover, ‘leading’ cancer cells have 
been shown to invade the ECM using proteolytic degradation (Gaggioli et al., 2007; 
Hotary et al., 2003; Sabeh et al., 2004; Wolf et al., 2007).  These cells cleave collagen 
fibers using matrix metalloproteinases (MMPs) and reorganize them into parallel 
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bundles, creating a tube-like ‘microtrack’ (Friedl and Wolf, 2008; Wolf et al., 2007). 
Other ‘following’ cancer cells can in turn migrate through these open environments, 
either individually (Gaggioli et al., 2007; Wolf et al., 2007) or as collective strands 
(Alcaraz et al., 2011; Ilina et al., 2011), which can eventually widen the microtrack 
further. While proteases are required to form these channels initially, cells that 
subsequently follow these cleared microtracks do not need to further degrade the 
matrix. Therefore this mode of migration in the secondary cancer cells may be one 
example of true protease-independent migration which exists in vivo, and we 
speculate that it may also help to explain the general ineffectiveness of clinical MMP 
inhibitors (Coussens et al., 2002), if they are administered after initial invasion has 
begun and microtracks have already been formed.  
 
While this type of migration behavior has been noted in several different cancer 
subtypes, including carcinomas and fibrosarcomas (Friedl and Wolf, 2003; Gaggioli et 
al., 2007; Wolf et al., 2007), it remains difficult to mimic the process in vitro. 
Microfabrication techniques have recently become popular for studying microtrack 
motility, analyzing tumor cell behavior within the confines of rigid PDMS or silicon 
channels (Balzer et al., 2012; Irimia and Toner, 2009; Mak et al., 2011; Pathak and 
Kumar, 2012; Rolli et al., 2010). These studies have shown that cancer cells will 
readily deform their cytoskeleton to squeeze through highly restrictive channels, to a 
greater extent than non-cancerous cell types (Mak et al., 2011). Additionally, several 
studies have demonstrated that cell migration speed is dramatically affected by 
channel width; once the channel width is significantly wider than the cell body width, 
to the point that the cell does not sense confinement, the cells will revert to a less 
persistent motile state, similar to that observed on unconstrained 2D environments 
(Balzer et al., 2012; Irimia and Toner, 2009). While these studies have yielded useful 
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insight into tumor cell behavior within physically confined spaces, the relevance of 
these findings to physiological conditions is uncertain. Specifically, PDMS substrates 
generally have a Young’s modulus of ~1000 kPa (Ochsner et al., 2007), while the 
native microenvironment in which these cancer cells are found tends to be < 1 kPa 
(Lopez et al., 2011; Paszek et al., 2005). Stiffness has been found to have a profound 
effect on tumor cell physiology, directly mediating cell spreading, adhesion, 
migration, and force generation (Kraning-Rush et al., 2012a; Levental et al., 2009; 
Paszek et al., 2005). Therefore, the stiff nature of the PDMS channels may induce 
changes in the cells’ cytoskeletal organization and function that are not necessarily 
recapitulated in vivo.  
 
Recently, a study by Pathak & Kumar has partially overcome this limitation by 
patterning microchannels using polyacrylamide, a soft, viscoelastic hydrogel whose 
mechanical properties can be precisely tuned (Pathak and Kumar, 2012). Using a 
stiffness range of 400 Pa to 120 kPa, they find that migration speed is increased with 
increasing stiffness under mechanical confinement in 10 m wide channels. 
Additionally, they attribute this behavior to an increased induction of polarity in actin 
stress fibers and traction forces in cells seeded in these narrow channels (Pathak and 
Kumar, 2012). While this technique allows for the separation of the individual effects 
caused by physiologically-relevant matrix stiffness and physical confinement, it does 
not recapitulate the subcellular fibrillar architecture of the ECM that can be sensed by 
tumor cells (Provenzano et al., 2006). Moreover, polyacrylamide cannot be degraded 
or remodeled by the cell. Alternatively, Ilina et al. have recently used two-photon laser 
microsurgery to create defined microtracks within dense 3D collagen matrices to study 
collective cell migration in tumor spheroids (Ilina et al., 2011). By utilizing a collagen 
matrix, this technique allows the cancer cells to proteolytically degrade and reorganize 
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the collagen fibers. However, the effects of laser ablation on the collagen fiber 
structure are unclear.    
 
In this study we present a technique in which cancer cell motility can be studied in a 
physiologically relevant, 3D environment which mimics the complex architecture of 
the native peritumoral ECM. Using micromolding technologies (Nelson et al., 2008), 
microtracks can be accurately and reproducibly patterned across a range of collagen 
densities, and can mimic the structure of native tracks produced by proteolytically 
active cancer cells. Our data indicate that these microtracks permit the rapid and 
persistent migration of epithelial cells which cannot invade a 3D collagen matrix. 
Additionally, highly metastatic breast carcinoma cells, which can significantly invade 
a 3D matrix, have enhanced motility within the collagen microtracks. Interestingly, 
this migration is not slowed upon MMP inhibition, suggesting that migration within 
previously established microtracks can continue to occur in the absence of MMP’s. 
This result may partially explain the lack of success of MMP inhibitors in clinical 
trials (Coussens et al., 2002). 
 
3.3  Materials and Methods 
Cell Culture and Reagents 
MDAMB231 highly metastatic breast adenocarcinoma cells (American Type Culture 
Collection (ATCC), Rockville, MD) were maintained in Minimum Essential Medium 
supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin 
(Invitrogen). GFP-expressing MDAMB231 cells (Cell BioLabs, San Diego, CA) were 
maintained in Dulbecco’s Modified Eagle Medium supplemented with 2 mM L-
glutamine, 10% fetal bovine serum, 0.1 mM MEM non-essential amino acids, and 1% 
penicillin-streptomycin (Invitrogen). MCF10A mammary epithelial cells (ATCC) 
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were maintained in Dulbecco’s Modified Eagle Media supplemented with 5% horse 
serum, 20 ng/mL EGF (Invitrogen), 10 g/mL insulin, 0.5 g/mL hydrocortisone, 100 
ng/mL cholera toxin (Sigma-Aldrich, St. Louis, MO), and 1% penicillin-streptomycin 
(Invitrogen)(Debnath et al., 2003). All cells were cultured at 37°C and 5% CO2. For 
migration studies, GM6001 and the functionally inactive structural analog to GM6001 
(N-t-butoxycarbonyl-L-leucyl-L-tryptophan methylamide, labelled here NC-GM6001) 
(Millipore, Billerica, MA) were applied to cells at a concentration of 20 M. BB2516 
(Sigma-Aldrich) was applied to cells at a concentration of 200 M (Wolf et al., 2003). 
A commercial protease inhibitor cocktail  (Cytoskeleton, Denver, CO) was applied 
containing working concentrations of 1 M pepstatin A, 1.5 M leupeptin, and 1 mM 
benzamidine, and 0.4 mM na-p-tosyl-L-arginine methyl ester (TAME).  
 
RNA Interference and qRT-PCR 
MDAMB231 cells at 70% confluency on tissue culture plastic were transfected with 2 
nM non-targeting (control) siRNA or siRNA targeting MMP14 (MT1-MMP) using 
Lipofectamine 2000 (2 g/mL, Invitrogen). The non-targeting sequence was 5’-UUC 
CUCUCCACGCGCAGUACAUUUA-3’. The sequence targeting MMP14 was 5’-
CCUACGAGAGGAAGGAUGGCAAAUU-3’. Both the control siRNA and the 
siRNA targeting MMP14 (accession number NM_004995.2) were synthesized by 
Invitrogen. siRNA knockdown was confirmed with qRT-PCR.  
 
Total RNA was isolated three days post-transfection using RNeasy® Plus Mini Kit 
(Qiagen, Valencia, CA) and was converted to cDNA by first combining 1 g total 
RNA, 4 M random primers (Invitrogen), and 0.5 mM dNTP mix (New England 
BioLabs, Ipswich, MA), and incubating for 5 minutes at 70°C. 1X reverse 
transcription buffer, 2U RNase inhibitor, and 10 U M-MuLV reverse transcriptase 
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(New England BioLabs) were added and the mixture was incubated at 42°C for 1 hour 
and 90°C for 10 minutes in a iCycler Thermal Cycler (Bio-Rad, Hercules, CA). 2U 
RNase H (New England BioLabs) was added to the mixture and incubated for 20 
minutes at room temperature prior to storage at -20°C. qRT-PCR was performed with 
1 g of cDNA and 0.4 M of specific primers against MMP14 (Forward: 5’-
TGTGACGGGAACTTTGACACCG-3’; Reverse: 5’-ACGCTGCCCTTGAAACTGT 
GGC-3’, Integrated DNA Technologies, Coralville, IA) and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH; Forward: 5’-CATGAGAAGTATGACAACAGC 
CT-3’; Reverse: 5’-AGTCCTTCCACGATACCAAAGT-3’) using 1X iQ SYBR 
Green Supermix (Bio-Rad) on a MyiQ Single-Color Real-Time PCR Detection 
System (Bio-Rad). 
 
Microscopy 
Phase contrast imaging was performed in a custom temperature, humidity, and CO2-
controlled stage of a Zeiss Axio Observer Z1m inverted phase contrast microscope 
equipped with a Hamamatsu ORCA-ER camera and operated by AxioVision software 
(v. 4.8.1.0). Confocal fluorescence and reflectance imaging was performed with a 
Zeiss LSM700 confocal microscope on a Zeiss AxioObserver Z1 inverted stand 
equipped with a long working distance water-immersion C-Apochromat 40x/1.1 NA 
Zeiss objective and operated by Zen software (v. 2010, Carl Zeiss MicroImaging 
GmbH, Jena, Germany). Confocal reflectance images were obtained as previously 
described (Carey et al., 2012; Kraning-Rush et al., 2011). 
 
Microtrack Fabrication 
Silicon Master Fabrication and Imaging 
Standard 100 mm-diameter silicon wafers containing wells measuring 10 x 300 and 10 
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x 1100 m2, spaced 500 m apart were coated with photoresist (SPR 220-3.0 series) 
and etched to a depth of 20 and 30 m as previously described (Charest et al., 2012). 
Wafers were imaged using a Leica 440 scanning electron microscope to confirm 
feature dimensions. These molds were used to cast poly(dimethylsiloxane) (PDMS, 
Ellsworth Adhesives, Germantown, WI) stamps using a standard 1:10 ratio of 
crosslinking agent to monomer.  
 
Preparation of Collagen Microtracks  
All collagen matrices were prepared using collagen extracted from rat tail tendons 
(Pel-Freez Biologicals, Rogers, AR) without pepsin as previously described (Carey et 
al., 2012). A 10 mg/mL stock solution was diluted to the desired collagen 
concentration (1.5 – 5 mg/mL) with ice-cold culture media and neutralized to pH 7.0 
with 1N NaOH. PDMS stamps were rendered non-adhesive by coating with a 1% 
solution of bovine serum albumin (BSA, Sigma-Aldrich) in PBS at room temperature 
for 30 minutes. Modified stamps were inverted on a drop of diluted neutralized rat tail 
type I collagen between two thin PDMS spacers (~1.25 mm thick) and allowed to 
polymerize for 90 minutes at 37°C in a method similar to that described by Nelson et 
al. (Nelson et al., 2008). To facilitate confocal fluorescence or reflectance imaging, 
microtracks were prepared on 43 x 50 mm glass coverslips, with 22 x 22 mm 
coverslips adhered with vacuum grease for spacers. Small glass coverslips were 
removed after polymerization and microtracks were mounted onto custom made 
chambers to create a 35 mm diameter well surrounding the patterned microtracks. For 
cellular experiments, after stamps were removed, a dilute suspension of cells was 
applied (~80,000 cells/mL) and allowed to settle within the collagen tracks for 2-3 
minutes at 37°C. Excess cells were carefully removed by rinsing with ice cold culture 
medium. A second thin layer of collagen, polymerized onto an 18 mm
2
 diameter round 
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glass coverslip, was inverted onto the tracks to serve as a lid. Microtracks were 
incubated with collagen lids for 5 minutes at 37°C before being immersed in culture 
medium.  
 
Microtrack Dimension Analysis 
Patterned Microtracks 
The dimensions of the patterned tracks were quantified from confocal reflectance 
images. 1 m z-stacks were acquired of each track, and analyzed using ImageJ 
software (v. 1.44p, National Institute of Health, Bethesda, MD). The center z slice was 
determined and a grid of horizontal and vertical lines spaced 10 m apart was overlaid 
onto the image. The line drawing function was used to measure the length across the 
track every 4 m (2 measurements per track) and the width every 20 m (15 
measurements per track). To measure the depth of the track, the orthogonal view 
function in the Zen software was used to visualize the track in the x-z plane. This 
image was exported and analyzed in ImageJ using a similar grid, with measurements 
taken every 20 m (15 measurements per track). Dimensions were quantified for n > 
45 tracks per collagen concentration and are reported as Mean ± SD.  
 
Naturally Formed Microtracks in 3D Collagen Matrices 
A 10 mg/mL type I collagen stock solution was diluted to a 1.5 mg/mL solution with 
ice-cold culture media and neutralized to pH 7.0 with 1N NaOH. GFP-MDAMB231 
cells were seeded into the collagen matrices in a glass bottom 24-well plate (MatTek, 
Ashland, MA) at low density (50,000 cells/mL) to minimize cell-cell interactions. 0.5 
mL solution volume was added to a 24 well plate and incubated for 1 hr at 37°C for 
collagen polymerization. Gels were overlaid with 0.5 mL pre-warmed culture media 
and incubated for 48 hours. Gels were fixed with 3.7% (v/v) formaldehyde (JT Baker, 
 80 
 
Phillipsburg, NJ) in phosphate buffered saline (PBS) and imaged with confocal 
fluorescence and reflectance. 
 
The dimensions of the natural tracks formed by the cells were quantified from 
confocal reflectance z-stacks with 1 m slices using ImageJ software. Z stacks were 
rotated such that the track was primarily horizontal and a grid of 10 x 10 m squares 
was overlaid onto the image. The width of the track was measured every 10 m. 
Widths were quantified for n > 25 tracks. 
 
Cellular Studies 
Fluorescent Staining 
Cells seeded in collagen microtracks or 3D collagen matrices were allowed to spread 
overnight and were fixed with 3.7% (v/v) formaldehyde in PBS and permeabilized 
with 1% (v/v) Triton (JT Baker) in PBS. Samples were blocked with PBS/0.02% (v/v) 
Tween (JT Baker) with 3% (w/v) BSA and incubated with a diluted 1:100 Alexa Fluor 
594-conjugated phalloidin (Invitrogen) in PBS to localize filamentous actin. Nuclei 
were stained with a 1:100 dilution of 4’,6-diamidino-2-phenylindole (DAPI, Sigma-
Aldrich) in purified deionized water. 
 
Cell Migration Studies and Morphology Analysis 
Cells were either seeded into 1.5 mg/mL type I collagen gels or into 3 mg/mL collagen 
microtracks at low density as described above. Gels and microtracks were incubated 
for 10 hours prior to phase contrast time-lapse imaging. Cells were imaged every 10 
minutes for 8 hours. Dividing cells and cells that did not move from their original 
location after 4 hours were excluded from analysis. Detailed information about these 
cells can be found in Table 3.1. ImageJ software was used to determine the area, 
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perimeter, aspect ratio (length of long axis / length of short axis), and circularity, 
defined as (4πArea/Perimeter2), where a circle has a value of 1, and a straight line has 
a value of 0 (Cornhill et al., 1980; Kraning-Rush et al., 2011). Cell centroid position 
based on cell outlines and was used to calculate the mean-square displacement 
(<d
2
>)(Stokes et al., 1991). For both the 3D migration within the collagen gels and 2D 
migration studies on tissue culture plastic, cell migration speed (S) was determined by 
fitting the <d
2
> and the time interval (t) to the persistent random walk equation: 
                                             (3.1) 
where P is the persistence time, using nonlinear least squares regression analysis as 
previously described (Reinhart-King et al., 2008). Because cells traveling in collagen 
microtracks do not travel in a random walk, but can only migrate in two directions, 
speed was calculated by dividing the final displacement by time, for cells migrating in 
one direction for a length of 100 minutes. Maximum invasion distance was quantified 
for all cells in both the 3D gels and the collagen microtracks by determining the 
displacement of the cell from its initial position at each time point up to 100 minutes. 
The maximum value calculated was considered the maximum invasion distance. 100 
minutes was selected as the cutoff point to minimize the number of cells which 
migrated out of the field of view in the microtracks. 
 
Statistical Analysis 
Data were compared using analysis of variance with a post-hoc Tukey’s Honestly 
Significant Difference (HSD) test or Student’s t test where appropriate using JMP 
software (v.9, SAS, Car, NC). Statistical significance was considered with p < 0.05. 
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3.4 Results 
Patterning of collagen microtracks 
It has been shown previously that some subsets of cancer cells are capable of 
proteolytically degrading and reorganizing ECM fibers in such a way that a stable 
cleared pathway through a 3D matrix is generated (Fig. 3.1A) (Friedl and Wolf, 2008; 
Wolf et al., 2007). Our goal was to re-create these pathways in vitro in a defined and 
controllable manner to create a system that could then be used to explicitly study this 
unique method of cancer cell migration (Fig. 3.1B). To accomplish this, we adapted a 
method pioneered by Nelson et al. (Nelson et al., 2008) that uses a PDMS stamp cast 
from a silicon master to micromold a neutralized collagen solution into wells with 
defined dimensions (Fig. 3.1C). 
 
To determine the relevant dimensions to use for patterning microfabricated tracks for 
our in vitro system, natural tracks formed by GFP-labeled MDAMB231 metastatic  
breast cancer cells embedded within collagen matrices were analyzed. After 48 hours 
of migration, the cells were fixed and natural tracks were imaged using confocal 
microscopy (Fig. 3.2A). The widths of the natural tracks were analyzed (Fig. 3.2B) 
and found to have an average width of 13.7 m (Fig. 3.2B, red dotted line). These 
tracks were widely heterogeneous, both within a single track (average SD = 2.74 m) 
and across tracks created by different cells (SD = 4.3 m). Standard photolithographic 
techniques were used to etch wells into a silicon wafer with a width of 10 m (Fig. 
3.3A), a width calculated in over 50% of the tracks analyzed. PDMS stamps cast from 
this wafer were then used to imprint wells into a collagen gel, creating an array of thin, 
shallow wells that could be readily imaged using conventional phase contrast 
microscopy for time lapse studies (Fig. 3.3B). Additionally, because of the inherent 
differences in the refractive index of the collagen fibers and the spaces between them,  
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Figure 3.1. Schematic of method for patterning collagen microtracks. (A) A 
cancer cell migrating in a 3D matrix cleaves extracellular matrix fibers using 
proteases, creating an open pathway at the rear of the cell body. (B) Within a patterned 
3D track, cancer cells can migrate through the matrix without the need for proteolytic 
activity. (C) Microtracks are created in a collagen gel using a PDMS stamp to 
micromold a neutralized collagen solution. 
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Figure 3.2. Metastatic cancer cells create heterogeneous tracks within 3D 
collagen matrices. (A) GFP-labeled MDAMB231 metastatic breast carcinoma cell 
creates a proteolytic track within a type I collagen matrix. Scale bar = 20 m. (B) Plot 
of track widths in naturally formed tracks indicate a wide range of widths observed 
across different tracks, as well as significant deviation within a single microtrack. 
Each point represents one track (Mean ± SD). Red dashed line indicates overall mean 
across all tracks analyzed. 
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Figure 3.3. Imaging of silicon master and collagen microtracks. (A) SEM image of 
silicon master etched with wells measuring 300 x 10 x 25 m (w, l, d). (B) Phase 
image of patterned collagen microtracks. (C) Confocal reflectance image of collagen 
fibrils around the tracks. Scale bars = 100 m. 
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the microstructure of the patterned tracks could be directly imaged using confocal 
reflectance microscopy (Fig. 3.3C)(Carey et al., 2012; Kraning-Rush et al., 2012b; 
Kraning-Rush et al., 2011). 
 
Patterned collagen microtracks mimic natural tracks formed by cancer cells 
By subsequently capping the polymerized collagen wells with an additional thin layer 
of polymerized collagen, an open pathway or ‘microtrack’ entirely encased in collagen 
was successfully created in vitro (Fig. 3.4A). The dimensions of the patterned tracks 
were characterized by measuring their length, width, and depth over 1.5 – 5 mg/mL 
collagen. Concentrations lower than 1.5 mg/mL and above 5 mg/mL became more 
difficult to consistently replicate using this method of collagen polymerization. Lower 
concentrations of collagen led to poorly formed tracks, as the collagen lids appeared to 
sink into the track body, while higher concentrations polymerized too quickly and had 
observable defects. Within this range, the track length across collagen concentrations 
was the parameter with the highest fidelity compared to the original pattern of the 
silicon master, with only a slight increase in length noted in the 5 mg/mL collagen 
condition (Fig. 3.4B). Our analysis indicated that, while all tracks were patterned with 
stamps of equal width (10 m) and depth (20 m), the resulting width increased with 
collagen density (Fig. 3.4C), and the resulting depth decreased with collagen density 
(Fig. 3.4D). While the achieved widths were similar to the width of the pattern, the 
achieved depths were around half the depth of the original pattern. However, the 
variation within a given track was fairly low. The average deviations in the length, 
width, and depth within a single microtrack were 0.88 m, 1.38 m, and 1.47 m 
(equivalent to 0.3%, 10%, and 13% difference). Notably, the deviation in width across 
all of the patterned microtracks (11.12 ± 1.29 m – 15.83 ± 3.89 m) encompasses 
over 90% of the range of widths created naturally by the metastatic breast cancer cells 
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Figure 3.4. Microtracks can be reproducibly patterned with a range of collagen 
densities. (A) Confocal reflectance image reflecting the measured dimensions of 
patterned collagen tracks. Scale bar = 50 m. Length (B), width (C), and depth (D) are 
quantified across tracks patterned in 1.5 – 5 mg/mL type I collagen. Mean ± SD; * 
indicates p < 0.05; n > 45 tracks, 2 independent experiments; dotted lines indicate 
length and width of original patterned silicon master. 
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(Fig. 3.2B). Additionally, the architecture of the native tracks was largely similar to  
the architecture observed in the patterned tracks (Fig. 3.5). The dimensions of the 
channel were not altered by the presence of cells. Importantly, the metastatic cancer 
cells were able to actively remodel their environment by attaching to, exerting tension 
on, and subsequently bundling surrounding collagen fibers (white arrows, Fig. 3.5) 
during a relatively short period of migration through the 3D microtrack. Notably, the 
cell within this microtrack is fully bounded by collagen, as indicated by the cross-
section and side-view of the track. We observed that over the course of migration 
through the patterned microtrack, the cell would occasionally pull away slightly from 
one or more walls, without overt preference for either the bottom of the track or the 
lid, but would rarely lose contact completely with the walls. Additionally, we noted 
that the degree of collagen contraction dynamically changes over the course of the 
cell’s migration, as it forms protrusions and pulls against the track walls.  
 
Next, the cell morphology of MDAMB231 cancer cells within a 3D matrix and a 
patterned microtrack was compared. Our data shows that seeding cells within the 
patterned track did not significantly affect their spread area (Fig. 3.6A) or perimeter 
(Fig. 3.6B). Additionally, similar patterns of aspect ratio and circularity are observed 
in both 3D matrices and patterned tracks (Fig. 3.6C). Similar results were observed in 
MCF10A mammary epithelial cells (data not shown). There was also no observable 
difference in actin organization in MDAMB231 cells seeded within 3D collagen or 
patterned tracks. In both cases, the actin was primarily cortical, with a notable lack of 
stress fibers within the cell (Fig. 3.6D-E).  
 
Collagen microtracks facilitate migration in invasive and non-invasive cell types 
Because tracks can provide an uninterrupted path for cells to follow (Ilina et al., 2011),  
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Figure 3.5. Patterned microtracks accurately reproduce tracks formed naturally 
by cancer cells.  Cell-tracker labeled MDAMB231 cell within a patterned collagen 
track which has a fibrillar architecture significantly resembling that of the native 
proteolytic track. Cross-sectional slices indicate that cell is fully bounded by collagen 
(z arrow, right), and that a clear pathway is available for the cell to travel through (z 
arrow, top). Asterisks indicate the ‘lid’ side of the track. Over a period of 5 hours, the 
cell is able to move over 50 m from its initial position, while remodeling the 
extracellular matrix by bundling collagen fibers (white arrows). Scale bars = 20 m. 
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Figure 3.6. The actin cytoskeleton of cells in microtracks is similar to that in a 3D 
matrix. No significant difference (p > 0.05) is observed in MDAMB231 cell area (A) 
or perimeter (B) when plated within a 3D collagen matrix or microtrack environment. 
Mean ± SD; n > 30 cells, 2 independent experiments. Cells in 3D matrices and tracks 
also have similar distributions of aspect ratio and circularity (C). Actin structure of the 
MDAMB231 cell within a 3D matrix (D) and within a patterned collagen track (E) is 
largely cortical. Fluorescent staining of actin fibers (left), confocal reflectance imaging 
of the collagen fibers (middle), and merge image with additional DAPI staining 
(right). View in channel is a single slice of the x-y plane. Scale bar = 20 m.  
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we first examined the effect of the nature of the collagen environment on cell 
migration of a non-invasive mammary epithelial cell line (MCF10A). When seeded 
within a 3D collagen matrix, these cells are able to spread and extend multiple 
protrusions into the matrix, but are largely unable to propel themselves through the 
matrix (Fig. 3.7A). Within 100 minutes, MCF10A cells are only able to penetrate less 
than 25 m away from their initial position (Fig. 3.7B). However, when seeded within 
the patterned collagen microtracks, MCF10A cells are able to quickly and persistently 
migrate through the matrix (Fig. 3.7C). Within 100 minutes of initiating migration, 
these cells are able to move >150 m away from their initial position (Fig. 3.7D), 
more than six times the distance they were able to achieve in a 3D matrix. As expected 
from these observations, the speed and invasion distance of MCF10A cells is 
significantly increased within the collagen tracks, compared to within 3D collagen 
matrices (Fig. 3.7E-F). Moreover, the percentage of motile cells in the tracks is 
increased by over three-fold, compared to cells in 3D collagen (Table 3.1). 
 
The migration behavior of a cell type which is consistently found to be highly invasive 
in a variety of extracellular matrices (Sabeh et al., 2009; Wolf et al., 2007), the 
MDAMB231 metastatic breast cancer cells, was also examined. These cells were able 
to efficiently migrate within 3D collagen, permeating between 50 and 100 m into a 
collagen matrix within 100 minutes (Fig. 3.8A). As expected, these cells were also 
able to migrate persistently within collagen tracks (Fig. 3.8B). Additionally, the 
percentage of motile cells was also increased by nearly 40% in the microtracks (Table 
3.1). 
 
Because previous studies have indicated that MDAMB231 cells require MMP activity 
to migrate (Sabeh et al., 2009), we treated these cells with GM6001, a commonly used  
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Figure 3.7. Tracks facilitate single cell migration in 3D collagen matrix in non-
invasive cells. (A) Time lapse phase contrast images of MCF10A mammary epithelial 
cells migrating in a 3D collagen matrix show relatively little net cell displacement. (B) 
Rose plot shows trajectories of MCF10A cells migrating within a fully 3D type I 
collagen matrix over 100 minutes. (C) Time lapse phase contrast images of MCF10A 
cells within a patterned 3D collagen track demonstrates the ability of these cells to 
significantly invade the track. (D) Rose plot shows trajectories of MCF10A cells 
migrating within collagen tracks for 100 minutes. Note that the trajectories have been 
arbitrarily rotated for a more direct visual comparison. (E) Quantification of cell 
migration speed and (F) maximum invasion distance indicates that MCF10A cells are 
able to migrate more quickly and travel a greater distance within the patterned 
collagen microtracks than within a 3D collagen matrix. Scale bars = 100 m. Mean ± 
SD; * indicates p < 0.05; n > 30 cells, 2 independent experiments. 
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Table 3.1. Analysis of behavior of MCF10A and MDAMB231 cells within 3D 
collagen matrices and patterned microtracks.  
  % Cells Engaging in Behavior  
 
MCF10A 
 
MDAMB231 
 
 
3D Matrix 
Tracks 
3D Matrix 
Tracks 
Motile 
24 
81 
56 
77 
Nonmotile 
66 
14 
21 
9 
Dividing 
10 
3 
21 
9 
Dead 
0          
3 
2 
5 
   n
a
 
124 
    73 
    92 
    64 
a
 Represents total number of cells observed 
 
broad spectrum MMP inhibitor (Sabeh et al., 2009). We found that within a 3D 
matrix, treatment with GM6001 appeared to slightly decrease the invasion of the 
MDAMB231 cells (Fig. 3.8C). Surprisingly, treating cells seeded within collagen 
microtracks with GM6001 significantly increased the invasive capacity of the 
MDAMB231 cells (Fig. 3.8D). When we quantified this data, we found that there was 
no statistically significant difference in cell speed with GM6001 treatment in 3D (Fig. 
3.8E). On the contrary, treatment with GM6001 significantly increased the speed (Fig. 
3.8E) of the MDAMB231 cells seeded within the track microenvironment while 
having no effect on cell migration on a rigid, 2D glass substrate (Fig. 3.8F). To further 
eliminate the possibility that this increase in speed is the result of off-target effects of 
GM6001, a functionally inactive structural analog of GM6001 (NC-GM6001) was 
applied to the cells in both 3D matrices and patterned tracks. Cells treated with NC-
GM6001 displayed speeds that were not statistically different from the speed of 
control cells in either 3D collagen matrices or patterned channels (Fig. 3.8E). 
 
To determine whether this observed increase in speed upon MMP inhibition was 
specific to this particular inhibitor, we treated cells with another commonly used broad 
spectrum MMP inhibitor which has been used clinically, BB2516 (Bramhall et al., 
2001; Wolf et al., 2003; Wolf et al., 2007), as well as a commercial protease inhibitor 
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Figure 3.8. Inhibiting MMP activity increases cancer cell migration through 
collagen microtracks. (A) Rose plot shows trajectories of MDAMB231 metastatic 
breast cancer cells migrating within a fully 3D collagen matrix and (B) in collagen 
tracks over 100 minutes. (C) Rose plots show that treatment with GM6001, a broad 
spectrum MMP inhibitor, decreases invasion in 3D, but (D) increases invasion within 
the collagen tracks. Note that the trajectories in (B) and (D) have been arbitrarily 
rotated for a more direct visual comparison to (A) and (C). (E) Quantification of speed 
indicates that treatment with GM6001 has no effect on speed in a fully 3D matrix, but 
increases the speed of cells within the microtracks. Additionally, treatment with a 
structural analog of GM6001 (NC-GM6001) has no significant effect on speed in 3D 
matrices or microtracks. Mean + SD; * indicates p < 0.05; n > 30 cells, 3 independent 
experiments. (F) GM6001 treatment of cells migrating on 2D glass substrates has no 
effect on cell speed. Mean + SD; n > 40 cells, 1 independent experiment. (G) 
Treatment of cells with other broad spectrum inhibitors (BB2516 and a commercial 
protease inhibitor cocktail) has no effect on cell speed in the tracks. Mean + SD; n > 
60 cells, 2 independent experiments. (H) Similarly, inhibiting MT1-MMP with siRNA 
significantly decreases speed in 3D matrices, but has no effect within tracks. Mean + 
SD; * indicates p < 0.05; n > 30 cells, 2 independent experiments. 
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cocktail (PIC). Interestingly, these data do not show the same trend of increasing 
speed with MMP inhibition observed with GM6001 (Fig. 3.8G). However, migration 
speed is not statistically different from control cells, indicating that treatment with 
these MMP inhibitors does not negatively affect cancer cell migration in the collagen 
microtracks.  
 
Finally, because most exogenous MMP inhibitors act on a broad range of substrates 
and their effects can be difficult to interpret, we chose to specifically focus on a single 
MMP. MT1-MMP has been repeatedly found to be the primary driver of cancer cell 
invasion in 3D (Hotary et al., 2003; Sabeh et al., 2009). Therefore, we specifically 
examined its role in migration within our 3D microtracks. We transfected the highly 
metastatic MDAMB231 breast cancer cells with siRNA targeting MT1-MMP and 
confirmed a 75% knockdown via qRT-PCR. These cells were seeded into either 3D 
collagen matrices or within the patterned collagen microtracks. Our results indicate 
that MT1-MMP knockdown significantly decreased speed within 3D matrices, but had 
no effect on migration speed within the tracks (Fig. 3.8H). These results support our 
findings with the broad spectrum MMP inhibitors, confirming that migration within 
the patterned microtracks can occur independently of MMP activity. 
 
3.5 Discussion 
In this study we demonstrate the use of patterned collagen microtracks to successfully 
mimic the natural tracks formed by cancer cells. Our method for studying microtrack 
migration in single cells is easy to perform using standard laboratory micromolding 
techniques (Fig. 3.1C). We show that tracks can be reproducibly patterned in collagen 
gels (Figs. 3.3-3.4), and using confocal reflectance microscopy, we show that the 
structure of the microtracks is very similar to the architecture of naturally created 
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proteolytic tracks (Figs. 3.2, 3.5). These tracks increase both the migration speed and 
invasion distance of invasive MDAMB231 breast cancer cells and non-invasive 
MCF10A mammary epithelial cells compared to migration speed within 3D collagen 
matrices (Figs. 3.7, 3.8). 
 
In this study we focus on mammary epithelial cells and breast carcinoma cells, 
primarily because the breast microenvironment contains many ‘track-like’ structures 
that our patterned collagen mimics (Gritsenko et al., 2012; Wolf et al., 2007). Initially, 
epithelial cells in the breast exist in duct structures, and tumor cells can migrate along 
these structures during carcinoma in situ before invasion actually occurs. Invasion 
begins when the basement membrane surrounding these ducts is degraded, allowing 
cells to penetrate beyond the duct, making first contact with the surrounding ECM 
fibers, and thus initiating invasion (Gritsenko et al., 2012). At this point the leading 
cancer cells can create new tracks into the surrounding tissue, as described previously 
(Friedl and Wolf, 2008). The structure of the mammary gland microenvironment is 
highly heterogeneous, with regions of loosely connected fibers and regions of densely 
bundled and aligned fibers that develop throughout neoplastic progression (Conklin et 
al., 2011; Gritsenko et al., 2012). Despite the increase in collagen density, there 
remain significant inter-fiber clefts in the peritumoral region which serve as a network 
of microtracks through which cancer cells have been observed to invade. Additionally, 
stromal carcinoma associated fibroblasts have also been shown to create proteolytic 
tracks that tumor cells can subsequently use to invade (Gaggioli et al., 2007).  
 
Although we have focused our study here on the breast microenvironment, these 
tracks could be used to mimic other physiologically relevant microenvironments. We 
use fibrillar type I collagen because it is the most dominant structural protein found in 
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the breast and its effects on tumor cells have been extensively studied in a variety of 
contexts (Levental et al., 2009). However, the techniques described here could be 
readily adapted for use with other structural protein compositions, such as laminin or 
fibronectin, to mimic other regions of the body. For example, there is considerable 
evidence that glioma cells in the brain can invade using similar track-like structures. 
Interstitial migration in the brain has been shown to occur along blood vessels, 
myelinated fibers, and white matter tracts (Gritsenko et al., 2012). These microtracks 
could prove to be a useful method for studying these methods of tumor migration as 
well. 
 
One of the most interesting and surprising results of this study was the effect of the 
broad spectrum MMP inhibitor GM6001 on the migration of metastatic MDAMB231 
breast cancer cells within the confined collagen tracks. While treatment with GM6001 
inhibited cell migration slightly within a 3D matrix, it had the opposite effect on cells 
seeded in the patterned microtracks (Fig. 3.8). We observed a significant increase in 
the migration speed of MDAMB231 cells treated with GM6001 within the 
microtracks. Because GM6001 is known to have significant off-target effects 
(Jacobsen et al., 2008), we treated cells with a functionally inactive structural analog 
(NC-GM6001) (Azuma et al., 2003). We did not observe a similar result with cells 
treated with this negative control, nor did treatment with GM6001 affect cell migration 
speed in 2D (Fig. 3.8F), suggesting that this result does not necessarily stem from an 
off-target effect of the drug. However, we acknowledge that the structural analog may 
not account for 100% of the off-target effects of GM6001. Moreover, our subsequent 
studies with additional broad spectrum inhibitors BB2516 and PIC, as well as our 
MT1-MMP siRNA knockdown studies suggest that this increased cell speed may not 
be a global phenomenon with respect to MMP inhibition, but may instead be specific 
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to this inhibitor. GM6001 acts on over 20 different targets (Levy et al., 1998), some of 
which are also inhibited to various extents by BB2516 and/or PIC, and therefore it is 
difficult to determine if one of these individual targets may be specifically responsible 
for this surprising result. Additionally, broad spectrum MMP inhibitors have been 
shown to induce activation of select MMP’s under certain conditions. In particular, 
BB2516 and GM6001 have both been shown to lead to enhanced pro-MMP2 
activation when tissue inhibitor of metalloproteinase 2 (TIMP2) is present (Ikejiri et 
al., 2005; Toth et al., 2000). Therefore, the complex and varied functions of these 
inhibitors can be difficult to interpret directly. 
 
There are several different mechanisms that could potentially explain the increased 
speed observed with GM6001 treatment, if it is not the result of a simple off-target 
effect. It is possible that one or more of the MMP’s expressed by MDAMB231 cells 
may expose specific cryptic binding sites (Ricard-Blum and Ballut, 2011; Rundhaug, 
2005) on the collagen fibers during proteolytic degradation. These additional binding 
sites may lead to increased cell adhesion and subsequent decreased motility. If these 
cryptic sites remain unexposed when the specific MMP’s responsible are inhibited 
under GM6001 treatment, then this could explain the resulting increase in cell speed. 
Importantly, we have ruled out MT1-MMP as the culprit for this behavior, as our 
siRNA knockdown studies did not yield a similar increase in cell speed; rather, there 
was no observed change in speed compared to controls.  
 
Additionally, we speculate that the increased migration speed of cancer cells under 
GM6001 treatment could potentially be the result of altered receptor shedding. 
Receptor shedding has been a noted phenomenon for many years (Black, 1980), but is 
still not thoroughly understood. Receptor shedding occurs when the extracellular 
 99 
 
region, or ectodomain, of cellular membrane proteins is cleaved by a molecule known 
as a ‘sheddase’ (Huovila et al., 2005). One key class of sheddases are the ADAM 
metalloproteinase disintegrins, although other MMP’s have been shown to induce 
shedding behavior as well (Huovila et al., 2005). Interestingly, ectodomain cleavage 
can either activate or inactivate membrane-bound receptors, depending on the specific 
receptor (Blobel, 2005). It is estimated that 2-4% of proteins on the cell surface are 
subjected to ectodomain shedding (Arribas and Massague, 1995). Ectodomain 
shedding can induce paracrine signalling through the release of growth factors 
(Blobel, 2005). Friedl et al. have shown that MV3 melanoma cells may routinely shed 
21 integrins at cellular detachment sites in 3D matrices, releasing adhesions and 
promoting cell migration, and suggest that this behavior may be a potential 
prerequisite for the release of adhesive junctions (Friedl et al., 1997; Huttenlocher et 
al., 1995). It is possible then that GM6001 may enhance the shedding of integrins or 
other adhesion molecules, which would subsequently decrease the adhesion of the 
MDAMB231 cells to the walls of the channels and potentially lead to increased 
migration speed. Interestingly, BB2516 is often used to inhibit the ADAM proteinases 
which are responsible for many receptor shedding events (Huovila et al., 2005). 
Therefore, this may potentially help explain the differences observed between 
GM6001 and BB2516 treatment. Additionally, GM6001 could be altering the matrix 
deposition or matrix reorganization activities of the cell. Further experiments will be 
required to determine the precise mechanisms governing this phenomenon. 
 
Regardless of the specific mechanism by which GM6001 increases cell speed in the 
microtracks, we observe no impairment in cell migration through the 3D microtracks 
under several different modes of MMP inhibition, suggesting that this behavior occurs 
in an MMP-independent fashion. These data lead us to speculate that perhaps one 
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reason that MMP inhibitors fail when administered to patients (Coussens et al., 2002) 
could be because cancer cells are able to continue migrating within pre-formed tracks 
regardless of current MMP activity. Therefore, if the cancer cells have already begun 
forming these structures at the time that treatment is initiated, then this could explain 
why the MMP inhibitor does not have a significant effect on invasion. 
 
3.6  Conclusions 
We have presented a straightforward and easily adaptable platform for studying tumor 
cell motility in patterned collagen microtracks which mimic the complex architecture 
of the native tumor microenvironment. We have shown that collagen tracks of single 
cell width can be reproducibly patterned over a range of collagen densities, and that 
these tracks qualitatively and quantitatively mimic native proteolytic collagen 
microtracks. Additionally, these tracks facilitate the migration of both non-invasive 
and invasive cell types in a 3D environment in an MMP-independent fashion, perhaps 
revealing novel insight into the clinical challenges currently facing MMP inhibitors.    
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CHAPTER 4 
 
ACTIN CYTOSKELETON AND FOCAL ADHESIONS REGULATE MMP-
INDEPENDENT CANCER CELL MIGRATION IN 3D MICROTRACKS 
 
 
4.1 Abstract 
While tumor cell invasion has long been believed to occur late in cancer progression, 
recent studies suggest that local invasion may actually occur quite early. Therefore, it 
is imperative to study the mechanisms which facilitate this early invasion to determine 
the best way to inhibit it and prevent subsequent metastasis. During invasion, tumor 
cells have been shown to use proteolysis to mechanically rearrange their extracellular 
matrix (ECM) to form tube-like “microtracks” which other secondary cancer cells can 
subsequently follow without having to degrade the matrix themselves. We have 
developed and characterized a novel in vitro 3D collagen microtrack model which 
mimics these tube-like structures. Although extensive work has characterized cancer 
cell migration in 2D and 3D environments, the modes of migration which cells employ 
to migrate within these open microtracks remain poorly understood. 
 
In this study, we examine both the effects of the extracellular microenvironment and 
the intracellular structures and signaling pathways that may drive microtrack 
migration. Interestingly, we find that, while increased collagen density significantly 
inhibits migration in a 3D matrix, cancer cell speed in patterned microtracks is 
unaffected by high collagen density, and cells are able to maintain average speed 
under a 1-integrin blocking antibody. Surprisingly, we find that cancer cell migration 
in microtracks is not dependent on Rho-mediated contractility, but does require an 
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intact, polarized actin and microtubule network, as well as focal adhesion formation 
and turnover. These findings contrast work in rigid channel structures, and show that 
using a physiologically-relevant matrix is essential to informing future clinical and 
non-clinical studies. Additionally, our studies suggest that targeting proteolysis or 
cellular contractility will not inhibit migration in pre-formed tracks, while selectively 
targeting the cancer cytoskeleton may be a better way to specifically inhibit migration 
in 3D microtracks and prevent subsequent metastatic invasion through these open 
paths.  
 
4.2 Introduction 
Despite being responsible for over 90% of cancer fatalities annually, the mechanisms 
governing metastatic invasion remain poorly understood. An inherently inefficient 
process, during metastasis only a small fraction of cells from the primary tumor prove 
capable of initially escaping the tumor microenvironment; even fewer survive the 
subsequent migration through the body, transit through the blood stream, and 
extravasation into tissue to form new substantive proliferating colonies (Bissell and 
Hines, 2011; Hou et al., 2011; Kumar and Weaver, 2009). Because the likelihood for 
tumor cells to complete this process is low, metastasis has been traditionally regarded 
as a later event in cancer progression, one that requires a substantial amount of time to 
allow phenotypic pressures to surface and select for the subset of tumor cells able to 
successfully navigate this complex ordeal. However, recent evidence shows that this 
process can actually begin quite early, and progress in parallel to the growth of the 
primary tumor (Klein, 2009). In a mouse model of breast cancer, disseminated tumor 
cells are detected in the bone marrow of mice within 4-8 weeks, prior to the detection 
of primary tumors of measurable size (>20 weeks) in the mammary gland (Husemann 
et al., 2008). mRNA analysis demonstrated an upregulation of MMPs and cathepsins 
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in these early tumor cells, suggesting that proteolysis could be a primary factor 
facilitating early invasion. 
 
The use of intravital microscopy (IVM) has also revealed more detail regarding the 
invasion process, as tumor cells can be observed in real time migrating away from the 
primary tumor in vivo (Beerling et al., 2011; Giampieri et al., 2010). Studies using 
IVM have shown that proteolytic activity during both single cell and collective cell 
invasion can lead to ECM remodeling and the subsequent formation of cleared matrix 
pathways, or ‘microtracks’ (Friedl and Gilmour, 2009; Giampieri et al., 2009). This 
process begins when tumor cells detach from the original tumor site and begin 
migrating into the stroma via mesenchymal migration (Friedl and Wolf, 2003). Cells 
generate protrusions along their leading edge which attach to the surrounding matrix 
through integrin binding and activation. As the pseudopod elongates, the cell generates 
Rho-mediated contractile forces to pull itself through the matrix. When the cell 
encounters a zone of physical resistance, where its nucleus is restricted by the 
surrounding ECM fibers, it activates a program of pericellular proteolysis to cleave 
these fibers and free the cell body to continue its forward migration (Friedl and Wolf, 
2008). As the cell pushes forwards, it will mechanically reorient and align the 
surrounding collagen fibers along the direction of migration. Finally, the anterior of 
the cell will release its matrix adhesions and glide forward. Thus, in its wake the cell 
leaves behind a proteolytic microtrack, approximately the width of a single cell. As 
subsequent cells move into this space, they no longer encounter the initial zone of 
physical resistance, and therefore have no impetus to degrade the ECM further. As 
multiple cells enter the microtrack, the microtrack can be widened further, both with 
and without further degradation, eventually forming a ‘macrotrack’ and enabling 
collective cell invasion, in the form of strands or sheets, through the ECM (Friedl and 
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Gilmour, 2009; Friedl and Wolf, 2003; Friedl and Wolf, 2008). Interestingly, stromal 
cells, such as cancer-associated fibroblasts (CAFs), have also been shown to create 
microtracks within a 3D ECM through a combination of proteolytic activity and force-
mediated matrix remodeling (Gaggioli et al., 2007; Giampieri et al., 2009).  
 
This form of migration in the follower cells suggests that a form of protease-
independent migration does exist in vivo, and could potentially contribute to the poor 
results obtained with clinical MMP inhibitors, if administered after initial invasion has 
begun. In point of fact, studies have shown that treatment with the synthetic MMP 
inhibitor batimastat initiated prior to tumor implantation and continued throughout the 
lifetime of the mice, led to 100% survival of those mice, with no metastases detected 
(Eccles et al., 1996). In contrast, mice whose treatment began after tumor implantation 
had only a slight reduction in number and size of metastases, and had corresponding 
poor survival rates. Additionally, recent in vitro studies have shown that treatment 
with a broad spectrum MMP inhibitor immediately upon seeding tumor cells within 
3D collagen gels prevents migration. However, if the inhibitor is administered 24 
hours later, cells have formed tracks within the collagen matrix, and can continue to 
migrate within those tracks under MMP inhibition (Fisher et al., 2009). 
 
Previous work in our lab has established a novel in vitro technique for studying 
proteolysis-independent cancer cell migration within fully 3D collagen microtracks 
(Kraning-Rush et al., 2013). We demonstrated that MMP inhibition with either broad-
spectrum protease inhibitors or targeted siRNA has no effect on cell migration speed 
within in vitro patterned collagen tracks (Kraning-Rush et al., 2013). Together, these 
studies suggest that proteolysis is undoubtedly an early requirement for invasion, but 
can perhaps be dispensed of once cells have completed the reorganization of matrix 
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fibers to form pathways through the ECM. Beyond this understanding, however, the 
mechanisms involved in governing this style of invasion remain unclear. Therefore, in 
this study we will examine the role that contractile force generation, actin filaments, 
microtubules, and focal adhesions play in mediating migration within patterned 3D 
collagen microtracks.  
 
4.3 Materials and Methods 
Cell Culture and Reagents 
MDAMB231 highly metastatic breast adenocarcinoma cells (American Type Culture 
Collection (ATCC), Rockville, MD) were maintained in Minimum Essential Medium 
supplemented with 10% fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA)  
and 1% penicillin-streptomycin (Life Technologies, Grand Island, NY). Cells were 
cultured at 37°C and 5% CO2. 4B4 and FITC-4B4 were obtained from Beckman 
Coulter (Brea, CA). Y27632, ML7, blebbistatin, tetradecanoyl phorbol acetate (TPA), 
bisindolylmaleimide I (BIM), Gö6976, cytochalasin D, nocodazole, and paclitaxel 
were acquired from Sigma-Aldrich (St. Louis, MO). CT04 was obtained from 
Cytoskeleton, Inc. (Denver, CO).  
 
RNA Interference and Western Blotting 
MDAMB231 cells at 50% confluency on tissue culture plastic were transfected with 
25 pM non-targeting (control) siRNA or siRNA targeting vinculin, p130Cas or zyxin 
using Lipofectamine 2000 (2 g/mL, Life Technologies). The non-targeting sequence 
was 5’-UUCCUCUCCACGCGCAGUACAUUUA-3’. The sequence targeting 
vinculin (accession number NM_001191370.1) was 5’-
UCCUGGAAAUCAAGCUGCUUAUGAA-3’. The sequence targeting p130Cas 
(accession number NM_001170715.1) was 5’-GCCUCAAGAUCUUGGUGGGCA-
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UGUA-3’. The sequence targeting zyxin (accession number NM_003461.4) was 5’-
CAUGACCAAGAAUGAUCCUUUCAAA-3’. All siRNA’s were synthesized by Life 
Technologies. siRNA knockdown was confirmed with Western blotting.  
 
MDAMB231 cells treated with siRNA in 6 well plates were rinsed once with ice-cold 
PBS and lysed using a solution of 25 mM Tris-HCl, pH 7.4, 0.4 M NaCl, 0.5% SDS 
(Sigma) for 5 minutes with mechanical scraping. Protease and phosphatase inhibitors 
were added to lysis buffer to prevent protein degradation (1 mM sodium fluoride, 1 
mM sodium orthovanadate, and 1:100 dilution of protease inhibitor cocktail 
containing working concentrations of 1.04 mM 4-(2-aminoethyl)benzenesulfonyl 
fluoride (AEBSF), 0.8 M aprotinin, 40 M bestatin, 14 M E-64, 20 M leupeptin, 
15 M pepstatin A, all from Sigma). Cell lysate was cleared by centrifugation at 
14,000 x g and the supernatant was snap frozen and stored at -80
o
C until analysis. 
Lysates were separated by SDS-PAGE and transferred onto nitrocellulose (Bio-Rad, 
Hercules, CA). Blots were probed using antibodies against vinculin (V284, Millipore), 
zyxin (Z4751, Sigma), and p130cas (sc-860, Santa Cruz Biotechnology Inc., Santa 
Cruz, CA). Horseradish peroxidase (HRP)-conjugated secondary antibodies were 
obtained from Cell Signaling Technology. After incubation in SuperSignal West Pico 
Chemiluminescent Substrate (Thermo Scientific, Rockford, IL), blots were exposed 
and imaged using a FujiFilm ImageQuant LAS-4000. Protein densitometry of blots 
was performed with ImageJ software (v. 1.47k, National Institutes of Health, 
Bethesda, MD).  
 
Flow Cytometry 
Matrix binding to 1-integrin was blocked with a mouse monoclonal antibody 4B4 
(Beckman Coulter). 1-integrin expression on the cell surface was quantified with a 
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4B4-FITC conjugate (Beckman Coulter) by FACS analysis using a FACS Aria high 
speed flow cytometer (BD Biosciences, Franklin Lakes, NJ). Separately, MDAMB231 
cells transfected with a GFP-tagged LifeAct plasmid were isolated using the FACS 
Aria flow cytometer. 
 
Microscopy 
Phase contrast imaging was performed in a custom temperature, humidity, and CO2-
controlled stage of a Zeiss Axio Observer Z1m inverted phase contrast microscope 
equipped with a Hamamatsu ORCA-ER camera and operated by AxioVision software 
(v. 4.8.1.0). Confocal fluorescence and reflectance imaging was performed with a 
Zeiss LSM700 confocal microscope on a Zeiss AxioObserver Z1 inverted stand 
equipped with a long working distance water-immersion C-Apochromat 40x/1.1 NA 
Zeiss objective and operated by Zen software (v. 2010, Carl Zeiss MicroImaging 
GmbH, Jena, Germany). Confocal reflectance images were obtained as previously 
described (Carey et al., 2012; Kraning-Rush et al., 2011). 
 
Polyacrylamide Gel Synthesis and Traction Force Microscopy 
Substrates with a Young’s moduli (E) of 5 kPa were synthesized using a ratio of 7.5% 
acrylamide (40% w/v solution, Bio-Rad) to 0.175% N,N’-methylene-bis-acrylamide 
(2% w/v solution, Bio-Rad) as described previously (Kraning-Rush et al., 2012b; 
Reinhart-King, 2008).  Substrate surfaces were functionalized using N-6-
((acryloyl)amido)hexanoic acid, synthesized in our lab (Califano and Reinhart-King, 
2010a), covalently bound to 0.1 mg/mL type I rat-tail collagen (Becton Dickinson, 
Franklin Lakes, NJ). Traction force microscopy (TFM) was performed as previously 
described (Dembo and Wang, 1999; Kraning-Rush et al., 2012b; Kraning-Rush et al., 
2011).  Briefly, cells were seeded on polyacrylamide substrates embedded with 0.5-
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m fluorescent beads and allowed to adhere and spread for 6-8 hours before drug was 
applied. TFM experiments were performed ten hours after initiation of treatment.  
Cells were imaged in phase and bead distributions were imaged in fluorescence before 
and after removal of the cell with trypsin.  Bead displacement within the substrate was 
tracked with correlation-based optical flow and converted into a strain field.  These 
strain fields were converted into traction stresses using the LIBTRC analysis library 
developed by Professor Micah Dembo of Boston University, who invented the basic 
theory that underlies TFM (Dembo and Wang, 1999).  Images were processed with 
LIBTRC software to determine the cellular traction vectors, T, the total magnitude of 
the force, |F|, and the projected cell area. |F| is an integral of the traction field over the 
entire area of the cell, 
           
      dxdyyxTyxTF yx
2/122 ,,
         (2.1) 
where  
      yxTyxTyxT yx ,,,,   is the continuous field of local traction vectors 
defined at local spatial coordinates (x,y) in the projected cell area(Reinhart-King et al., 
2005).  20-60 cells were analyzed per condition.  
 
Microtrack Fabrication 
Collagen microtracks with dimensions of 10 x 1100 x 20 m (w x l x d) were prepared 
using collagen extracted from rat tail tendons (Pel-Freez Biologicals, Rogers, AR) 
without pepsin as previously described (Kraning-Rush et al., 2013; Nelson et al., 
2008). Briefly, patterned PDMS stamps were rendered non-adhesive by incubation for 
30 minutes at room temperature with 1% BSA (Sigma) in PBS before being washed 
twice with a neutralized collagen solution and inverted over a drop of neutralized 
collagen between either two thin PDMS spacers for phase-contrast imaging or onto the 
glass bottom of a modified petri dish (MatTek, Ashland, MA) for confocal imaging. 
Collagen was allowed to polymerize for 90 minutes at 37
o
C before stamps were 
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removed and MDAMB231 cells were seeded into the tracks at low density to 
minimize cell-cell interactions. Patterned microtracks were capped with a collagen lid 
polymerized separately on an 18 mm diameter glass coverslip before being overlaid 
with 2 mL pre-warmed culture media.  
 
Cell Migration Studies and Morphology Analysis 
Cells were either seeded into 1.5-5 mg/mL type I collagen gels or into 1.5-10 mg/mL 
collagen microtracks at low density. Gels and microtracks were incubated for 6-8 
hours prior to phase contrast time-lapse imaging. Cells were imaged every 5 minutes 
for 20 hours for drug treatment experiments and 10 hours for untreated experiments. 
Dividing cells and cells that did not move from their original location after 4 hours 
were excluded from analysis. ImageJ software was used to determine the area, 
perimeter, aspect ratio (length of long axis / length of short axis), and circularity, 
defined as (4πArea/Perimeter2), where a circle has a value of 1, and a straight line has 
a value of 0 (Cornhill et al., 1980; Kraning-Rush et al., 2011). Cell centroid position 
based on cell outlines was used to calculate the mean-square displacement 
(<d
2
>)(Stokes et al., 1991). For 3D migration within the collagen gel matrix, cell 
migration speed (S) was determined by fitting the <d
2
> and the time interval (t) to the 
persistent random walk equation: 
        
 
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
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
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
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t
ePtPSd 12 22                                    (3.1) 
where P is the persistence time, using nonlinear least squares regression analysis as 
previously described (Reinhart-King et al., 2008). 
 
Because cells traveling in collagen microtracks do not travel in a random walk, but can 
only migrate in one of two directions, speed was calculated by dividing the final 
displacement by time, for cells migrating in one direction for a length of 100 minutes. 
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Maximum invasion distance was quantified by determining the displacement of the 
cell from its initial position at each time point up to 100 minutes. The maximum value 
calculated was considered the maximum invasion distance. 100 minutes was selected 
as the cutoff point to minimize the number of cells which migrated out of the field of 
view in the microtracks. 
 
Drug Treatments 
To assess the effects of various inhibitors on cell migration behavior within patterned 
collagen microtracks, cells were seeded as described above. Cells were allowed to 
adhere and spread for 6-8 hours before imaging. Drug was either applied immediately 
prior to imaging or after 4-5 hours of ‘control’ imaging. In either instance, 
quantification of cell speed occurred post-drug treatment.  
 
Fluorescent Staining 
Cells seeded in collagen microtracks were allowed to spread overnight and were then 
fixed with 3.7% (v/v) formaldehyde in PBS and permeabilized with 3:7 ratio 
methanol:acetone for 5 minutes at -20
o
C. Samples were blocked overnight with 
PBS/0.02% (v/v) Tween (JT Baker) with 3% (w/v) BSA (Sigma) and incubated with 
1:100 mouse anti-vinculin primary antibody (#V9131, Sigma) for 2 days at 37
o
C 
under gentle agitation. Cells were then incubated with 1:200 Alexa Fluor 488 goat 
anti-mouse secondary antibody (Life Technologies) for 2 hours and washed overnight 
to remove excess background staining. Cells were then imaged using confocal 
microscopy as previously described (Carey et al., 2012; Kraning-Rush et al., 2013).  
 
GFP-LifeAct Transfection 
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GFP-LifeAct plasmid was a kind gift from Jan Lammerding (Cornell University). 
MDAMB231 cells were seeded at 60% confluence in a 12 well plate and transfected 
after 24 hours. Cells were transfected by combining 3 g DNA plasmid and 3 L 
Transit-2020 transfection reagent (Mirus Bio LLC, Madison, WI) in 100 L 
OptiMEM (Life Technologies) for 20 minutes before adding dropwise to cells in 
complete medium. Optimal transfection was achieved at 48 hours, at which time 
transfected cells were isolated using FACS as described above and seeded into 
collagen microtracks for subsequent confocal imaging.  
 
Statistical Analysis 
Data were compared using analysis of variance with a post-hoc Tukey’s Honestly 
Significant Difference (HSD) test or Dunnett’s test where appropriate using JMP 
software (v.10, SAS, Car, NC). Statistical significance was considered with p < 0.05. 
 
4.4 Results 
Microtrack migration is independent of collagen density and 1 integrin function 
It has been demonstrated that cancer cells can proteolytically degrade the ECM and 
reorganize the cleaved ECM fibers into open pathways which other cells can traverse 
(Friedl and Wolf, 2008; Wolf et al., 2007). Previously, we have established a 
technique to mimic these tracks in vitro by patterning microtracks of single cell width 
within 3D collagen hydrogels. Cells seeded within these microtracks are bounded 
circumferentially by collagen fibers, but can migrate unidirectionally forward or 
backward through the track (Kraning-Rush et al., 2013). To investigate the 
relationship between collagen density and metastatic cancer cell migration, we seeded 
highly metastatic MDAMB231 breast cancer cells into either 3D collagen gels, 
wherein cells are bound on all sides by collagen (Fig. 4.1A), or within patterned 3D  
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Figure 4.1. Collagen density regulates 3D matrix invasion, but not microtrack 
migration. A) Confocal reflectance images of a 3D type I collagen matrix at 1.5, 3 
and 5 mg/mL, showing decreased fibril length and pore size with increasing density. 
B) Confocal reflectance images of microtracks patterned in 1.5, 3 and 5 mg/mL type I 
collagen. Scale bar = 50 m. C) Motile fraction of cells significantly decreases with 
increased collagen density in a 3D matrix. D) Cell speed does not significantly 
decrease within open collagen tracks of the same collagen densities as the 3D 
matrices. E) Time lapse phase contrast images show no difference in MDAMB231 
metastatic breast carcinoma cells migrating within patterned 3D collagen tracks of 
increasing density. Mean ± SD; n > 40 cells.  
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collagen microtracks (Fig. 4.1B) of increasing collagen density. Qualitative analysis of 
the collagen fibers using confocal reflectance imaging showed that within both 
environments, as collagen density is increased from 1.5 to 5 mg/mL, the fiber length 
and pore size decrease. Next, we quantified the number of cells able to move away 
from their initial position within 3D collagen matrices of different collagen densities. 
We find that as collagen density increases, the fraction of cells able to migrate within 
the matrix decreases dramatically, and cells are essentially unable to move within 
dense 5 mg/mL collagen matrices (Fig. 4.1C). In contrast, the motile fraction of cells 
within patterned microtracks does not change with collagen density (data not shown). 
The migration speed of motile cells decreases slightly, but not significantly, over a 
broad range of 1.5 – 10 mg/mL collagen (Fig. 4.1D). Additionally, it is important to 
note that cell speed can vary greatly within the collagen microtracks, ranging from 
~0.5-1.5 m/min. Time-lapse phase microscopy images of representative cells 
migrating in 1.5, 3, and 10 mg/mL patterned collagen tracks show similar 
displacements over 100 minutes (Fig. 4.1E). These data suggest that once the steric 
hindrance of the 3D matrix is overcome, cells become significantly less sensitive to 
ECM density. 
 
To further explore the relationship between a tumor cell’s adhesiveness to collagen 
fibers and migration within patterned collagen tracks, we used a function blocking 
antibody (4B4) to block the 1 integrin on cancer cells after they were seeded within 
the collagen tracks. First, we used a fluorescently conjugated blocking antibody to 
determine the threshold concentration of antibody required to achieve maximal 
blocking. FACS analysis showed that maximal blocking was reached at 10 g/mL 
(Fig. 4.2A-B), consistent with previous reports (Zaman et al., 2006). Interestingly, as 
cells treated with the 1 blocking antibody travel through the collagen microtracks,  
 114 
 
 
 
 
 
 
 
 
 
Figure 4.2. Cell migration within patterned collagen microtracks continues under 
1 integrin blocking. A) Flow cytometry data shows intensity distribution of 4B4-1 
labeled MDAMB231 cells compared to control. B) Mean fluorescence data shows that 
maximum blocking of 1 integrin is reached at 10 g/mL 4B4. C) Time lapse phase 
contrast images show 1-blocked MDAMB231 cells acquire an ‘inchworm’ type 
morphology to migrate within the collagen microtrack. D) Quantification of the aspect 
ratio of a control and 4B4-treated cell during 70 minutes of migration demonstrates the 
morphology switch in the 4B4-treated cell. E) Cell migration speed within collagen 
microtracks is not significantly decreased when 1 integrin is blocked. Mean + SD; n 
> 70 cells.  
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they vacillate between an elongated and mesenchymal-like state (high aspect ratio) 
and a more rounded, amoeboid-like state (low aspect ratio), leading to an ‘inchworm’ 
style of migration (Fig. 4.2C-D). In contrast, control cells tend to migrate in a steady, 
typically elongated fashion (Fig. 4.1E, 4.2D, open circles). In this manner, they are 
able to maintain cell migration speed similar to control cells (Fig. 4.2E), and may also 
yield insight into why migration speed appears to be largely unaffected by collagen 
density (Fig. 4.1D). 
 
Cellular contractility is dispensable for microtrack migration 
Previous research shows that migration through a 3D matrix requires a balance 
between cell/matrix adhesiveness and traction forces, and suggests that as 
adhesiveness is decreased, a correlating increase in traction force may be required to 
maintain normal migration speeds (Zaman et al., 2006). Therefore, we next looked at 
the explicit role of contractile force generation in mediating cell migration within the 
open pathway of the microtrack. First, we targeted several key members of the 
primary contractility signaling pathway with specific small molecule inhibitors: 
myosin light chain kinase (MLCK, inhibited with ML7), Rho-associated coiled-coil 
containing protein kinase (ROCK, inhibited with Y27632), and the Rho family 
GTPases (inhibited with CT04). We confirmed that these inhibitors decreased 
contractility by performing traction force microscopy (TFM) on treated MDAMB231 
cells seeded on 5 kPa polyacrylamide substrates (Fig. 4.3A). Next, we treated cells 
seeded within the patterned collagen tracks with the same dosages of the inhibitors. 
Interestingly, we found no decrease in migration speed, even when 90% of the cell’s 
traction forces were inhibited with CT04 (Fig. 4.3B). However, when we lower the 
affinity of myosin to actin using the nonmuscle myosin IIA inhibitor, blebbistatin, we  
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Figure 4.3. Contractility inhibition does not impair cell migration in collagen 
tracks. A) Traction forces of MDAMB231 cells on 5 kPa polyacrylamide gels after 10 
hours of treatment with a MLCK inhibitor (ML7), ROCK inhibitor (Y27632), or Rho 
inhibitor (CT04). Mean + SEM; * indicates p < 0.05; n > 30 cells. B) Cell migration 
speed within collagen microtracks is not significantly decreased when contractility 
inhibitors are applied. Mean + SD; n > 30 cells. C) Inhibition of myosin IIa with 
blebbistatin significantly reduces cell speed. Mean + SD; * indicates p < 0.05; n > 50 
cells. D) Time-lapse phase-contrast images show blebbistatin-treated MDAMB231 
cells become elongated, with multiple protrusions, migrating within the collagen 
microtrack.  
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observe a small but significant decrease in migration speed within the patterned tracks 
(Fig. 4.3C). Time-lapse phase microscopy images reveal that cells moving through the 
collagen tracks become elongated, with multiple protrusions extending from the cell 
body (Fig. 4.3D). 
 
Focal adhesions drive persistent migration 
Because myosin II plays a key role in the formation and maintenance of focal 
complexes (Giannone et al., 2007), we next chose to analyze the consequences of 
directly inhibiting focal adhesion formation using siRNA. We chose to first target 
vinculin, a prominent, well-characterized focal adhesion protein shown to be vital to 
regulating cell motility and through both structural and signaling means (Goldmann et 
al., 2013; Mierke et al., 2010). Vinculin simultaneously binds F-actin and talin and -
actinin, the latter two of which bind integrins, thus mediating the connection of the 
cell cytoskeleton to the extracellular matrix and helping to transmit cellular forces 
(Ziegler et al., 2006). It has been shown that vinculin is required early in focal 
adhesion formation, with some evidence showing its presence even in nascent focal 
adhesions, which are highly transient (Tan et al., 2010). Additionally, vinculin knock 
down has been shown to correlate with smaller and fewer focal adhesions, which turn 
over rapidly (Saunders et al., 2006; Zent and Pozzi, 2010).  
 
We first demonstrated that focal adhesions are present in cells within the collagen 
microtracks, with punctuate clustering of vinculin observed at the cell periphery (Fig. 
4.4A, white arrows). Next, we knocked down vinculin expression by ~80% using 
targeted siRNA, confirmed with western blotting (Fig. 4.4B-C). We then seeded 
vinculin KD cells into patterned collagen microtracks and observed their migration 
behavior. While they maintained migration speed similar to cells treated with control  
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Figure 4.4. Focal adhesions are critical for maintaining directional persistence 
within collagen microtracks. A) Confocal fluorescence image of focal adhesions 
stained for vinculin (white arrowheads) within an MDAMB231 cell seeded in a 
collagen track. Scale bar = 20 m. B) Western blotting confirmed knockdown of focal 
adhesion proteins vinculin, p130Cas, and zyxin by ~65-85% (C). D) Cells with 
vinculin and p130Cas proteins knocked down are able to maintain migration speed 
similar to control cells, while zyxin knockdown cells exhibit slightly decreased 
migration speed. Mean + SD; n > 100 cells. E) While control siRNA cells are able to 
maintain migration in a single direction for > 2 hours, vinculin siRNA treated cells 
travel back and forth, reversing direction several times. F) While two thirds of control 
cells migrate without changing direction, only 30% of vinculin siRNA cells are able to 
migrate persistently, while the other 70% reverse direction at least once, and often 
several times. n > 50 cells. 
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siRNA (Fig. 4.4D), we observed that, rather than migrate persistently in one direction 
through the microtrack, as control cells typically do, vinculin KD cells would reverse 
direction multiple times, sometimes in quick succession (Fig. 4.4E-F).  
 
We next assayed two additional focal adhesion proteins which have previously been 
suggested to play a role in mediating migration within 3D collagen matrices – zyxin 
and the scaffolding protein p130Cas (Fraley et al., 2012). Previous research suggests 
that both of these proteins are recruited to mature focal adhesions on 2D substrates, 
and may be less common or absent in nascent adhesions (Beningo et al., 2001; O'Neill 
et al., 2000). However, it has also been demonstrated that there is little association 
between the roles of specific focal adhesion proteins in 2D and 3D motility (Fraley et 
al., 2010). Our results indicate that knockdown of p130Cas does not significantly 
affect cell migration speed within the collagen microtracks, while knockdown of zyxin 
does slightly but significantly decrease migration speed (Fig. 4.4B-D). While zyxin 
depletion has previously been shown to induce periodic oscillations in HT1080 
fibrosarcoma cells migrating within 3D collagen matrices (Fraley et al., 2012), we did 
not observe this phenotype in zyxin siRNA-treated MDAMB231 cells migrating 
within our patterned collagen microtracks. 
 
Next, because it has been shown in the literature that protein kinase C (PKC) 
activation can induce focal adhesion formation in 2D (Woods and Couchman, 1992), 
we stimulated MDAMB231 cells within patterned microtracks with 12-O-
Tetradecanoylphorbol 13-acetate (TPA), a phorbol ester known to activate both 
classical and novel PKCs. Treatment with TPA leads to a statistically significant 
increase in cell speed in the motile population of cells (Fig. 4.5A). To confirm this  
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Figure 4.5. PKC activation and inhibition control cell migration speed within 
collagen tracks. A) Activating PKCs with tetradecanoyl phorbol acetate (TPA) 
significantly increases cell speed, while PKC inhibition (B) via Gö6976 or 
bisindolylmaleimide I (BIM) decreases cell migration speed. Mean + SD; n > 50 cells. 
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finding, we then treated cells within the microtracks with two commonly used 
inhibitors of PKCs, bisindolylmaleimide I (BIM), a general inhibitor which targets 
both classical and novel PKCs, and Gö6976, which is restricted to targeting classical 
PKCs. Both BIM and Gö6976 significantly reduced cell migration speed within the 
collagen microtracks, with BIM inducing a slightly greater effect than Gö6976 (Fig. 
4.5B). These results support our hypothesis that focal adhesion activation and turnover 
could potentially be driving migration within the microtracks. 
 
Actin filaments and microtubules are required for migration 
Because focal adhesions are responsible for transmitting signals from the ECM to the 
actin cytoskeleton (Mierke et al., 2010), we next addressed the role of the cytoskeleton 
in mediating cell migration through the collagen microtracks. Immunostaining within 
the patterned collagen tracks (Fig. 4.6A) shows distinct actin stress fibers (top), as 
well as an established microtubule network (middle). The overall orientation of the 
actin and microtubule cytoskeleton was determined using OrientationJ analysis. 
OrientationJ is a free ImageJ plug-in which can be used to characterize the orientation 
and isotropy of an image both qualitatively (by hue) and quantitatively (by angle 
relative to the horizontal axis) (Brownfield et al., 2013; Fonck et al., 2009). The 
prevalence of blue-purple pseudo-coloring in both actin and microtubule images (Fig. 
4.6B) indicates fiber orientation that is largely parallel with the horizontal axis, which 
lies along the length of the track (see inset). Quantification of the orientation angles of 
the fibers was assessed with respect to the axis of the microtrack (0
o
), and confirms 
that ~70% of both actin fibers and microtubules align within 10 degrees of the track 
axis (Fig. 4.6C).  
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Figure 4.6. Actin filaments and microtubules align along the length of the 
microtrack. A) Confocal fluorescence images of stained actin filaments (red) and 
microtubules (green) of a MDAMB231 cell within a patterned collagen track (dotted 
white line). Scale bar = 10 m. B) Orientation analysis of the actin and microtubule 
structure (maximum z projection) reveals a significant orientation bias towards the 
axis of the track (set at 0°) Inset is a legend for hue with orientation angle. C) 
Quantification of the orientation analysis showing ~70% of actin filaments (top) and 
microtubules (MTs, bottom) aligned within ±10° of microtrack axis. Mean ± SEM; n 
= 14 cells.  
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We then treated cells with inhibitors cytochalasin D (CD) and latrunculin A (LA), 
which depolymerize actin by binding to the growing, barbed, ends of F-actin or by 
binding G-actin, respectively. Both drugs abolished migration in collagen channels 
(Fig. 4.7A-B, black bars), even in cells that were migrating quite persistently prior to 
treatment (Fig. 4.7C). Because previous reports in the literature suggest that cancer 
cells can continue to migrate in rigid PDMS channels when actin is depolymerized 
(Balzer et al., 2012), we repeated these experiments in PDMS channels of equal width 
to the patterned collagen tracks. Interestingly, we find that a subset of cells is able to 
continue to migrate in the rigid channels under actin depolymerization, although their 
speed is slower than controls (Fig. 4.7A-B, white bars). Surprisingly, we observe that 
CD and LA may have some differential effects, as a larger subset of LA-treated cells 
are still able to migrate compared to CD-treated cells, which appear to qualitatively 
shift their mode of migration to a more amoeboid, less adhesive style (data not 
shown). Next, we transfected the MDAMB231 cells with a plasmid encoding Lifeact, 
a 17 amino acid peptide which stains F-actin without interfering with actin dynamics 
(Riedl et al., 2008). After seeding transfected cells into the patterned collagen tracks 
and allowing them to spread overnight, we imaged actin fibers in real time as a cell 
moved through the microtrack before and after treatment with CD (Fig. 4.7D). After 
addition of CD, we observe an overall dissociation of stress fibers into small actin 
bundles throughout the cell body. Qualitative OrientationJ analysis shows more 
disorganized fibers, no longer aligned with the microtrack axis (Fig. 4.7E).   
 
Finally, we also interfered with microtubule dynamics by either inhibiting microtubule 
polymerization with nocodazole (NC), or stabilizing microtubules with paclitaxel 
(TX) in cells within the collagen microtracks. Under both conditions, there was a 
marked decrease in the number of motile cells, as well as the speed of the motile cells  
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Figure 4.7. Inhibition of actin polymerization affects cell migration differentially 
in collagen tracks and PDMS* channels. A) Cytochalasin D (CD) and latrunculin A 
(LA) abolish motility within patterned collagen microtracks (black bars), while cells 
are still able to migrate within PDMS channels (white bars) under LA and, to a lesser 
extent, CD treatment. B) Migration speed of motile cells within PDMS channels does 
not change under CD or LA treatment. Mean + SD; n > x cells; * indicates p < 0.05; † 
indicates value of 0. C) Time lapse phase contrast images show MDAMB231 cells 
immediately stop moving within the collagen microtracks upon treatment with CD. D) 
Time lapse confocal microscopy images of GFP-LifeAct transfected cells within  
collagen microtracks show that upon treatment with CD, stress fibers depolymerize 
and actin becomes restricted to punctate bundles within the cell. E) Orientation 
analysis of cells under CD treatment shows a loss of polarization along the microtrack 
axis. *PDMS channel experiments performed in collaboration with Michael Mak and 
David Erickson. Collagen channel experiments performed in collaboration with Olivia 
Torre.  
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Figure 4.8. Depolymerizing or bundling microtubules impairs cell migration in 
collagen tracks. A) Nocodazole (NC) and Paclitaxel (TX) reduce motility within 
patterned collagen microtracks. B) Migration speed of motile cells within collagen 
tracks and PDMS channels decreases under NC and TX treatment. Mean + SD; n > 45 
cells; * indicates p < 0.05. Collagen channel experiments performed in collaboration 
with Olivia Torre.  
 
 
 
 
 
 
 
 126 
 
(Fig. 4.8A-B). This data is consistent with results observed in rigid PDMS channels 
(Balzer et al., 2012; Irimia and Toner, 2009; Mak et al., 2013). We speculate that this 
result is due to a loss of the cell’s ability to polarize, a behavior which microtubules 
have long been considered responsible for (Kaverina et al., 2000). Additionally, it is 
important to note that though these two drugs are primarily used to target 
microtubules, they can also affect actin filament structure (Danowski, 1989; Kraning-
Rush et al., 2011).  
 
4.5 Discussion 
While the sequential process of microtrack creation by leader cells and invasion by 
follower cells during cancer progression has been illustrated plainly over the last 
decade, little is known about the fundamental principles governing migration within 
these track structures. Using a novel collagen micropatterning technique, our previous 
research conclusively demonstrated that this form of migration was independent of 
matrix metalloproteinase (MMP) activity, once the track structures were in place 
(Kraning-Rush et al., 2013). Here, we investigate in more detail the role of 
extracellular matrix density, adhesion molecules, signaling pathways, and cytoskeletal 
architecture in mediating microtrack migration of breast carcinoma cells. We find that, 
while increased collagen density drastically reduces a cancer cell’s ability to invade in 
a 3D matrix, it has little effect on a cell’s capacity to migrate through a patterned 3D 
microtrack. Our results indicate that focal adhesions, PKC activation, actin filaments, 
and microtubules are particularly important for the maintenance of persistent 
migration within the tracks.  
 
In contrast, we find that contractile force generation is dispensable for migration 
within the microtrack environment, as evidenced by unimpaired cancer cell migration 
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under inhibition of Rho, ROCK, and MLCK. This result is consistent with previous 
reports in the literature suggesting that Rho/ROCK activity is critical for track-
generating behaviors and matrix remodeling. Provenzano et al. have demonstrated that 
Rho and ROCK are required for the reorganization and alignment of ECM fibers, but 
when tumor cells are exposed to an environment in which the ECM fibers have been 
pre-aligned, this contact guidance is sufficient to facilitate subsequent invasion 
(Provenzano et al., 2008b). Similarly, work by Brownfield et al. recently showed that 
during epithelial branching, contractility is required for the alignment of collagen 
fibers, but is not required for the cells to sense alignment (Brownfield et al., 2013). 
Moreover, Gaggioli et al. showed that Rho/ROCK function is required in stromal 
fibroblasts to generate microtracks within the matrix, but is not required in the 
squamous cell carcinoma cells which follow these microtracks (Gaggioli et al., 2007). 
It has also been shown that some cancer cell lines which maintain an elongated 
morphology also do not require Rho/ROCK signaling to migrate (Sahai and Marshall, 
2003). Our results contribute to these findings by demonstrating that the contact 
guidance behavior within collagen microtracks is similarly independent of Rho-
mediated contractility. Together, these findings implicate Rho/ROCK contractility in 
an earlier invasion step, likely during microtrack formation.  
 
Instead, our results point towards focal adhesions and the cytoskeleton as primary 
regulators of cancer cell migration in collagen microtracks. When vinculin is knocked 
down with siRNA, we find that cancer cells are still able to move within the tracks, 
but cannot maintain persistent migration; instead, 70% of cells transfected with 
vinculin siRNA reverse direction at least once, in contrast to the 35% of control cells 
which reverse direction. This data is consistent with a previous study showing that 
inhibition of vinculin significantly inhibited persistent distance of HT1080 
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fibrosarcoma cells in a 3D matrix (Fraley et al., 2010), and implicate vinculin as a 
mediator of cell polarity (Carisey et al., 2013). Mierke et al. also demonstrated that 
vinculin knockout cells were significantly less invasive in a 3D matrix than wild type 
cells (Mierke et al., 2010). Interestingly, they also demonstrated that vinculin-
expressing cells generated significantly higher traction forces, and therefore, they 
subsequently attribute the invasive behavior of vinculin-expressing cells to their 
ability to generate force and overcome the restrictive environment of a dense 3D 
matrix (Mierke et al., 2010). These data coupled with our results indicate that vinculin 
may thus play a role in both microtrack generation during initial invasion and in 
subsequent microtrack migration, perhaps through different mechanisms. Our data 
show that impaired traction forces do not affect persistent migration within the 
microtrack. Therefore, vinculin may also play a role in mediating cell polarity during 
migration (Carisey et al., 2013). Cells with decreased or absent vinculin are thus 
dually impaired – not only unable to exert force to remodel and invade a collagen 
matrix (Mierke et al., 2010), but also unable to persistently migrate within a 
permissive 3D environment. 
 
Interestingly, while previous results have indicated that zyxin depletion leads to 
increased cell speed and oscillating 1D-like migration in the majority of HT-1080 
fibrosarcoma cells migrating within a fully 3D matrix (Fraley et al., 2012), we do not 
directly observe this phenotype within patterned collagen microtracks. One important 
factor which may contribute to these differing observations may be the nature of the 
collagen environment in which these cells are moving. Fraley et al. demonstrate that 
zyxin-depleted cells within a 3D matrix create exceptionally narrow cell tracks 
compared to control cells, which lead to a more restrictive environment than the 
patterned tracks used in this study (Fraley et al., 2012). We speculate that the nature of 
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these cell tracks may potentially be indicative of the cells’ altered ability to degrade 
the matrix, with the result being that cells may not be able to continually degrade the 
matrix. Instead, the cells may oscillate between a matrix-degrading phenotype and a 
motile phenotype, during which they probe the track they have created, leading to the 
observed periodic migration. Significantly more work would be required to 
sufficiently support this hypothesis, which is outside the current scope of this work. 
Alternatively, our results may be explained by the simple fact that, within the open 
pathway of a microtrack, cells will continue to migrate. Within our patterned channels, 
cells which encounter the barrier at the end of the channel typically reverse direction 
and subsequently migrate unidirectionally the other way, regardless of drug or siRNA 
treatment. Therefore, our results may actually be consistent with the previous results, 
depending on what the impetus is for the reversal of the leading edge in zyxin-
depleted cells migrating within 3D collagen. Overall, our results suggest that the role 
of zyxin in mediating 3D migration behavior may be more complicated than 
previously believed, and may require a more in depth analysis of the matrix-degrading 
capabilities of zyxin-depleted cells before it can be firmly established and understood. 
  
Additionally, previous work indicates that p130Cas knockdown cells exhibit impaired 
motility, with decreased cell speed, but increased persistence contributing to a 
unidirectional migratory phenotype in 3D (Fraley et al., 2012; Gu et al., 1999). Our 
data is not inconsistent with these results. Rather, our previous results demonstrate that 
the presence of an open microtrack induces a unidirectional migratory phenotype in 
cells which are otherwise unable to maintain any form of persistent migration in 3D 
(Kraning-Rush et al., 2013). In other words, the unidirectional phenotype is already 
the dominant phenotype in control cells migrating within the patterned collagen tracks. 
 130 
 
Therefore, we would not expect that knocking down p130Cas in cells within the 
patterned tracks to generate an altered phenotype.  
 
While the role of actin filaments and microtubules in mediating 2D and 3D behaviors 
has been fairly well-established (Danowski, 1989; Kraning-Rush et al., 2011; 
Stamenovic et al., 2002), studies have not yet addressed these structures in cells within 
a physiologically-relevant microtrack environment. However, actin and microtubule 
function has recently been studied within rigid PDMS channels (Balzer et al., 2012; 
Irimia and Toner, 2009; Mak et al., 2013). Here, we confirm the findings previously 
shown using actin inhibitors cytochalasin D (CD) and latrunculin A (LA). We find 
that a subset of cells treated with CD and LA are able to continue migration through 
rigid PDMS channels, while migration was completely abolished in cells under the 
same treatment in collagen channels of equal width. However, we find that the 
remaining motile population within the PDMS channels does exhibit decreased 
migration speed. Our PDMS experiments are consistent with a recently published 
computational model of dendritic cells under confinement, which demonstrates that a 
pressure buildup in the cell, modeled as a viscoelastic gel, caused by the confinement 
induced by the rigid channel walls, is sufficient to produce a forward flow of the gel 
(Hawkins et al., 2009). Their model also shows that migration under confinement 
relies on increasing friction caused by the pressure buildup, and is independent of 
adhesion to the channel or contractility within the cell (Hawkins et al., 2009). Our 
results, interpreted in the context of this model, suggest that the collagen microtrack, 
being an inherently compliant substrate, may not be able to induce the same pressure 
buildup within the cell. Therefore, the impetus which drove cell migration forward 
within the rigid channel environment is not present, and migration is immediately 
abrogated upon actin depolymerization. This difference highlights the need to 
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carefully consider the cellular microenvironment when designing new models and 
interpreting results accordingly. Interestingly, our results demonstrating that either 
stabilizing or depolymerizing microtubules impairs cell migration by interfering with 
polarization within collagen microtracks is consistent with similar experiments in rigid 
channels which (Balzer et al., 2012; Irimia and Toner, 2009). These results 
demonstrate that microtubules play an essential role in the migration of cells under 
confinement in a wide range of microenvironments.  
 
These studies are the first to systematically analyze the mechanisms guiding MMP-
independent cell migration within collagen microtracks. Here we use a novel in vitro 
method to pattern 3D collagen microtracks which mimic natural proteolytic 
microtracks. We demonstrate that Rho-mediated contractile force generation is 
dispensable for microtrack migration, which instead requires an intact actomyosin and 
microtubule cytoskeleton and focal adhesions. Collectively, our data suggests that 
these elements are critical to facilitating MMP-independent cancer cell migration 
within 3D patterned collagen microtracks.  
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CHAPTER 5 
 
ADDITIONAL DATA 
 
Portions of these data were published in Scientific Reports (Staunton, 2013). 
 
Over the course of generating data for this dissertation, I have embarked on several 
notable side projects and collaborations which merit further discussion. In this chapter, 
I will provide the motivation, results, conclusions, and potential future steps for two of 
these studies.  
 
5.1  MCF10A and MDAMB231 Characterization 
Preface and Background 
When I first began my graduate research five years ago, I chose to focus my work on 
breast cancer. One of the first decisions I had to make was which cell lines I wanted to 
begin working with. There was a vast array of cell lines available to choose from, each 
with unique properties and with various numbers of publications filled with previous 
research from which I could gather information. I ultimately chose two cell lines 
which had been published on frequently: the MCF10A mammary epithelial cell line, a 
spontaneously transformed line considered by different sources to be ‘normal’ or 
‘nonmalignant’, and the highly invasive MDAMB231 highly metastatic breast 
adenocarcinoma cell line. Although these cells had been widely published on, there 
was no single source devoted to a comparison between the two cell lines. Therefore, 
the first goal of my work was to complete a comparison study of these two cell lines, 
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analyzing their migration, proliferation, spreading area, and force generation on 
substrates of physiological stiffness. This idea was picked up shortly thereafter by the 
National Cancer Institute’s Physical Sciences-Oncology Centers network leadership, 
which began a full-fledged characterization utilizing the broad spectrum of techniques 
available throughout the network’s labs. As part of that study, I quantified the traction 
forces of both cell lines on laminin-coated substrates (Staunton, 2013). Here, I present 
that data, and I put it in the context of the data gathered on collagen-coated substrates, 
presented previously in Chapter 2 (Fig. 2.3A).  
 
Methods 
Wound Healing Assay: Cells were seeded in a six-well plate at a density of 10,500 
cells/cm
2
 and grown to confluence. At confluence, a sterile 200 L pipette tip was 
used to scratch 3 parallel lines into the monolayer. The media in each well were 
refreshed, and an initial time point was captured. Cells were imaged every 12 hours 
until wound was completely filled with cells. Open wound area was outlined and 
quantified in ImageJ. 
 
2D PA Gel Migration: For single cell migration studies, cells were seeded on PA gels 
of varying Young’s moduli (0.2 – 10 kPa) coated with 0.1 mg/mL type I collagen and 
glass at a density of 625 cells/cm
2
. Cells were imaged every 20 minutes for 8 hours. 
Cell centroid position based on cell outlines was determined using ImageJ, and was 
used to calculate the mean-square displacement (<d
2
>) (Stokes et al., 1991). The speed 
(S) and direction persistence time (P) were determined by fitting the <d
2
> and the time 
interval (t) to the persistent random walk equation (Eq. 3.1) using nonlinear least 
squares regression analysis as previously described (Kraning-Rush et al., 2013; 
Reinhart-King et al., 2008). 
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Cell Spreading Area: Cells were seeded at a density of 625 cells/cm
2
 onto 
polyacrylamide (PA) hydrogels of 0.5-30 kPa coated with 0.1 mg/mL type I collagen, 
as well as on uncoated tissue culture plastic and were allowed to spread for 10-16 
hours. Individual cells were then imaged using phase contrast microscopy. Cell 
spreading area was quantified by tracing the outline of each cell in ImageJ.  
 
2D Proliferation: Cells were seeded on PA gels of varying Young’s moduli (1 – 10 
kPa) coated with 0.1 mg/mL type I collagen at a density of 5,210 cells/cm
2
. At each 
time point, gels were washed with ice-cold PBS and fixed with 0.5% crystal violet in 
20% methanol for 3 hours. Gels were rinsed, and crystal violet was eluted with 0.1 M 
sodium citrate (pH 4.2 in 50% ethanol) for 30 minutes. Absorbance was read on a 
BioTek Quant Microplate Spectrophotometer at 595 nm.  
 
3D Proliferation: Cells were seeded within 250 L 1.5 mg/mL type I collagen gels 
and allowed to spread and proliferate for 0-5 days. Acellular gels were polymerized 
and used for a negative control. At each time point, gels were dissolved with papain 
for 14 hours at 60
o
C. Samples were then analyzed using a Quant-iT PicoGreen dsDNA 
Reagent Kit (Invitrogen). Fluorescence was read on a BioTek Quant Microplate 
Spectrophotometer at 485 nm. 
 
Force Generation: PA gels of specific Young’s moduli (5 kPa) were synthesized as 
previously described (Kraning-Rush et al., 2012b), and derivatized with 0.1, 10, and 
50 g/mL of laminin from Engelbreth-Holm-Swarm murine sarcoma basement 
membrane. Cells were seeded onto these gels at a density of 312 cells/cm
2
, allowed to 
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spread overnight, and analyzed by traction force microscopy as previously described 
(Kraning-Rush et al., 2012b). 
 
Results & Discussion 
First, I analyzed the ability of the MCF10A and MDAMB231 cells to migrate on 
tissue culture plastic. Using a conventional wound healing assay, I found that the 
MDAMB231 cells were able to close the wound more quickly than MCF10A cells 
(Fig. 5.1A-B). I also noted that MCF10A cells appeared to migrate collectively, 
maintaining cell-cell connections, whereas MDAMB231 cells appeared to migrate into 
the wound space as single cells. Additionally, the MDAMB231 cells never formed a 
robust monolayer; rather, they began migrating over the top of one another. Next, I 
plated these cells on more 2D polyacrylamide (PA) substrates of physiologically 
relevant stiffness (Young’s Moduli 0.2-10 kPa). The softest substrates (0.2 kPa), have 
been shown to be similar in stiffness to normal mammary tissue, while stiffer 
substrates (5-10 kPa) mimic the stiffness of tumorigenic breast tissue (Paszek et al., 
2005). Interestingly, I found that MDAMB231 cells migrated most quickly on soft 2D 
substrates, while the speed of individual MCF10A cells tended to increase with 
substrate stiffness (Fig. 5.1C). Both cell lines appeared to move at similar speeds on 
stiff substrates (e.g. PA gels of 5-10 kPa and glass). I then analyzed the relationship 
between cell area and stiffness of the two cell lines, again using PA gels. I noted a 
biphasic relationship with stiffness, with maximal spreading area on 5 kPa substrates 
(Fig. 5.1D). 
 
Next, I compared the proliferation rates of the MCF10A and MDAMB231 cells. First, 
I plated cells on soft (1 kPa) and stiff (10 kPa) substrates. No significant difference 
was observed between proliferation on soft (1 kPa) and stiff (10 kPa) substrates for  
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Figure 5.1. Highly metastatic MDAMB231 cells exhibit increased migration. A) 
Representative 10X phase images of the mammary epithelial (MCF10A) and highly 
metastatic (MDAMB231) cancer cells after wounding (0 hr) and throughout their 
migration into the scratch area (24 and 36 hrs) on tissue culture polystyrene. Scale bar 
= 100 m. B) Scratch area normalized to scratch area immediately after wounding is 
plotted against time for mammary epithelial (MCF10A, blue circles) and highly 
metastatic cancer (MDAMB231, red triangles) cell lines. The highly metastatic cancer 
cells invade the wound site more quickly than the mammary epithelial cells, requiring 
only 24 hours to regain 95% confluency. C) Migration speed plotted against the 
Young’s Modulus of the PA substrate (E = 0.2 – 10 kPa) for MCF10A and 
MDAMB231 cell lines. D) Cell area is plotted against the Young’s Modulus of the 
substrate (E = 0.5 – 30 kPa). Both the MCF10A and MDAMB231 cancer cell lines 
exhibit a biphasic relationship between cell spread area and substrate stiffness, with a 
peak area at 5 kPa. Mean ± SEM; *** indicates p < 0.001, ** indicates p < 0.01.  
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Figure 5.2. MCF10A and MDAMB231 exhibit differential proliferation on 2D 
and 3D substrates. A) Proliferation curves of MCF10A and MDAMB231 cells on 1 
kPa and 10 kPa gels over 6 day period, quantified with a crystal violet colorimetric 
assay. Statistics shown comparing stiffness within cell type. B) Proliferation curves of 
MCF10A and MDAMB231 cells cultured in 3D collagen matrices over a 5 day period, 
quantified with a PicoGreen fluorimetric assay. Mean ± SEM. *** indicates p < 0.001, 
** indicates p < 0.01, * indicates p < 0.05.  
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either the MCF10A or MDAMB231 cell lines (Fig. 5.2A), suggesting that in these cell 
types, proliferation may not be regulated by the mechanical microenvironment. 
Interestingly, I observed that the MCF10A non-tumorigenic cell line exhibited greater 
proliferation than the highly metastatic cells, a result that was later confirmed during 
the PS-OC’s characterization study (Staunton, 2013). However, when cells are seeded 
in 3D collagen matrices, the differences in their proliferation behavior become less 
dramatic. After normalizing to the number of cells seeded at day 0, I observed that 
MDAMB231 cells had higher proliferation at day 3, but by day 5, MCF10A cells had 
proliferated slightly, but significantly, more (Fig. 5.2B).  
 
For the PS-OC’s characterization studies, I chose to characterize traction forces 
generated by these two cell lines on laminin-coated substrates. I had previously 
collected on the forces exerted by these cells on collagen-coated substrates, and set out 
to determine what, if any differences would be seen on laminin-coated substrates. The 
stiffness of all the substrates in this study was held constant at a Young’s modulus of 5 
kPa. My initial observations were consistent with the trend I observed on collagen-
coated substrates. I found that on substrates with the highest laminin concentration 
used (50 g/mL), the MDAMB231 cells exerted higher traction stresses than the 
MCF10A cells, and that these stresses appeared localized to the cell periphery (Fig. 
5.3A). When I then looked at the net traction forces across a range of laminin 
concentrations (0.1 – 50 g/mL), I found that MDAMB231 cells exerted significantly 
stronger forces across the entire range (Fig. 5.3B). Note that 50 g/mL of laminin was 
used here in place of 100 g/mL (maximum collagen concentration used in previous 
study), because at high concentrations the laminin began to noticeably aggregate and 
interfere with the traction measurements. Finally, I compared the net traction forces of 
cells on laminin with the net traction forces previously observed on collagen coated  
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Figure 5.3. MDAMB231 cells generate high forces on laminin-coated substrates. 
A) Representative traction maps (left) and corresponding phase images (right) of 
MCF10A and MDAMB231 cells seeded on 5 kPa gels derivatized with 50 g/mL 
laminin.  Scale bar = 50 m. B) MDAMB231 cells exert higher traction forces than 
MCF10A cells across a range of 0.1 – 50 g/mL laminin. Mean + SEM, * indicates p 
< 0.0001. C) Forces exerted by MDAMB231 cells are increased on laminin-coated 
substrates, while forces exerted by MCF10A cells are decreased on laminin-coated 
substrates as compared to collagen-coated substrates. Note that collagen data is from 
Chapter 2 (Fig. 2.3A) and published in (Kraning-Rush et al., 2012a). The laminin data 
was separately published in (Staunton, 2013).  
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PA gels (data from Chapter 2) (Kraning-Rush et al., 2012b). Interestingly, I found that 
the laminin-coated surface led to increased forces in the MDAMB231 cells, compared 
to the collagen-coated surface, but had the opposite effect on the MCF10A cells (Fig. 
5.3C). The MCF10A cells were found to exert weaker forces on laminin-coated 
substrates than on collagen-coated substrates. This result leads to interesting 
speculation regarding the different effects the ECM can have on cellular behavior. The 
differential effects of laminin are particularly interesting, given that laminin is a 
primary component of the basement membrane, a structure which surrounds tumors. 
The basement membrane represents one of the first barriers to metastatic invasion, as 
cells must degrade the membrane to break through it. Based on our results, I speculate 
that the presence of laminin may contribute to an upregulation of cellular force 
generation in tumor cells to facilitate their subsequent invasion through the basement 
membrane.  
 
Future Work 
Between the work presented here and the wider dissemination of knowledge through 
the publication of the results of the PS-OC’s Cell Line Exercise (Staunton, 2013), the 
comparison between these two cell lines can be considered fairly complete. However, 
one key issue that arose during the undertaking of these projects is the fact that these 
cell lines, while excellent models for their respective cell types, have some notable 
limitations. The most important limitation is that the MDAMB231 and MCF10A cells 
are genetically distinct – they bear no relationship to one another, in terms of their 
original derivation. Additionally, while the MCF10A cells are often called ‘normal’ 
cells, this is a misnomer. These cells are transformed and will thus replicate 
indefinitely. As such, they inherently cannot behave in the same manner that a primary 
mammary epithelial cell would. Furthermore, like many cell lines, they have been 
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shown to suffer from genetic drift (Burdall et al., 2003), meaning that cells at high 
passage number are questionable, and highly dependent on the quality of care with 
which they are maintained. Future work should focus either on characterizing many 
more cell lines to yield a broader picture of the cancerous and normal phenotypes, or 
else on characterizing isogenic cell lines in more depths, such as the MCF10AT series 
of cells (Santner et al., 2001), which are derived from the MCF10A cells used here. 
Ultimately, primary cells would yield the most relevant experimental data. 
 
 
5.2 Effects of Hypoxia on Force Generation in MDAMB231 Cells 
Preface 
This project was initiated in April 2010 at the first annual Physical Sciences – 
Oncology Centers (PS-OCs) Network Investigators’ Meeting in National Harbor, MD. 
At the meeting, there was a call for submissions for a Young Investigator Trans-
Network Project award. The goal of these awards was to foster collaboration between 
young scientists (graduate students and postdoctoral fellows) from different PS-OCs in 
an effort to encourage young scientists to embrace the sharing of knowledge and 
techniques across the network. The process was designed such that the young 
investigators initiated and solidified their collaborations on the first day of the 
conference, then wrote a two page proposal containing an identification and statement 
of the problem, a brief research plan with specific aims, project milestones, a 
description of team expertise, and an estimated budget breakdown for the $10,000 
award. The proposal deadline was the afternoon of the second day of the conference, 
followed up with a two minute presentation to the PS-OC steering committee that 
evening.  
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The subsequent data is the result of a collaboration formed in just this manner between 
myself and Dr. Daniele Gilkes, from the Johns Hopkins PS-OC, a postdoctoral fellow 
working jointly in Dr. Gregg Semenza and Dr. Denis Wirtz’s labs, studying the effects 
of the extracellular matrix and hypoxic conditions on tumor cell migration. This 
collaboration lasted for roughly a year and a half, in which time I generated 
interesting, but somewhat conflicting data that was not pursued further. For the 
purposes of this dissertation, only the results collected in the Reinhart-King lab are 
presented. 
 
Background 
The tumor microenvironment is a complex, heterogeneous mix of chemistry and 
mechanics that work together to drive cancer cell proliferation, migration, and 
invasion (Anderson et al., 2006; Cairns et al., 2003). Many factors influence the 
different stages of cancer progression, including chemical and mechanical cues, cell-
cell interactions, and cell-matrix interactions. However, the effect of these independent 
factors on tumors does not exist in a vacuum. While these factors have been studied 
independently, few have been analyzed concurrently within the same system to 
elucidate potential synergistic effects. In this study, the synergistic effects of substrate 
stiffness and hypoxic growth conditions on cell force generation, cell morphology, and 
hypoxia-mediated protein expression levels will be assessed.  
 
Hypoxia has been clinically linked to metastasis and poor patient prognosis, although 
the underlying mechanism remains unclear (Erler et al., 2006; Zhong et al., 1999). 
Moreover, hypoxia has been shown to exert a powerful selective pressure on cell 
populations in vitro, creating more aggressive cancer cells (Graham et al., 1999). 
Pioneering work by the Semenza lab has shown that the ability of cells to survive and 
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adapt to hypoxic conditions is dependent on hypoxia-inducible factor 1 (HIF1), which 
regulates many key angiogenesis, invasion, and migration genes (Krishnamachary et 
al., 2003; Tang et al., 2004; Wang and Semenza, 1993) and has also been shown to 
play a role in vascular remodeling (Rey and Semenza, 2010). Previous studies in the 
literature have found that exposure to hypoxic conditions can increase the 
invasiveness, migration, and matrix metalloproteinases (MMP) activity in 
MDAMB231 breast cancer cells in vitro (Indelicato et al., 2010). Additionally, 
hypoxia has also been shown to act in an epigenetic fashion, altering the expression of 
genes involved in stress responses and angiogenesis, with an indirect causal link to 
metastasis (Koong et al., 2000; Lal et al., 2001; Semenza, 2002; Semenza, 2010; 
Subarsky and Hill, 2003).  
 
While much work has been done on understanding the regulators and effectors of 
HIF1, the effect of the tumor microenvironment on HIF1 expression and regulation 
has been minimal. Previous work has used poly(acrylamide) (PA) gels with tunable 
mechanical properties to look at the traction forces generated by cancer cells on 
substrates that mimic physiological stiffness (Paszek et al., 2005). Compliant 
substrates (1 kPa) are used to mimic normal breast tissue, while stiff substrates (10 
kPa) are used to mimic the stiffness of a tumor. In the Reinhart-King lab, I have 
shown a marked increase in the magnitude of traction forces generated by highly 
metastatic breast cancer cells plated on stiffer substrates under normoxic conditions 
(Kraning-Rush et al., 2012a). As tumor cells naturally exist in a stiff stromal substrate, 
it is likely that the mechanics of the microenvironment that affect force generation 
could also play an important role in mediating the hypoxic response in tumor cells. 
Alternatively, because hypoxia is associated with more aggressive tumors, and I have 
shown that more aggressive tumor cells generate increased contractility, it seems  
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likely that hypoxic conditions can drive force generation in cancer cells. 
 
Therefore, the objective of this project is to characterize the effects of substrate 
stiffness and hypoxia on tumor cell force generation, cell morphology, cell migration, 
and hypoxia-mediate protein expression. I hypothesize that culture under hypoxic 
growth conditions and stiff, tumor-like substrate will cause a synergistic increase in 
force generation in MDAMB231 metastatic breast cancer cells that hypoxia or 
stiffness alone could not create. My goal is to assess the effects of hypoxia and 
substrate stiffness on cancer cell behavior to elucidate cross-talk between hypoxic 
regulation and contractility, and more broadly, to generate a more accurate model for 
studying cancer progression. 
 
Methods 
MDAMB231 metastatic breast carcinoma cells were seeded onto 5 kPa 
polyacrylamide hydrogels conjugated with 0.1 mg/mL type I collagen, synthesized as 
previously described (Kraning-Rush et al., 2012b). Cells were allowed to spread for 
~10 hours under normoxic conditions before exposure to experimental conditions. 
Control cells were kept under normoxic conditions, while other cells were transferred 
into an oxygen controlled incubation chamber held constant at 1% O2, 5% CO2, and 
balance N2 at 37
o
C. These cells were then exposed to either hypoxia or hypoxia 
followed by normoxia (reoxygenation). Traction forces of single cells were obtained 
as previously described. It should be noted that cells under hypoxic conditions were 
either exposed to normoxia for the duration of TFM data collection (as for Fig. 5.4A), 
or transferred into a stage-top incubator and kept under 1% O2 during data collection 
(as for Fig. 5.4B-D).  
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Results and Discussion 
Initial results using a large oxygen controlled chamber kept in an incubator suggested 
that hypoxic conditions may decrease force generation, and that reoxygenation may 
increase force generation compared to cells cultured under normoxic conditions (Fig. 
5.4A). However, because the wide variability in these data resulted in no statistical 
significance, I next explored the range of heterogenous responses to hypoxia within 
the MDAMB231 cell population using a stage top O2-controlled incubation system. I 
next quantified the forces generated by individual cells over time under different 
oxygenation conditions. For my control cells, I incubated MDAMB231 cells on gels 
for 24 hours, prior to 5 hours of TFM analysis. When I normalize the force to the 
initial time point, I find some fluctionation in force, but the majority of the cells do not 
exhibit a significant increase in force (Fig. 5.4B). In contrast, when I expose cells to 7 
hours of hypoxia (Fig 5.4C, blue region), I find an initial decrease in force generation 
followed by a peak force generation significantly higher than the control (normoxic, 
green region) time point. Furthermore, under reoxygenation conditions (red region), I 
see a general increase in force. However, it is important to note the wide variety in 
force patterns of the cells, and the lack of synchronicity of a hypoxic response. These 
differences most likely contribute to the overall decrease in force initially observed 
under hypoxia (Fig. 5.4A). In a final experiment, I cultured cells either under hypoxia 
for 6, 12, 24, 36, and 48 hours, or under 24 hours of hypoxia followed by 6, 12, or 24 
hours of normoxia (reoxygenation). The results of this experiment showed that cell 
forces increased under hypoxia for the first 24 hours, then appeared to decrease at 36 
and 48 hours (Fig. 5.4D). Interestingly, the cells under reoxygenation conditions had 
significantly lower forces, suggesting that perhaps the increase in forces due to 
reoxygenation observed in Fig. 5.4C may be quite transient (< 2 hours). Overall, these 
data suggest that a subset of the cancer cell population may be activated under hypoxic 
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Figure 5.4. Traction forces generated under hypoxia, normoxia and 
reoxygenation. A) Preliminary experiments indicated that traction forces are 
decreased under hypoxia and increased under reoxygenation, although not 
significantly. B) Traction forces of individual cells cultured under normoxia indicate 
that cellular forces can fluctuate by as much as 50% over a period of 5 hours. Each 
line represents one cell. C) Traction forces of individual cells cultured first under 
normoxia (green), then under hypoxia for 7 hours (blue), before finally being exposed 
to normoxia again (red, reoxygenation), indicate that forces may first increase under 
hypoxia, then decrease over time before increasing again under normoxic conditions. 
D) Average traction forces of cells cultured under hypoxia (open circles), or under 
hypoxia for 24 hours followed by reoxygenation (closed squares), compared to 
normoxic controls (red, dotted line) suggest a transient increase in force under 
hypoxia, but a decrease in force under 6 hours or more of reoxygenation. Mean + 
SEM.  
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conditions to exert stronger forces, but not in a prolonged fashion. This transient 
increase in forces could still potentially contribute to the increase in invasion noted in 
the literature. Alternatively, the increased invasion could be due to any number of 
factors unrelated to contractility, such as increased proteolytic degradation or altered 
metabolism. 
 
Future Work 
This is the first study, to my knowledge, of the direct effects of oxygenation 
conditions on cancer cell traction forces. Because the results obtained throughout this 
study did not point to a strong trend of changing forces under hypoxia, it was 
ultimately given lower priority and I did not continue work on it after the grant 
funding ended. However, a great deal of future work could be done on this project to 
better elucidate what is happening at the molecular level with these cells under 
hypoxic conditions. Additionally, altering the stiffness of the polyacrylamide gels 
could induce a more decisive difference in cellular forces. For example, cells cultured 
on softer substrates could be more sensitive to reoxygenation conditions, or cells on 
stiffer substrates could have a synergistic increase under hypoxia and exert forces even 
higher than the elevated forces I have previously described on stiff substrates. Future 
work could also include examining the force generation of HIF-1 and HIF-2 
knockdown cells under normoxia and hypoxia.  
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CHAPTER 6 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
6.1  Conclusions 
Our knowledge of the principles guiding cancer initiation and progression is 
continuing to expand rapidly, and each new study brings us closer to a thorough 
understanding of the disease, but also inevitably highlights the remaining questions 
that must be answered. This thesis contributes to the body of research on cancer 
metastasis by first identifying a potential biophysical indicator of metastatic cells, 
increased contractile force generation, and by then demonstrating when and how this 
behavior contributes to invasion. Moreover, these studies highlight the inherent 
adaptability and plasticity of cancer cells by showing that cellular contractility can be 
dispensable under certain circumstances. Using micropatterned collagen channels 
which mimic the natural invasion paths cells create in vivo, this work demonstrates 
that once cells have remodeled their microenvironment to sufficiently permit invasion, 
cancer cell migration can become reliant upon a different set of unique biophysical 
properties. While this work suggests some potential targets for therapy, it ultimately 
exemplifies the need for a more complete spatial and temporal understanding of 
cancer progression.  
 
In Chapter 2, I hypothesized that increased contractile force generation could be a 
distinguishing characteristic of metastatic cancer cells. This hypothesis resulted from 
the observation that many of the behaviors which tumor cells must engage in within 
the body to invade appear to be dependent upon the cells’ ability to generate force. 
Examples of these behaviors include remodeling the basement membrane to facilitate 
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the initial escape from the primary tumor, reorganizing the surrounding extracellular 
matrix fibers in the stroma, and transmigrating through the endothelial cell barrier to 
reach the bloodstream. Therefore, I sought to determine whether cellular force was 
increased in cancer cells with the ability to metastasize in vivo. Using polyacrylamide 
gels which mimic the stiffness of the breast tumor microenvironment (Young’s 
Modulus (E) = 5 kPa) and 2D traction force microscopy, I found that human-derived 
metastatic cells of multiple lineages (breast, lung, and prostate) generated significantly 
increased traction stresses compared to their non-metastatic counterparts. Moreover, I 
found that both increased stiffness and increased extracellular matrix protein density 
induced metastatic and non-metastatic cells to exert stronger contractile forces, with 
the metastatic cells maintaining higher traction stresses than the non-metastatic cells 
under each condition tested. 
 
While these measurements were collected on 2D substrates, previous research in our 
lab has demonstrated that 2D traction forces correlate well with contractility observed 
within 3D collagen matrices (Kraning-Rush et al., 2011). Additionally, several of the 
cancer cell behaviors in which we first noted force generation playing a role occur on 
a 2D-like surface. In particular, both the basement membrane and the endothelial cell 
barrier are surfaces within the body in which tumor cells will migrate and exert force 
in 2D. The basement membrane is a thin but mechanically strong structure (Hotary et 
al., 2006; Kalluri, 2003), and the tumor vasculature has been demonstrated to stiffen 
significantly during tumor progression (Lopez et al., 2011). Both of these 
environments, when interpreted in the context of my results, could directly cause 
increased traction forces to be generated in nearby tumor cells and could potentially 
enhance invasion. Interestingly, increased matrix stiffness has also been shown to 
induce an increase in invadopodia and matrix degradation (Parekh et al., 2011), 
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suggesting that matrix stiffness can directly mediate tumor metastasis both through 
increasing contractile forces and increasing proteolytic activity, perhaps even 
synergistically. Conversely, inhibiting collagen crosslinking – which leads to a 
decrease in both overall collagen content and in mechanical stiffness – has also been 
shown to reduce cell proliferation and lengthen the period of time over which a tumor 
remains dormant and non-invasive (Levental et al., 2009). Together, my results couple 
with these studies to demonstrate the importance of matrix stiffness in governing 
initial invasion, and suggest that increased force can contribute to this early invasive 
behavior. 
 
Next, I chose to examine the role of force generation in mediating migration in a more 
physiologically relevant 3D system during later stages of invasion. First, I developed 
and perfected a micromolding technique which could be used to effectively separate 
and define the independent roles of contractile force and proteolytic degradation. 
Cancer cells migrating within a traditional 3D collagen matrix have been previously 
shown to require both behaviors to successfully degrade, remodel, and migrate 
through ECM fibers (Sabeh et al., 2009; Wyckoff et al., 2006). Therefore, determining 
the relative contribution of force generation and proteolysis, as well as the explicit 
functional role of each in 3D migration is quite difficult using these 3D matrices. To 
this end, in Chapter 3 I present a technique to pattern fully 3D channels which mimic 
the natural microtracks that are formed by cancer cells in vivo through a complex 
process of degrading, reorganizing and ultimately aligning the extracellular matrix 
surrounding a tumor. Patterned in collagen, our channels are compliant, retaining 
stiffness similar to physiological stromal tissue, while also maintaining the fibrous 
nature of the native ECM. These are critical elements of the tumor microenvironment 
which contribute to metastatic invasion, and which have not been captured in 
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previously developed PDMS and polyacrylamide models. I confirm that my in vitro 
microtracks mimic naturally formed tracks in both size and structure, and also confirm 
that cancer cells seeded within the microtracks are morphologically similar to cells in 
3D.   
 
Using this novel technique, I observe that patterned microtracks permit the rapid and 
exceptionally persistent migration of non-metastatic epithelial cells otherwise unable 
to invade a 3D collagen matrix. Additionally, I find that the migration speed of highly 
metastatic cells is also significantly higher within the microtracks, compared to 
migration in more restrictive 3D matrices. I validated the use of this technique for 
removing the element of proteolytic degradation from 3D migration studies by 
confirming that cell migration speed is unaffected by several commercial protease 
inhibitors or siRNA targeting MT1-MMP, repeatedly shown to be the dominant MMP 
driving proteolytic degradation and subsequent invasion into collagen matrices 
(Hotary et al., 2003; Sabeh et al., 2009). In this manner, I developed a technique for 
studying MMP-independent 3D migration. Therefore, I then returned to my initial 
focus on force generation, and examined the specific contribution of contractile forces 
to this method of 3D invasion. 
 
In Chapter 4, I more closely examined the mechanisms governing migration of breast 
cancer cells within our patterned 3D collagen microtracks by analyzing the roles of 
Rho/ROCK contractility, focal adhesions, and the cytoskeleton. Surprisingly, I 
discovered that Rho/ROCK-mediated contractility is dispensable for this mode of 
migration, as 90% inhibition of traction forces results in no observable decrease in cell 
speed within the track environment. I also find that cancer cells can adapt their 
motility phenotype to compensate for 1-integrin blocking with no loss of speed. 
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Interestingly, I determine that persistent, directional migration within the microtracks 
is dependent on focal adhesion formation, specifically requiring the presence of the 
classical focal adhesion protein vinculin. Moreover, the presence of an intact and 
dynamic cytoskeleton is critical to microtrack migration, as interference with actin or 
microtubule polymerization abolishes cell migration. These studies suggest that taxane 
drugs routinely used in chemotherapy to target microtubules to prevent tumor cell 
division and proliferation could also simultaneously combat metastatic invasion in this 
manner. However, it is important to keep in mind that cancer cells will often develop a 
subpopulation which is resistant to taxane treatment. It is likely that the anti-migratory 
benefits of taxanes would be abolished in the taxane-resistant population. 
 
The findings presented in this dissertation not only aid in our understanding of the role 
of force generation in cancer progression, but also illuminate the ways in which cancer 
cells are able to adapt and react to their ever-changing microenvironment. The 
knowledge gained through these experiments can be used to further develop 
appropriate therapies to successfully target and inhibit cancer invasion. Importantly, 
this work highlights the necessity of studying cancer cell migration in the most 
physiologically-relevant model available. Additionally, in the future it will be critical 
to develop a more thorough temporal understanding of cancer progression, and to 
carefully evaluate the distinct mechanisms governing tumor behavior at each stage of 
progression.  
 
6.2 Future Directions 
Although the work described in this dissertation contributed significantly to our 
knowledge of cellular forces during metastatic cancer progression, additional work is 
required to fully understand the principles guiding tumor invasion, particularly 
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regarding the adaptability and plasticity of tumor cells in response to their 
microenvironment. More specifically, a great deal remains to be discovered regarding 
metastatic invasion along proteolytic microtracks in vivo. There are several avenues of 
approach which could prove useful in progressing the field even further.  
 
Quantifying Traction Forces of Primary Cancer Cells 
While in Chapter 2 I demonstrate a trend of increasing 2D contractile force with 
increasing metastatic potential within several cell lines, this phenomenon should be 
confirmed using patient-derived cells. While cell lines are easy to work with and are 
generally considered to be an accurate representative of cancer cells (Masters, 2000), 
they have been shown to exhibit genetic and phenotypic drift, and may vary 
considerably from primary cells in terms of metabolic activity, growth rate, and 
receptor content (Burdall et al., 2003). Therefore, my studies of traction forces should 
be validated with primary cells, particularly through multiple comparisons of the 
forces generated by primary and secondary tumor cells derived from the same patient. 
However, there are numerous obstacles to successfully using primary tumor cells. 
While tumor samples themselves are not difficult to acquire, isolating individual 
cancer cells from the non-cancerous epithelial and stromal cells which surround them 
presents a significant challenge. Techniques have been developed (with differing 
degrees of success) which attempt to isolate cancer cells using differential 
centrifugation (Ponti et al., 2005) or seeding single cells into 96 well plates and 
subsequently growing up individual clonal populations (Marsden et al., 2009). 
Because traction force microscopy is a technique inherently designed to measure the 
forces of individual cells, it is critical that the single cells all be of tumor origin, with 
as little contamination as possible. Ideally, the lineage of each individual cell would be 
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confirmed either prior to or after the TFM measurement is acquired, perhaps utilizing 
a specific live cell stain.  
 
Additionally, it would be of interest to analyze the force profiles of cells during 
different phases of cancer progression. My studies indicate that traction forces may be 
important for specific behaviors, while largely dispensable for others. Therefore, it 
would be interesting to observe whether the strength of these forces would vary or 
correlate directly with certain phases.  For example, one could compare the forces 
generated by cells within the primary tumor, cells which have begun to breach the 
basement membrane and invade into the ECM, circulating tumor cells (CTCs) in the 
bloodstream, and cells which have established metastases and micrometastases in 
secondary locations. This knowledge would greatly contribute to determining how the 
requirement for contractile force changes during metastasis, and would aid in 
confirming or refuting my hypothesis that contractile force is required for specific 
behaviors throughout progression, primarily in the earlier stages leading to invasion 
and during extravasation and intravasation.  
 
It could also be informative to compare the force profiles of cells which have 
metastasized to different organs, to determine whether different stromal 
microenvironments require different degrees of contractile force. However, there is 
obviously inherent difficulty in this type of study. Once a tumor is known to have 
metastasized, the course of treatment for the patient is typically drastically changed. 
While it is common to surgically excise a primary tumor, metastases are rarely 
operated on – rather, they are treated with chemotherapy or radiation. Additionally, 
even if cells from a metastatic site could be acquired, it is likely that the patient would 
have undergone adjuvant therapy, which can considerably alter a tumor cell’s 
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characteristics. Instead, for this type of study, the best compromise would be to use 
tumors collected from mice. While the relevance of mouse-derived tumors to human 
cancer is still being debated (Dennis, 2006), this is the best way for a systematic study 
on a larger scale to be conducted. In this study, a mouse would be sacrificed and cells 
from each metastatic site, as well as the primary tumor, would be collected and 
analyzed for force generation and other biophysical properties.  
 
Future Studies Using Collagen Microtracks 
The technique and results described herein regarding patterned collagen microtracks 
have opened the door for a wealth of new studies and applications. The use of 
patterned collagen wells for studying branching morphogenesis in epithelial cells has 
already been extensively described (Gjorevski and Nelson, 2010; Gjorevski and 
Nelson, 2012; Nelson et al., 2008), but the use of this technique for studying single 
cell migration seems to be limited to the results presented here. Future work should 
further elucidate the effects of channel dimension on cancer cell migration. The 
resolution of micromolding features into collagen hydrogels is < 1 m (Nelson et al., 
2008; Tang et al., 2003). This size is smaller than the standard cell nucleus (Friedl et 
al., 2011), and studies in rigid channels have shown this to be too narrow to permit 
migration through the channel via nuclear deformation and squeezing (Mak et al., 
2013). Therefore, the full range of dimensions applicable to cell behavior is available 
for testing. Moreover, different features or pathways could be patterned into the 
microtrack, to explore cellular decision making during invasion into physiologically 
relevant matrices (Mak et al., 2011; Mak et al., 2013). For example, intersecting 
pathways of different angles or curvatures could be utilized. 
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While my data indicate that contractile force generation is dispensable for migration 
through our collagen microtracks, future work could examine this finding more 
closely by integrating fluorescent bead markers into the collagen matrix to track 
deformations of the microtrack walls during migration. In this manner, it may be 
possible to calculate approximations of traction stresses being applied to the wall. It is 
important to keep in mind, however, that collagen matrices have complex, non-linear 
mechanical properties which could complicate this quantification. 
 
Future work should also investigate the role of ECM protein deposition within the 
collagen microtracks. It is well-known that both normal and malignant cells can 
deposit various ECM proteins, including collagen, fibronectin, and laminin (Levental 
et al., 2009; Streuli et al., 1995; Williams et al., 2008). For example, MCF10A 
mammary epithelial cells seeded onto substrates coated with fibronectin begin 
synthesizing and depositing additional fibronectin (Williams et al., 2008). It is 
possible that cancer cells within the patterned microtracks may similarly be depositing 
matrix proteins which could affect subsequent cell migration through the track. 
Additionally, the microtracks could be coated with exogeneous ECM proteins prior to 
cell seeding to determine whether individual ECM proteins could aid in driving cell 
migration. Likewise, the collagen channels could potentially be filled with a second 
hydrogel solution containing cells to analyze the effects of an interface. This latter 
possibility could prove a useful in vitro model for studying glioma migration, which 
has been shown to follow white matter tracts in the brain (Beadle et al., 2008; 
Gritsenko et al., 2012).  
 
In Vivo Studies of Collagen Microtracks 
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The greatest impact of the current work lies in the validity of my model as an accurate 
mimic of the native microtracks generated by tumor cells during metastatic invasion. 
However, to achieve maximum impact, future studies should strive towards studying 
microtrack invasion in vivo. I anticipate that this type of study could be approached in 
two different ways. Both approaches would require using mice which either 
spontaneously develop tumors or in which tumor spheroids could be implanted into 
the mammary fat pad. For the first approach, microtracks could be synthetically 
created in the stroma near the tumor using the laser ablation technique described by 
Ilina et al. (Ilina et al., 2011). For the second approach, one could image the tumor 
stroma using intravital microscopy to find natural microtracks created by the invasive 
cancer cells as they migrate away from the primary tumor (Beerling et al., 2011; 
Condeelis and Segall, 2003). Both approaches have benefits and limitations. While 
creating synthetic microtracks alleviates the difficulty of finding the natural 
microtracks, it may not accurately recapitulate them. During native microtrack 
formation, tumor cells must proteolytically cleave ECM fibers, exposing epitopes to 
which cancer cells can subsequently bind and interact. It is unclear what effect these 
epitopes may have on cancer cell migration, demonstrating the need to study 
microtrack formation in more detail. After a protocol for studying microtrack in vivo is 
developed, future work could then involve microinjecting various inhibitors into the 
channels to confirm that the same mechanisms that I observe in vitro are also at work 
in vivo.  
 
Ultimately, future directions of this work will provide additional insights into how 
cancer cells utilize contractile forces to facilitate invasion, as well as potential 
therapies for preventing or inhibiting metastatic migration through proteolytic 
microtracks. 
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APPENDIX A 
 
PROTOCOL FOR TRACTION FORCE MICROSCOPY AND ANALYSIS 
 
Portions of this chapter were published in a book chapter titled “Quantifying Traction 
Stresses in Adherent Cells” in Methods in Cell Biology (Kraning-Rush et al., 2012b). 
 
Materials: 
Traction chambers 
35 mm petri dish (for lids) 
Polyacrylamide gels containing fluorescent beads 
Kimwipes 
Razor blade 
Vacuum grease 
T25 flask of confluent cells 
Trypsin 
Complete media 
1X PBS 
 
Data Collection: 
1. Chamber Setup and Cell Seeding 
The following steps should be performed within a sterile biosafety cabinet. 
a. UV sterilize one traction chamber and one 35 mm petri dish for each PA gel, 
as well as several KimWipes (Kimberly-Clark, Neenah, WI), paper towels, and 
a syringe filled with vacuum grease (Dow Corning, Midland, MI) for 20 
minutes. 
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b. Remove the coverslip containing the PA gel from PBS using a razor blade and 
place on paper towel. Using a KimWipe, gently dry off the excess PBS 
surrounding the gel surface. Be careful not to touch the gel surface with the 
KimWipe.  
c. Invert the traction insert so that the ridged side is facing down. Apply a thin 
line of vacuum grease around the circular opening.  
d. Invert the coverslip with the PA gel over the traction insert such that the PA 
gel is centered over the opening.  
e. Gently press down on the coverslip until the vacuum grease has formed a tight 
seal around the entire opening. If the chamber leaks, it is likely that the 
coverslip was not properly sealed to the traction insert, and more vacuum 
grease is required. 
f. Flip over the traction insert and add 2 mL sterile PBS to the gel to keep it 
hydrated during cell seeding. Repeat these steps until all PA gels are attached 
to their respective traction inserts. At this point, gels can be stored overnight 
prior to cell seeding if desired. 
g. Passage the desired cell population and determine the cell count. Seed 2,000-
4,000 cells onto each PA gel, depending on the size of the cells and the 
duration of incubation prior to imaging. Typical incubation times in our lab 
range from 6 to 18 hours, although this time can be extended if desired. 
However, note that if the cells begin to proliferate, finding isolated cells to 
analyze becomes more difficult. 
 
2.  Acquiring Traction Images 
a. Place traction insert containing cell-seed PA gel onto the stage of the 
microscope.  
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b. Using a 10X objective, identify isolated cells and mark their positions. 
c. Using a 20X objective, acquire a phase contrast image of the cell, focusing 
primarily on the cell boundaries. Immediately acquire a fluorescent image of 
the uppermost layer of beads directly beneath the cell. It is important that these 
two images are taken as close in time as possible, as cells can change position 
(and thus change the underlying bead placement) fairly rapidly, and both 
images need to be consistent for quantification. Repeat for each cell. Note that 
for compliant gels (<2.5 kPa), it may be appropriate to use a 10X objective to 
acquire these images, to obtain a significant population of fluorescent beads 
with negligible movement. 
d. Aspirate media from the well, being careful not to touch the PA gel surface 
with the pipette, as this will cause distortion of the bead layer and become 
unusable. 
e. Rinse well three times with 3 mL PBS.  
f. Apply 1 mL of trypsin. Let sit for 5-10 minutes depending on cell type.  
g. Aspirate trypsin and wash with PBS. Check all fields of view to confirm that 
the cells of interest have been removed. If not, repeat PBS rinse. Once cells are 
removed, keep the gel hydrated with PBS. 
h. Return to the location of the first cell. Open the corresponding stressed image. 
Align the beads in the x and y directions such that they line up at a distance far 
from the cell. It is generally easier to do this in a corner. Some error is 
acceptable in this adjustment, as the tracking software described above will 
ignore the most common bead displacement (Marganski et al., 2003).  
i. Adjust the z direction such that the same layer of beads is in focus. Acquire an 
image of the unstressed bead field. 
j. Repeat for each marked location. 
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Data Analysis: 
1. Export ZVI files to TIF files. 
a. Open AxioVision software. Go to File -> Export. 
b. Select the folder with the files you want to export. Click OK. 
c. Unclick “Create project folder” and unclick “Generate merged images”.  
d. Change to export as TIFs (Tagged Image Files). Set 5% compression. 
e. Click “Batch”. Click “Add files” and select all the zvi files you want to export 
in the folder. 
f. Click “Run Batch”. 
2. Make excel spreadsheet using template file. Write in the folders and cells for each 
gel. Give each cell a separate row. 
3. Crop each set of 3 TIFs with the same number using Microsoft Office Picture 
Manager. 
a. Open the three TIFs in Picture Manager. Open p0x001 image last.  
b. Click “Edit Pictures”, then click “Crop”. 
c. Compare the n0x and s0x001 images. Look for any bright spots that disappear 
or beads that disappear. Look for any movement around the edges of the frame 
that are caused by cells pulling outside the field of view. Drag edge of frame to 
past the offending mark. Note the # pixels moved. 
d. Crop other 2 images the same way.  
e. Click “OK” then click “Save”. Close images. 
f. Repeat for every set of images in the folder 
4. Label new folder “MMDDYY” according to date of the experiment. Create 
subfolders within this folder labeled “raw5rx” where 5 is the stiffness of the gel 
and x is #1 -> 9 then #1a -> 1z.  
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5. Copy the 9 sets of images into this file. Files should be labeled n01 -> n09, p01001 
-> p09001, and s01001 -> s09001.  
6. Change the file types from .TIF to .tif.  
7. Note all file name changes and locations in the excel spread sheet. 
 
Running Linux LIBTRC algorithm: 
1. Copy folder with date title MMDDYY onto Linux computer. 
2. Open first folder (raw5r1). Make a new folder called “raw5”.  Move all image files 
into this sub-folder. 
3. In “scripts” folder, open “run” file. Change date to match the date of your folder. 
Save and close. 
4. In “scripts” folder, open “run5” file. Change date (located below the parameters) 
and title of experiment (near top) to match the date of your folder and reflect the 
experiment. 
5. From scripts folder, copy “opfscript” into raw5r1 folder. 
6. From scripts folder, copy “fitscript”, “hacscript”, “lodscript”, “pltscript”, “run5” 
and “run” into raw5 folder. 
7. Click File -> Open in Terminal. Type “./opfscript “raw5/n*” “raw5/s*”. Will only 
need to do this once and then it will remember this command and you can just 
press the up arrow to get to it. Click enter. Script will begin running. Do not close 
this window. 
8. Repeat for all raw5r_ folders. These will take anywhere from a few hours to 
overnight to run. 
9. After script has finished running, a new line will appear in the terminal screen. 
Also, a folder will appear in the raw5r_ folder labeled “raw”. It will have one file 
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corresponding to each set of images, labeled s0x001b.raw. Copy all of these files 
into the “raw5” folder. 
10. Open the “raw5” folder. Click File -> Open in Terminal. Type  “>xtrace –w=12 –
h=12. Click enter. 
11. Choose File > select phase image from directory. Press “Display Image”. Phase 
image should appear in window. 
12. Type in “p0x001cr1.raw” (where x refers to #1-9, from p0x001 label) and click 
“Log Points” (?). Click anywhere on the cell outline and click around the cell to 
outline the entire cell body. Click on the first point to save the outline. 
13. If there is a second cell, change label to “p0x001cr2.raw” and repeat. Can only 
outline 2 cells per image. 
14. Repeat for every phase image in folder. 
15. Close window. 
16. Double click on “run5” script in “raw5” folder. Click Run in Terminal. A new 
window will open, do not close it. It will run quick, < 2 minutes. 
17. When it finishes, there will be a new folder labeled “tpl” in the “raw5” folder. 
Open this folder. 
18. Each set of images now has a tpl file that corresponds to it. 
19. Open the first tpl file. Change corresponding “NPIXX” and “NPIXY” to 
correspond to your new pixel counts in x and y. Maintain e+03 label – change only 
the first four numbers (e.g. if your new size is 864 x 302, NPIXX should read 
0.864e+03 and NPIXY should read 0.302e+03). 
20. Save file and close. Repeat for all tpl files. If there is no adjustment to the image, 
you don’t have to change the tpl file for that image. 
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21. Double click on “run” script in “raw5” folder. Click Run in Terminal. Be very 
careful not to click the “run5” script again or it will rewrite your tpl data and you 
will have to re-input your sizes.  
22. When this finishes running (anywhere from 20 min – 2 hours, depending on what 
is running concurrently), you will have a new folder, “figs” containing three 
folders: mag, dex, and tbs. These contain the images of the traction vectors in color 
contour plots (mag), the bead displacement vectors (dex), and the calculated 
traction vectors (tbs). Running this script will also update the “tpl” file to contain 
all of the traction data that I use for quantification. The data from these files will 
be input into a code that extracts the data to Excel.  
 
Inputting Data into Excel: 
1. Add the “TFM Template Sheet – Post Sheet” to your excel document in which you 
recorded the size of the new images.  
2. Copy the cells from the “pre” sheet into the “post” sheet. Delete the columns 
corresponding to ‘Left’, ‘Right’, ‘Top’, ‘Bottom’, and ‘New Dimensions’. Move 
columns for “Phase”, “Folder” and “Notes” to the appropriately labeled columns 
on the “post” sheet.  
3. Copy files from MMDDYY folder on Linux computer onto a portable drive. 
4. In Windows, open two windows. In the first, open folder “tfm_extract_fixed” then 
“tfm_extract”. In the second, open the folders within the MMDDYY folder to get 
to the “raw5” folder which contains the “tpl” folder. Don’t open the “tpl” folder. 
5. Drag the “tpl” folder onto the “tfm_extract.exe” folder in the other window. 
6. Open the resulting .txt file (extracted_bunchofnumbers.txt). May have to set it to 
default open in Excel the first time. 
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7. Change column A to be right justified so you can see the end of the file names. 
Delete all rows with the ~ after the file name so that you have (at most) 9 rows, 
one for each image set. Can also delete column B if desired. 
8. Copy cells from the extracted document into the appropriate places on the post 
sheet. Note that in the extracted document, frames with two cells have separate 
columns for the second cell’s data, while the post sheet has separate rows for the 
second cell’s data. 
9. Repeat for each tpl folder until all data has been input. 
 
Checking TFM Data: 
1. Going back through and checking the data, each will be color-coded. Green is 
good, yellow is probably good, orange is probably bad and red is bad. Can also 
include notes. 
2. On the excel sheet, in the “delchi” column, note any delchi number that is less than 
3. These are generally the most suspect cells. Delchi is a measure of the error 
calculated in the stress map.  
3. Open the “dex” plot and the three images (phase, null, and stressed) for each field 
of view and check the arrows on the dex plot against the bead movement you 
observe by eye. If there is a stray arrow that doesn’t make sense, mark it in the 
notes and consider the cell questionable (orange/red). Can also check against the 
“tbs” plot. 
4. Also check that the output |F| value is similar to what you would expect based on 
your observed bead movement. Note accordingly. 
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APPENDIX B 
 
PROTOCOL FOR PATTERNING COLLAGEN CHANNELS 
 
Portions of this protocol were adapted from (Nelson et al., 2008). 
 
Materials: 
Silicon wafer with pattern 
Spin-coater 
Sigma-cote 
PDMS (monomer and initiator) 
Large petri dish 
 
Casting PDMS Stamps: 
1. Wash wafer (if needed) with ethanol. Use a kimwipe to gently clean the surface. 
2. Place wafer on spin-coater (1st floor teaching lab) and coat with Sigma-cote (4oC) 
a. Open the vacuum line (turn on vacuum pump outside of lab in hallway). 
b. Open the air line. 
3. Remove wafer from spin-coater. 
4. Mix PDMS (10:1 ratio of monomer to initiator) in a plastic container 
a. For correct stamp height (~5 mm), calculate M (total mass of PDMS needed) 
using the following relation: d
2
/M = 0.26388 m
2
kg
-1
, where d = diameter of 
petri dish used. Alternatively, for large petri dish, 70 g monomer, 7 g initiator 
is appropriate. 
5. Degas PDMS mixture in vacuum chamber (repeatedly, until bubbles don’t form 
under vacuum). 
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6. Place wafer in the bottom of a large petri dish and pour PDMS over the center of 
the wafer. 
7. Gently push down on the center of the wafer (the wooden end of a cotton swab 
works well) to remove any PDMS underneath it. 
8. Place in oven for ~2 hours at 60oC (may be left overnight, but longer bake times 
make the cured PDMS more brittle). 
9. Gently remove the PDMS from the wafer and place patterned-side up in another 
dish. Remove excess PDMS from wafer.  
 
Materials: 
PDMS stamps (from above) 
PDMS spacers (use above protocol to cast thin layer of PDMS in petri dish) 
Razor blade 
100% ethanol 
18 mm diameter round coverglass 
1% (w/v) BSA in PBS (sterile) 
10 mg/mL rat tail type I collagen stock (keep on ice) 
1 N NaOH (keep on ice) 
Complete media (keep on ice) 
15 mL centrifuge tubes (keep on ice) 
Forceps  
6 well plate 
 
Patterning Collagen Wells: 
1. Carefully cut stamps in 4 x 4 sets using a razor blade. 
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2. In a biosafety cabinet, sterilize stamps by dipping them in 100% ethanol, wiping 
the back (non-feature) side with paper towel, and placing on petri dish until dry, ~ 
2 min. Sterilize round 18 mm diameter coverslips for lids (set diagonally against 
petri dish) and spacer pieces (2/stamp). 
3. Coat the feature side surface of the stamp with 120 L of 1% (w/v) BSA in sterile 
1X PBS (0.01 g in 1 mL – can prepare stock of this and store at 4oC). Incubate for 
at least 30 minutes at room temperature or overnight at 4
o
C. Ensure that all air 
bubbles are removed from the surface of the stamp before starting. Use side of 
pipet tip to ‘roll’ BSA across entire surface of the stamp. 
4. Prepare a neutralized collagen solution of 3 mg/mL. A final volume of 120 - 180 
L is needed for each stamp for each step (2X washes, 1X lids, 1X channels) 
(prepare a little extra in each). Have separate tubes of collagen solutions for 
washes, lids, and channels. Use lower volume for washes and higher volume for 
channels. 
a. Calculate volume of collagen needed: 
i. (desired [ ] )*(desired vol.) / (stock [ ] ) = vol. collagen needed 
b. Calculate volume of 1 N NaOH needed: 
i. Vol. collagen needed *0.023 = vol. NaOH needed 
c. Calculate volume of media needed: 
i. Desired final vol. – vol. collagen – vol. NaOH = volume media 
5. Prepare collagen ‘lids’ by pipetting 120 L of neutralized collagen on the surface 
of an ethanol sterilized 18 mm round coverslip. Use the edge of a yellow pipette 
tip to ‘roll’ collagen across surface. Work quickly, and don’t make more than four 
lids in one batch of collagen. Make one lid/stamp, plus an extra one or two for 
backup. 
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6. Aspirate the BSA solution from the stamps. Can touch the middle of the array to 
remove more. Try not to touch the features. Wash the BSA-coated surfaces 2X 
w/neutralized collagen (120 L/wash/stamp). 
7. Place a drop (160-180 L) onto the bottom of a 6 well plate, between (2) 1 mm 
PDMS spacers. Invert collagen-washed stamp over drop. Place dishes and lids in a 
37
o
C incubator for 1.5 hours.  
 
Materials:  
T25 flask of confluent cells 
Trypsin 
Complete media (have both warmed and ice-cold on hand) 
 
Protocol for Seeding Cells in Collagen Wells  
1. Prepare a suspension of cells. Keep the cells on ice.  
a. Passage cells normally, then remove some suspension to second tube and spin 
down at normal centrifugation rate for those cells. Resuspend in ice cold media 
and count.  
b. Make a 3 mL suspension of 70,000 cells/mL.  
2. Carefully remove the stamp from the collagen gel by pulling straight up with 
sterilized forceps. Avoid shearing the gel to prevent distortion of the molded wells. 
3. Immediately add a drop (~120 uL) of cells to the molded surface of the collagen 
gels. Under a phase contrast microscope (scope in tissue culture room), monitor 
the sample. As soon as the wells are filled with cells (~1-2 min), check the seeding 
density on the scope, and if necessary, wash the sample by tipping the dish at a 45
o
 
angle and gently pipetting 120 uL of cold media across the surface to remove 
excess cells. While holding at an angle, aspirate solution at bottom of well.  
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a. Can repeat these steps if you accidentally wash away too many cells. 
4. Place the sample in the incubator for 5 minutes to allow cells to adhere to the 
collagen. 
5. After the cells have started to adhere to the gel, gently cover the gel with a 
collagen lid. Allow the collagen lid to settle for 5 minutes in the incubator. Fill the 
dish with 2.5 mL of warmed complete media and return to incubator. Allow 6 
hours minimum for cell spreading before beginning experiment. 
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APPENDIX C 
 
PROTOCOL FOR IMMUNOSTAINING IN COLLAGEN CHANNELS 
 
 
Materials: 
43 x 50 mm coverglass 
22 x 22 mm coverglass 
Kim wipes 
Traction chambers 
Vacuum grease 
35 mm petri dishes 
 
Seeding Cells for Immunostaining: 
1. Activate 43 x 50 mm coverglass, one for each channel. 
2. Attach two 22 x 22 mm coverglass slips on either side of the long edge of the 43 x 
50 mm glass using vacuum grease. These slips will serve as ‘spacers’. Press down 
gently on small converslips with q-tip to seal.  
3. Prepare stamps and polymerize collagen channels as described in Appendix B.  
4. When channels have completed polymerization, carefully remove small glass 
spacers without damaging the patterned collagen.  
5. Carefully dab around edges of polymerized collagen with a Kim wipe to absorb 
excess collagen. If there are ‘wet’ looking areas on the vacuum grease, dab dry. 
6. Invert the traction insert so that the ridged side is facing down. Apply a thin line of 
vacuum grease around the circular opening.  
7. Invert the 43 x 50 mm coverslip with the polymerized collagen channels over the 
traction insert such that the channels are centered over the opening.  
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8. Gently press down on the coverslip until the vacuum grease has formed a tight seal 
around the entire opening. If the chamber leaks, it is likely that the coverslip was 
not properly sealed to the traction insert, and more vacuum grease is required. 
9. Flip over the traction insert and continue with cell seeding protocol described in 
Appendix B. Use 35 mm petri dish as ‘lid’ to maintain sterility. 
10. Incubate overnight at 37oC.  
 
Materials: 
1X PBS 
3.7% formaldehyde 
1% Triton-X 
(or ice-cold 3:7 methanol:acetone mixture) 
0.5% (v/v) Tween-20 in 1X PBS 
3% (w/v) BSA in 0.5% Tween-20 in 1X PBS 
1% (w/v) BSA in 0.5% Tween-20 in 1X PBS 
1% (w/v) BSA in 1X PBS 
Primary antibody (1
o
 Ab) 
Secondary antibody (2
o
 Ab) 
Phalloidin 
DAPI 
Orbital shaker 
Aluminum foil 
 
Immunostaining: 
1. Rinse the dish 2X with RT 1X PBS.  
2. Fix with 2 mL of 3.7% formaldehyde for 15-30 minutes at RT.  
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3. Wash 3X with 1X PBS for 10 minutes each, rocking at RT. 
a. Note that samples may be stored at 4oC at this step for a few days if necessary. 
4. Add 2 mL of 1% Triton-X in 1X PBS for 5 minutes at RT, rocking. 
a. Alternatively, for staining of actin and focal adhesions, can fix for 5-10 
minutes in 2 mL of 3:7 methanol:acetone mixture at -20
o
C. 
5. Wash 3X with 0.5% (v/v) Tween-20 in 1X PBS for 10 minutes each. 
6. Block with 3% (w/v) BSA in 0.5% (v/v) Tween-20 in 1X PBS for 3 hours at RT, 
rocking. This step can also be done overnight at 4
o
C, rocking. 
7. For best staining, the glass coverslip on which the collagen lid was polymerized 
should be carefully removed using forceps prior to incubation with the 1
o
 Ab to 
maximize diffusion.  
8. Prepare 1o Ab in 1% (w/v) BSA in 1X PBS. 1:50 -1:200 is a good working range, 
depending on the antibody. Use 1 mL per channel.  
9. Add 1o Ab onto each channel. Incubate 1-2 days @ 37oC on the orbital shaker, 
gently rocking. Use square petri dishes to guard against leaks onto the shaker. 
10. Remove 1o Ab and store in fridge for future use (~1-2 weeks). 
11. Wash 3X with 1% BSA in 0.5% Tween-20 in 1X PBS for 10 minutes each at RT, 
rocking. 
12. Prepare 1 mL of 2o Ab for each channel in 1% BSA in 1X PBS, usually 1:200. 
Incubate for 2 hours at RT, rocking and covered with aluminum foil. 
13. Wash 3X with 0.5% Tween-20 in 1X PBS for 10 minutes each at RT, rocking. 
14. Wash 2X with 0.5% Tween-20 in 1X PBS for 1 hour each at RT, rocking. 
15. Wash overnight at 4oC in 1X PBS, rocking. 
16. Wash 3X with 1X PBS for 5 minutes each at RT, rocking. 
17. Incubate cells with 1:100 phalloidin in 1X PBS for 2 hours at RT, rocking. 
18. Wash 3X with 1X PBS for 10 minutes each at RT, rocking. 
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19. Incubate cells with 1:100 DAPI in MilliQ water for 20 minutes at RT, rocking. 
20. Wash 3X with 1X PBS for 10 minutes each at RT, rocking. 
21. Image immediately. 
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APPENDIX D 
 
PROTOCOL FOR TRANSFECTION OF CANCER CELLS (siRNA AND DNA 
PLASMIDS) 
 
Materials for siRNA Transfection: 
20 M siRNA 
Lipofectamine 2000 transfection reagent 
1.7 mL centrifuge tubes 
OptiMEM 
Complete media without pen/strep 
 
siRNA Transfection Protocol: 
Day 0: 
1. Plate cells in a 6 well plate at a density of 50,000 cells/well. Let spread and 
adhere overnight. 
Day 1: 
1. Cells should be ~40-50% confluent.  
2. Dilute 5 L Lipofectamine 2000 in 250 L OptiMEM in a separate 1.7 mL 
centrifuge tube (one per well). 
3. Let sit 5-15 minutes at RT. 
4. Meanwhile, dilute 1.25 L siRNA in 250 L OptiMEM in a 1.7 mL centrifuge 
tube (one per well).  
5. Combine mixture by pipetting gently, and incubate for 20 minutes at RT.  
6. Rinse cells 1X with 1 mL of pen/strep-free media. 
7. Add 2 mL of pen/strep-free media per well.  
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8. Add 0.5 mL of siRNA-Lipofectamine complex dropwise to each well.  
9. Incubate 4 hours at 37oC, then aspirate and replace with complete media.  
Day 4: 
1. Seed cells into desired vessel (e.g. polyacrylamide gel, 3D collagen gel, 
collagen channels, etc.).  
 
Materials for DNA Plasmid Transfection: 
DNA plasmid 
Transit-2020 transfection reagent 
1.7 mL centrifuge tubes 
OptiMEM 
 
Protocol for DNA Plasmid Transfection: 
Day 0: 
1. Plate cells in a 6 or 12 well plate at a density of 200,000 or 90,000 cells/well. 
Let spread and adhere overnight. 
Day 1: 
1. Cells should be ~70% confluent.  
2. Add 100 L OptiMEM (per 12 well) or 200 L (per 6 well) to a microfuge 
tube (one per well).  
3. Add 3 g DNA (per 12 well) or 8 g DNA (per 6 well) to the tube. Pipette 
gently to mix and let sit at RT for 5 minutes. 
4. Add 3 L Transit-2020 (per 12 well) or 7.5 L Transit-2020 (per 6 well) to the 
tube. Mix gently and let sit at RT for 15-30 minutes.  
5. Add dropwise to cells in well in complete media and incubate at 37oC. Note 
that there is no need for pen/strep-free media, or to change media 4 hours later. 
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Day 3: 
1. Seed cells into desired vessel (e.g. polyacrylamide gel, 3D collagen gel, 
collagen channels, etc.).  
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APPENDIX E 
 
PROTOCOL FOR CULTURING CELLS UNDER HYPOXIC CONDITIONS 
 
1. Plate cells onto desired surface. 
2. Place tissue culture items into modular incubation chamber. 
3. Open both inlet and outlet ports. Connect gas mixture (1% O2, 5% CO2, 94% 
N2) to inlet port. 
4. Flush gas mixture in for 4 minutes, not exceeding 2 psi.  
5. Close outlet port. Remove gas line and close inlet port. 
6. Place chamber into cell culture incubator. 
7. Reflush after 1 hour of incubation to remove any remaining O2. This is 
particularly important if chamber is over half filled with dishes. 
8. Culture additional 23 hours.  
9. Run experiment. Reflush as needed between removing dishes. 
10. For reoxygenation experiments, remove dishes and replace media with fresh 
media.  
11. Incubate under normal conditions for 18 hours.  
12. Run experiment.  
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APPENDIX F 
 
PROTOCOL FOR ANALYZING CELL MIGRATION SPEED IN 2D, 3D, AND 
COLLAGEN CHANNELS 
 
Acquiring Migration Videos 
1. Seed cells onto 2D, 3D, or channel substrates and allow to spread for a 
minimum of 6 hours. 
2. Equilibrate plate on microscope with chamber set to 37oC, 5% CO2, and 40% 
humidity for at least 30 minutes (can be done during position marking). 
a. On main ‘Live’ screen, click ‘Properties’, go to ‘Frame’ and adjust 
binning to 2 x 2. This reduces the size of acquired files by reducing 
number of pixels per image (and also reduces exposure time). 
3. In AxioVision software, open ‘Multidimensional Acquisition’ under 
Acquisition tab.  
4. Set parameters of experiment. 
a. ‘Experiment’ tab: Change image name on experiment tab to ID your 
experiment. ‘Settings for experiment’ should be blank. 
b. ‘C’ tab: Turn voltage on microscope to 1.7V, select ‘fixed’ exposure 
time and click ‘Measure’ to set one exposure for all positions. Turn 
voltage off when done. Make sure hardware settings are blank. 
c. ‘T’ tab: For 2D and channel experiments, set images to acquire every 5 
minutes (every 10 minutes is okay for 3D experiments). Set desired 
total time (usually 10-24 hours, depending on study). Change ‘Settings 
before/after’ to: 
i. Workgroup: TL On 
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ii. Workgroup: TL Off 
d. ‘XY’ tab: Save positions and focus on MarkFind on XY tab. Use a 
different color for each well. I do not recommend changing ID labels 
here – it is tedious and unnecessary. Just record positions in your lab 
notebook and identify which well correlates to which experimental 
condition.  
i. IMPORTANT: Uncheck ‘Apply setting before/after timepoint 
per position’. Otherwise light will turn on and off between 
positions.  
e. Press start.  
f. Watch a full run before walking away from the microscope. 
g. Readjust focus after 1-2 hours. 
 
Analyzing Cells for Random Walk Migration (e.g. 2D, 3D) 
1. In AxioVision, export .zvi files to .jpeg files to facilitate analysis and data 
transfer (File -> Export; choose 5% compression). 
2. In ImageJ, open one migration video by importing the series of .jpeg files (File 
-> Import -> Image Sequence).  
3. Play the video to get a sense for migration movement. Identify each cell as 
‘motile’, ‘non-motile’, or ‘dead/dying.’ Separately count the number of cells 
which divide – this number is independent from the first classification (e.g. a 
dividing cell can also be motile).  
a. Note: Only count each cell once, and only consider motility prior to a 
division event. Do not include the motility of the daughter cells in these 
counts. 
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4. In excel, record the number of cells in each category (listed as separate 
columns). Additionally, record notes about the cells which remain motile for at 
least 8 hours (e.g. 49 frames acquired at 10 minute intervals). Identify each 
motile cell by a descriptor of where it is within the frame (e.g. left, middle), 
and by the frame number at which it begins migrating. 
5. In ImageJ, select measurements (Analyze -> Set Measurements) of Area, 
Perimeter, Centroid (X, Y), Fit Ellipse, and Shape Descriptors, and Display 
Label.  
6. For each cell, trace the cell body at every other time point (e.g. every 20 
minutes). As each trace is completed, click ‘Measure’ or ‘Ctrl+M’ on the 
keyboard. Repeat until cell has been traced 25 times.  
7. Convert centroid position for trajectory from pixels to microns.  
8. Input trajectory into Matlab and adjust the Nfit of the data (line 20, see next 
section) until the least squares regression closely approximates the calculated 
mean squared displacement. Check that line 7 indicates the appropriate time 
interval between images. 
9. Open ‘Results.xls’ spreadsheet from Matlab code and copy output to new excel 
sheet, noting the calculated speed and persistence time.  
 
Matlab Code for Random Walk Migration: 
(1) clear all 
(2) global ts MSDs 
(3) data=xlsread('Trajectory.xlsx'); %load and does not convert to 
0.645 um/pix 
(4) x=data(:,1); 
(5) y=data(:,2); 
(6) clear data; 
(7) dt=20;  %minutes between images 
(8) n=length(x); 
(9) MSD=zeros(n-2,1); 
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(10)  
(11) % calculate the mean squared displacement for range of time 
intervals 
(12) for i=1:n-2 
(13)     MSD(i)=0; 
(14)     for j=1:n-i-1 
(15)   MSD(i)=MSD(i)+(x(j+i)-x(j))^2+(y(j+i)-y(j))^2; 
(16)     end 
(17)     MSD(i)=MSD(i)/(n-i); 
(18) end 
(19)  
(20) ignore_last_x_points=12; %CHANGE FIT HERE 
(21) Nfit=length(MSD)-ignore_last_x_points; 
(22) ts=[1:Nfit]*dt; 
(23) MSDs=MSD(1:Nfit); 
(24) % perform nonlinear least squares regression of migration model 
to MSD 
(25) % data, to determine the best-fit parameters S and P. see 
Lauffenberger & 
(26) % Linderman (1993), equation 6-35a. Uses separate m-file 
"SSEcellmig.m" 
(27) c=fminsearch(@SSEcellmig,[.5;100],optimset('MaxFunEvals', 
10000,'MaxIter', 10000)); 
(28) migration_speed=c(1)    %S in units of microns/min 
(29) persistence_time=c(2)   %P in units of min 
(30)  
(31) % plot of cell path in x-y space 
(32) subplot(3,1,1) 
(33) plot(x,y,'r-',x,y,'bx') 
(34) xlabel('x  (\mum)') 
(35) ylabel('y  (\mum)') 
(36)  
(37) % plot of MSD as a function of dt, along with best-fit model 
(38) t=[1:length(MSD)]*dt; 
(39) fit=2*c(1)^2*(c(2)*ts-c(2)^2*(1-exp(-ts/c(2)))); 
(40) subplot(3,1,2) 
(41) plot(t,MSD,'b.',ts,fit,'r-') 
(42) xlabel('t  (min)') 
(43) ylabel('MSD  (\mum^2)') 
(44)  
(45) % plot of MSD as a function of dt, along with best-fit model, 
cutting out 
(46) % non-fitting points 
(47) t=[1:Nfit]*dt; 
(48) fit=2*c(1)^2*(c(2)*ts-c(2)^2*(1-exp(-ts/c(2)))); 
(49) subplot(3,1,3) 
(50) plot(t,MSDs,'b.',ts,fit,'r-') 
(51) xlabel('t  (min)') 
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(52) ylabel('MSD  (\mum^2)') 
(53)  
(54) % save results 
(55) A(:,1)=x; 
(56) A(:,2)=y; 
(57) for i=1:length(ts) 
(58)     A(i,3)=ts(i); 
(59)     A(i,4)=fit(i); 
(60) end 
(61) A(1,5)=c(1); 
(62) A(1,6)=c(2); 
(63) saving_results = xlswrite('results.xls',A); %RENAME WHEN DONE 
 
Analyzing Cell Migration in Collagen Channels 
1. In AxioVision, export .zvi files to .jpeg files to facilitate analysis and data 
transfer (File -> Export; choose 5% compression). 
2. In ImageJ, open one migration video by importing the series of .jpeg files (File 
-> Import -> Image Sequence). 
3. Play the video to get a sense for migration movement. Identify each cell as 
‘motile’, ‘non-motile’, or ‘dead/dying.’ Separately count the number of cells 
which divide – this number is independent from the first classification (e.g. a 
dividing cell can also be motile).  
a. Note: Only count each cell once, and only consider motility prior to a 
division event. Do not include the motility of the daughter cells in these 
counts. 
4. In excel, record the number of cells in each category (listed as separate 
columns). Additionally, record notes about the cells which remain motile in 
one direction for longer than 100 minutes (e.g. 20 frames acquired at 5 minute 
intervals). Identify each motile cell by a descriptor of where it is within the 
channel (e.g. left, middle, 2
nd
 from right), and by the frame numbers over 
which it migrates in a single direction (e.g. t5-t150, which would correspond to 
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25 minutes – 12.5 hours). This facilitates a calculation of speed during the first 
100 minutes of migration, as well as speed over the maximum invasion 
distance. 
a. Note: Cells should only be tracked when they are isolated within the 
cell and not interacting with the channel end. If cells subsequently 
come into contact with another cell or the channel end, then the final 
time point should be taken as the time point just prior to this 
interaction. 
b. Note: A cell can be analyzed more than once, as long as each time 
period is at least 100 minutes (e.g. if a cell reverses direction, or comes 
in contact with a cell then loses contact and migrates uni-directionally 
again). 
5. Repeat for every migration video acquired for a given experiment.  
6. In ImageJ, select measurements (Analyze -> Set Measurements) of Area, 
Perimeter, Centroid (X, Y), Fit Ellipse, and Shape Descriptors, and Display 
Label.  
7. For each cell previously identified as ‘motile’ for 100 minutes or longer, trace 
the cell at the first time point, the 100 minute time point, and the final time 
point (e.g. 3 traces per cell). As each trace is completed, click ‘Measure’ or 
‘Ctrl+M’ on the keyboard. 
8. For each video, find a defect in the collagen (e.g. bubble, debris, bright spot) 
that is located well apart from the channel and away from any moving cells. 
Circle the defect and collect measurements at each time point previously 
recorded for cells in that video. The centroid position of the defect will be used 
to later subtract out any bulk movement of the entire channel, to obtain a more 
precise distance travelled measurement. 
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9. After every 50 or so measurements, copy and paste the measurements from 
ImageJ into a temporary excel sheet. After collecting data from all of the 
migration videos for a given experiment, copy and paste the data into the 
appropriate locations in your final spreadsheet for analysis. For the collagen 
defects that were analyzed for each migration video, only copy and paste the 
centroid position for each time point (X0, Y0). 
10. Convert centroid position from pixels to microns.  
11. Calculate the migration displacement of each cell at both the 100 minute time 
point and the final time point: 
                                  
 
                    
 
 
12. Calculate the speed of each cell over the first 100 minutes and over the entire 
length of analysis (e.g. initial to final time point): 
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APPENDIX G 
 
LIST OF PUBLICATIONS 
 
Publications Completed at Cornell University 
1. Huynh J, Bordeleau F, Kraning-Rush C, and Reinhart-King C. Substrate 
Stiffness Regulates PDGF-Induced Circular Dorsal Ruffle Formation in 
Vascular Smooth Muscle Cells Through Myosin Light Chain Kinase Control 
of Cellular Contractility. Accepted for publication, Cellular and Molecular 
Bioengineering, DOI 10.1007/s12195-013-0278-7. 
2. Kraning-Rush C, Carey S, and Reinhart-King C. Microfabricated Collagen 
Tracks Facilitate Single Cell Metastatic Invasion in 3D. Integrative Biology, 
2013:5 606-16.  
3. Staunton, JR et al. (The Physical Sciences-Oncology Centers (PS-OC) Cell-
Line Project Team). A Physical Sciences Network Characterization of 
Nonmalignant and Metastatic Cells. Scientific Reports, 2013:3 1449. 
4. Kraning-Rush C and Reinhart-King C. Controlling matrix stiffness and 
topography for the study of tumor cell migration. Cell Adhesion & Migration, 
2012:6(3). 
5. Carey S, Kraning-Rush C, Williams R, and Reinhart-King C. Biophysical 
Control of Invasive Tumor Cell Behavior by Extracellular Matrix 
Microarchitecture. Biomaterials, 2012:33 4157-65.  
6. Kraning-Rush C, Carey S, Califano J, and Reinhart-King C. Methods in Cell 
Biology (Chapter: Quantifying Traction Stresses in Adherent Cells) Elsevier, 
New York, 2012:110 139-78.   
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7. Kraning-Rush C, Califano J, and Reinhart-King C. Cellular Traction Stresses 
Increase with Increasing Metastatic Potential. PLoS One, 2012:7(2) e32572.  
8. Kraning-Rush C, Carey S, Califano J, Smith B, and Reinhart-King C. The 
Role of the Cytoskeleton in Cellular Force Generation in 2D and 3D 
Environments. Physical Biology, 2011:8 015009. 
 
Previous Publications 
9. Ainslie K, Kraning C, and Desai T. Microfabrication of an Asymmetric, 
Multi-layered Microdevice for Controlled Release of Orally Delivered 
Therapeutics. Lab on a Chip, 2008:8 1042-1047. 
10. Kraning C, Benz T, Bloome K, Campanello G, Fahrenbach V, Mistry S, 
Hedge C, Clevenger K, Gligorich K, Hopkins T, Hoops G, Mendes S, Chang 
H-C, and Su M-C. Determination of Surface Coverage and Orientation of 
Reduced Cytochrome c on a Silica Surface with Polarized ATR Spectroscopy. 
Journal of Physical Chemistry C, 2007:111(35) 13062-13067. 
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